data_2mrf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mrf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -117.48 143.28 46.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 109.415 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.515 HG21 HG12 ' A' ' 216' ' ' ILE . 18.1 m -142.67 172.14 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 122.737 0.415 . . . . 0.0 110.19 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.85 147.11 29.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.188 0.995 . . . . 0.0 111.224 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.405 ' N ' HD13 ' A' ' 216' ' ' ILE . 7.0 t -85.58 106.56 9.71 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.173 0.989 . . . . 0.0 108.46 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.45 -23.83 33.01 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.291 2.661 . . . . 0.0 113.608 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.7 -54.8 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 C-N-CA 123.026 0.53 . . . . 0.0 111.986 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 12.4 p -108.3 -19.21 13.55 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.19 5.12 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 122.847 0.26 . . . . 0.0 113.696 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.85 147.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.284 0.634 . . . . 0.0 111.301 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.89 126.71 47.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.152 0.581 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.6 155.95 29.35 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.551 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 157.26 29.03 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.996 2.464 . . . . 0.0 112.953 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -39.14 40.96 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.44 1.496 . . . . 0.0 113.86 -167.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 52.7 p -68.07 -50.36 55.59 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.32 0.648 . . . . 0.0 111.041 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.35 -30.51 63.38 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.869 -172.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 211' ' ' ILE . 9.6 tp -77.42 -40.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.198 0.599 . . . . 0.0 110.948 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.44 -43.53 93.12 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.543 0.527 . . . . 0.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -43.38 90.15 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.407 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -52.03 67.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 123.334 0.396 . . . . 0.0 110.322 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.51 -30.73 68.64 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.788 0.68 . . . . 0.0 111.146 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.86 -47.86 76.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.806 0.842 . . . . 0.0 110.846 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.6 t -75.07 -26.75 59.59 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.993 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 36.1 m -77.78 -30.76 51.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.123 0.969 . . . . 0.0 111.65 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 124.097 0.959 . . . . 0.0 108.853 176.398 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.765 0.317 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.3 mttt -128.15 141.37 51.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.914 0.886 . . . . 0.0 109.248 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.58 HG23 HG12 ' A' ' 216' ' ' ILE . 12.1 m -140.73 158.79 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.561 0.344 . . . . 0.0 110.321 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.0 146.5 35.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.777 0.831 . . . . 0.0 110.011 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.49 ' HA ' HD13 ' A' ' 216' ' ' ILE . 8.0 t -82.58 107.69 9.85 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.774 0.83 . . . . 0.0 109.14 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.55 -27.98 53.06 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.647 2.231 . . . . 0.0 113.142 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 4.1 t -85.39 -43.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.973 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.92 -28.32 5.95 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 118.514 0.597 . . . . 0.0 112.333 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 101.57 23.69 9.28 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 136.51 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 117.625 0.712 . . . . 0.0 111.738 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -89.03 130.66 35.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 109.974 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 155.91 29.3 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 110.285 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 29.7 Cg_endo -59.54 155.21 43.26 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.988 2.459 . . . . 0.0 113.68 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -44.4 -38.48 4.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.676 1.99 . . . . 0.0 114.609 -170.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.9 p -71.01 -52.29 20.44 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.554 0.742 . . . . 0.0 111.25 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -74.1 -27.12 60.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.127 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 202' ' ' VAL . 7.3 tp -79.27 -40.91 22.39 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.174 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -57.38 -43.05 83.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.66 -48.48 79.16 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.388 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -53.97 47.41 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.871 0.468 . . . . 0.0 110.878 -172.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.406 HD23 HG13 ' A' ' 216' ' ' ILE . 3.3 pp -66.14 -31.47 72.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 124.13 0.894 . . . . 0.0 110.838 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.74 -57.87 8.63 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 0.0 110.197 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.5 t -63.93 -33.48 75.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.381 1.072 . . . . 0.0 110.837 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.7 m -69.46 -44.28 71.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 111.014 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.479 1.006 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.077 177.698 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -118.57 141.22 48.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.938 0.495 . . . . 0.0 110.785 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.579 HG23 HG12 ' A' ' 216' ' ' ILE . 15.9 m -142.4 160.63 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.996 0.918 . . . . 0.0 109.727 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.73 147.07 30.73 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.488 0.715 . . . . 0.0 110.283 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 216' ' ' ILE . 34.4 t -79.53 110.16 14.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.315 0.646 . . . . 0.0 110.327 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.96 -24.09 37.84 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.609 2.873 . . . . 0.0 113.61 -171.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 t -85.48 -55.27 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 0.0 111.703 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.01 -27.81 9.93 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.59 26.55 8.54 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.03 0.772 . . . . 0.0 115.03 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.48 134.76 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 117.434 0.617 . . . . 0.0 111.489 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -84.39 125.52 32.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.52 151.87 24.77 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.13 0.972 . . . . 0.0 110.876 -169.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.7 161.46 28.47 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.025 2.484 . . . . 0.0 112.689 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.52 -32.15 62.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.484 1.114 . . . . 0.0 112.674 -169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.7 p -66.25 -52.41 47.96 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.187 0.595 . . . . 0.0 111.017 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -76.74 -26.18 54.3 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.779 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 202' ' ' VAL . 5.6 tp -72.8 -43.92 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.849 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.53 -45.72 73.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.536 0.523 . . . . 0.0 109.869 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -67.4 -42.31 83.5 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.464 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -50.34 33.15 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.699 0.227 . . . . 0.0 111.079 -170.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.478 HD23 HG13 ' A' ' 216' ' ' ILE . 2.4 pp -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.708 0.63 . . . . 0.0 109.765 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.75 -52.79 61.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.92 0.888 . . . . 0.0 110.856 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.0 t -67.76 -27.99 67.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.817 1.247 . . . . 0.0 111.291 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 35.3 m -82.11 -26.43 33.57 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 111.353 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.686 0.795 . . . . 0.0 108.983 173.199 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.747 0.308 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.83 141.04 48.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.912 0.885 . . . . 0.0 108.805 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 216' ' ' ILE . 15.3 m -144.24 158.29 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.44 0.696 . . . . 0.0 109.602 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.17 145.23 33.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.286 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.442 ' HA ' ' CD1' ' A' ' 216' ' ' ILE . 46.1 t -80.36 109.57 13.25 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 110.093 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.32 -27.61 67.93 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.309 2.673 . . . . 0.0 113.392 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.4 t -87.79 -29.03 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.576 0 C-N-CA 123.59 0.756 . . . . 0.0 112.89 -173.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 18.9 p -129.5 -34.36 1.81 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.194 -0.941 . . . . 0.0 112.061 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 96.44 53.85 1.41 Allowed Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.822 0.289 . . . . 0.0 113.822 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.86 130.0 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.633 0.773 . . . . 0.0 109.872 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.56 126.0 30.32 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 215' ' ' HIS . 1.2 pt -154.29 151.76 24.9 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.64 161.38 24.87 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.929 2.42 . . . . 0.0 112.665 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.26 -31.22 53.07 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.47 1.106 . . . . 0.0 113.259 -169.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.6 p -66.86 -51.75 51.77 Favored 'General case' 0 C--O 1.25 1.129 0 C-N-CA 122.716 0.406 . . . . 0.0 111.087 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 211' ' ' ILE . 18.1 t-160 -74.48 -31.51 62.24 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.225 -171.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 202' ' ' VAL . 4.5 tp -67.78 -46.18 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.965 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -54.44 -46.59 73.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.623 0.577 . . . . 0.0 110.355 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -67.5 -40.86 85.2 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.52 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -70.73 -49.42 47.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.471 0.308 . . . . 0.0 110.49 -170.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.24 -31.83 72.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 109.642 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.87 -55.46 29.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.118 0.967 . . . . 0.0 111.073 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -69.9 -24.17 63.35 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.154 0.981 . . . . 0.0 111.201 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 34.2 m -81.37 -30.11 33.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.894 0.878 . . . . 0.0 111.062 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 110.792 -0.077 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.474 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.7 mttt -115.01 134.2 55.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.431 0.692 . . . . 0.0 110.514 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.04 173.42 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.871 0.868 . . . . 0.0 110.095 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -89.86 146.99 24.03 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.127 0.571 . . . . 0.0 111.019 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.527 ' HB2' HD11 ' A' ' 211' ' ' ILE . 15.5 t -79.27 117.82 69.1 Favored Pre-proline 0 C--O 1.219 -0.511 0 C-N-CA 123.792 0.837 . . . . 0.0 109.839 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.03 -28.43 87.04 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.972 2.448 . . . . 0.0 112.669 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.0 t -85.77 -46.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.372 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.418 ' SG ' HG23 ' A' ' 209' ' ' VAL . 18.4 p -111.78 -33.57 6.28 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.04 6.88 31.73 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.418 HG23 ' SG ' ' A' ' 207' ' ' CYS . 28.2 m -83.5 145.85 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 0.0 112.213 -176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.07 133.15 35.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 0.0 109.974 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.75 147.62 15.42 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.294 1.038 . . . . 0.0 109.979 -169.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.474 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 48.1 Cg_endo -66.82 161.7 40.89 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.428 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -53.29 -34.72 58.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.718 1.207 . . . . 0.0 113.573 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.7 p -68.6 -50.39 51.93 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.796 0.839 . . . . 0.0 110.817 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.2 t-160 -80.17 -17.31 52.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.912 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 204' ' ' CYS . 4.3 tp -76.36 -44.73 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.689 0.677 . . . . 0.0 109.708 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -53.46 -45.66 69.6 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 124.084 0.865 . . . . 0.0 109.572 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.47 -50.22 64.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.442 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -65.39 -44.99 85.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 117.92 0.327 . . . . 0.0 110.334 -168.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.03 -35.38 78.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.239 0.962 . . . . 0.0 109.478 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.78 -54.3 46.81 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.921 0.888 . . . . 0.0 110.312 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.8 t -62.77 -33.86 76.04 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.042 1.337 . . . . 0.0 111.409 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 30.4 m -79.36 -29.66 42.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.644 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.667 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 94.1 mttt -125.72 138.37 53.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.385 0.674 . . . . 0.0 110.211 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 216' ' ' ILE . 20.8 m -139.4 164.56 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.54 0.736 . . . . 0.0 109.784 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 147.5 28.88 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.621 0.768 . . . . 0.0 109.864 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.481 ' HA ' HD13 ' A' ' 216' ' ' ILE . 10.3 t -81.89 109.78 16.81 Favored Pre-proline 0 C--O 1.222 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 109.159 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.47 -23.17 62.82 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.19 2.593 . . . . 0.0 113.374 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 11.8 t -87.54 -38.05 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.434 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 209' ' ' VAL . 14.5 p -125.95 -29.2 3.11 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -170.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.18 -5.63 30.31 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.477 HG23 ' SG ' ' A' ' 207' ' ' CYS . 21.5 m -69.12 133.19 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 117.407 0.603 . . . . 0.0 111.773 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.26 124.06 30.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.571 0.748 . . . . 0.0 109.305 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.414 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.9 OUTLIER -150.93 151.47 29.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.595 0.758 . . . . 0.0 110.803 -169.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 39.4 Cg_endo -63.62 160.79 34.58 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.941 2.428 . . . . 0.0 112.797 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.97 -37.43 32.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.348 1.459 . . . . 0.0 113.736 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.2 m -67.71 -51.14 53.04 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.37 -32.17 68.18 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 202' ' ' VAL . 5.5 tp -70.87 -45.32 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -53.4 -45.85 69.47 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -66.91 -48.75 67.72 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.201 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -47.15 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.604 0.362 . . . . 0.0 110.388 -168.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -32.73 74.06 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 123.881 0.738 . . . . 0.0 109.682 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -57.59 12.3 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 123.269 0.628 . . . . 0.0 110.708 174.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.6 t -63.36 -30.94 71.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 36.1 m -79.18 -32.12 44.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.804 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.486 1.325 0 C-N-CA 123.481 0.712 . . . . 0.0 111.655 -170.282 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 90.3 mttt -124.26 143.84 50.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.365 0.666 . . . . 0.0 110.394 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 216' ' ' ILE . 19.0 m -142.43 163.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.678 0.791 . . . . 0.0 109.753 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 146.69 35.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.801 0.84 . . . . 0.0 110.967 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.512 ' HA ' HD11 ' A' ' 216' ' ' ILE . 9.8 t -84.01 107.74 11.6 Favored Pre-proline 0 C--O 1.218 -0.599 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -56.89 -25.7 63.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.885 2.39 . . . . 0.0 113.127 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.96 -43.98 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.625 0.77 . . . . 0.0 112.13 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' A' ' 209' ' ' VAL . 10.1 p -125.36 4.71 7.71 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -170.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.23 45.65 95.69 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 125.223 1.392 . . . . 0.0 115.208 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.457 HG22 ' SG ' ' A' ' 207' ' ' CYS . 27.6 m -117.48 128.69 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.17 126.07 31.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.414 0.685 . . . . 0.0 109.704 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -152.78 150.68 25.05 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.725 0.81 . . . . 0.0 111.472 -169.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 28.1 Cg_endo -60.49 156.98 38.55 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 123.192 2.595 . . . . 0.0 113.14 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.08 -39.04 12.27 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.229 1.812 . . . . 0.0 114.311 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 37.7 p -69.02 -51.65 36.94 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.317 0.58 . . . . 0.0 111.078 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 12.2 t60 -70.37 -32.29 69.91 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.549 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.669 HG12 HG22 ' A' ' 202' ' ' VAL . 5.0 tp -71.8 -46.09 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.494 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . 0.486 HD21 HG22 ' A' ' 216' ' ' ILE . 0.9 OUTLIER -57.11 -44.21 83.03 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.183 0.302 . . . . 0.0 110.329 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -69.52 -42.39 74.76 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.974 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -64.47 -50.46 67.4 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.583 -172.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.432 HD22 HG13 ' A' ' 216' ' ' ILE . 1.6 pp -69.19 -32.83 72.39 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.889 0.743 . . . . 0.0 110.096 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.42 -55.51 27.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.674 0.79 . . . . 0.0 110.115 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -64.96 -33.1 75.24 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 124.348 1.059 . . . . 0.0 110.674 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 32.7 m -73.61 -36.03 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.961 0.904 . . . . 0.0 111.314 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.586 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.504 0.192 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 91.8 mttt -126.91 132.47 50.88 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.147 0.579 . . . . 0.0 109.864 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 216' ' ' ILE . 30.4 m -135.79 164.03 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.561 0.744 . . . . 0.0 110.006 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.28 147.24 32.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.271 1.028 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.445 ' HA ' HD11 ' A' ' 216' ' ' ILE . 23.5 t -82.68 108.81 13.33 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.017 0.527 . . . . 0.0 109.764 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.42 -27.24 75.08 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.026 2.484 . . . . 0.0 113.231 -170.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.2 t -86.72 -36.53 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 123.304 0.642 . . . . 0.0 111.976 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.5 p -122.72 -37.54 2.75 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 118.571 0.623 . . . . 0.0 112.176 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.21 -3.34 14.1 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.8 140.02 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 118.425 1.112 . . . . 0.0 112.12 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.95 128.73 34.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -153.2 149.78 22.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.254 0.621 . . . . 0.0 111.025 -170.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 37.9 Cg_endo -63.33 161.7 29.88 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.871 2.381 . . . . 0.0 113.154 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.67 -41.92 44.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.05 1.74 . . . . 0.0 114.573 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.5 p -71.5 -43.56 66.29 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.262 0.553 . . . . 0.0 110.643 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 37.8 t-80 -75.14 -22.81 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.532 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -77.2 -45.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.554 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -51.26 -48.33 62.22 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.783 0.677 . . . . 0.0 110.558 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -69.98 -45.14 67.98 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.344 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -62.59 -51.51 67.02 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 117.869 0.304 . . . . 0.0 110.811 -173.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 216' ' ' ILE . 2.1 pp -64.21 -34.27 77.72 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.915 0.759 . . . . 0.0 110.162 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.36 -54.38 37.71 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.053 0.846 . . . . 0.0 111.289 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -65.37 -27.66 68.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.902 1.281 . . . . 0.0 110.981 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.421 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.1 m -80.66 -36.17 32.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.511 1.124 . . . . 0.0 111.811 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.511 0.725 . . . . 0.0 109.801 -176.109 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 93.2 mttt -116.52 137.82 51.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.168 0.587 . . . . 0.0 110.026 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.549 HG21 HG12 ' A' ' 216' ' ' ILE . 16.1 m -141.69 164.09 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.746 0.818 . . . . 0.0 110.125 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.64 146.56 34.01 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.495 1.118 . . . . 0.0 111.023 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.506 ' HA ' HD12 ' A' ' 216' ' ' ILE . 19.2 t -84.86 106.19 8.11 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 123.622 0.769 . . . . 0.0 109.154 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -54.32 -25.43 39.0 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.6 2.867 . . . . 0.0 113.62 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.79 -57.1 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.835 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.4 ' SG ' HG23 ' A' ' 209' ' ' VAL . 18.6 p -99.17 -31.34 11.79 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.07 0.395 . . . . 0.0 111.719 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.86 2.79 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.4 HG23 ' SG ' ' A' ' 207' ' ' CYS . 30.1 m -120.61 140.41 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.119 0.568 . . . . 0.0 110.853 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.58 133.71 35.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.897 0.479 . . . . 0.0 109.993 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.4 OUTLIER -157.16 149.43 17.74 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 0.0 110.483 -171.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 37.0 Cg_endo -61.62 159.14 33.66 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.963 2.442 . . . . 0.0 112.897 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -50.3 -37.66 37.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.278 1.431 . . . . 0.0 113.944 -170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.1 p -69.53 -50.82 41.45 Favored 'General case' 0 C--O 1.254 1.298 0 C-N-CA 123.043 0.537 . . . . 0.0 110.912 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.57 -31.43 69.6 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.368 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.549 HG12 HG21 ' A' ' 202' ' ' VAL . 5.7 tp -70.09 -42.42 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.887 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.32 -50.57 61.98 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.22 -42.01 72.85 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.236 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -51.33 61.66 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.455 HD21 HG13 ' A' ' 216' ' ' ILE . 1.9 pp -64.82 -35.32 80.73 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.819 0.7 . . . . 0.0 110.073 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.75 -52.96 61.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.654 0.74 . . . . 0.0 110.685 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -67.83 -25.27 65.48 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.706 1.202 . . . . 0.0 111.438 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.78 -36.55 28.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.286 1.034 . . . . 0.0 111.671 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.529 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.9 mttt -121.01 137.77 54.49 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.215 0.606 . . . . 0.0 110.552 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.58 HG23 HG12 ' A' ' 216' ' ' ILE . 16.0 m -141.66 161.71 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.584 0.754 . . . . 0.0 110.628 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.41 146.31 32.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.631 1.172 . . . . 0.0 110.918 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.529 ' HA ' HD11 ' A' ' 216' ' ' ILE . 20.1 t -84.01 109.79 21.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 123.599 0.76 . . . . 0.0 109.744 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.08 -23.3 60.2 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.27 2.647 . . . . 0.0 113.691 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 -50.28 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.484 0.713 . . . . 0.0 111.754 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.6 p -113.23 -26.36 8.44 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 94.39 41.67 4.16 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.25 136.9 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.109 0.564 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -86.14 127.64 34.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.982 0.513 . . . . 0.0 109.777 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -154.08 152.02 25.74 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.251 1.02 . . . . 0.0 110.361 -169.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 36.9 Cg_endo -61.25 160.04 28.42 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.198 2.599 . . . . 0.0 112.917 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -53.66 -34.89 60.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.038 1.335 . . . . 0.0 113.532 -168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 57.4 p -70.83 -47.73 57.84 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.38 0.672 . . . . 0.0 111.281 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -69.93 -34.37 73.38 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -73.29 -40.47 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.073 0.549 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -55.14 -46.49 75.68 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -66.93 -44.32 80.97 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.247 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -55.85 12.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.759 0.424 . . . . 0.0 110.567 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 216' ' ' ILE . 1.3 pp -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.94 0.775 . . . . 0.0 109.976 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.45 -57.63 11.93 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.081 0.863 . . . . 0.0 110.711 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 27.0 t -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.134 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 11.7 m -76.47 -46.03 28.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.107 0.963 . . . . 0.0 110.59 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 N--CA 1.476 0.852 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 -179.188 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.419 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.5 mttt -117.18 144.69 44.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.429 0.692 . . . . 0.0 109.754 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 216' ' ' ILE . 23.9 m -143.23 169.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 122.844 0.458 . . . . 0.0 110.087 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.09 147.69 26.05 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.6 0.76 . . . . 0.0 110.481 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.426 ' CA ' HD13 ' A' ' 216' ' ' ILE . 4.2 t -73.53 120.08 79.26 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.537 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.55 -25.26 80.3 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.204 1.936 . . . . 0.0 111.874 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.03 -55.61 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 C-N-CA 123.623 0.769 . . . . 0.0 111.956 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 7.9 p -120.05 7.08 10.81 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.58 2.39 80.26 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 162.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.55 138.12 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.702 0.751 . . . . 0.0 112.202 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -91.57 124.98 36.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 0.0 110.652 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.566 HG13 HD11 ' A' ' 216' ' ' ILE . 0.3 OUTLIER -155.76 158.44 31.76 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.312 1.045 . . . . 0.0 110.063 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.419 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 35.0 Cg_endo -61.62 158.95 34.45 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.039 2.493 . . . . 0.0 113.615 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -48.72 -34.85 12.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.887 1.675 . . . . 0.0 113.622 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -70.4 -52.78 19.89 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.562 0.745 . . . . 0.0 111.135 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -80.42 -23.66 40.18 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.531 -173.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 211' ' ' ILE . 9.8 tp -80.12 -37.48 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 117.853 0.297 . . . . 0.0 111.305 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.9 -42.19 99.7 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -62.41 -45.76 91.65 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.865 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -48.8 74.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.629 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 1.8 pp -65.69 -33.5 76.03 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 124.003 0.815 . . . . 0.0 110.299 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.64 -57.89 10.98 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.399 1.079 . . . . 0.0 110.989 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 t -65.54 -28.51 69.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.983 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 40.6 m -80.58 -31.46 36.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.931 0.892 . . . . 0.0 111.911 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 88.5 mttt -127.11 129.0 47.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.584 HG21 HG12 ' A' ' 216' ' ' ILE . 20.9 m -136.03 165.24 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 122.811 0.444 . . . . 0.0 110.423 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.68 146.25 36.16 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.373 1.069 . . . . 0.0 111.004 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.54 ' HA ' HD13 ' A' ' 216' ' ' ILE . 11.7 t -86.56 105.52 8.01 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.82 -24.74 32.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 123.407 2.738 . . . . 0.0 113.68 -171.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.71 -53.26 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.35 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.466 ' SG ' HG22 ' A' ' 209' ' ' VAL . 16.2 p -110.54 -15.51 13.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.03 49.89 6.14 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 123.452 0.549 . . . . 0.0 113.382 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.466 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.3 m -120.46 132.63 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 122.995 0.518 . . . . 0.0 110.123 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.83 129.27 34.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.6 OUTLIER -152.43 151.97 28.22 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.488 0.715 . . . . 0.0 111.053 -172.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 32.3 Cg_endo -60.89 158.7 32.39 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.859 2.372 . . . . 0.0 113.044 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.19 -38.53 40.39 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.203 1.401 . . . . 0.0 114.122 -167.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.3 p -69.64 -49.62 52.05 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-O 121.348 0.594 . . . . 0.0 110.805 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.95 -33.02 73.87 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.677 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.584 HG12 HG21 ' A' ' 202' ' ' VAL . 5.9 tp -72.87 -40.86 60.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.93 -50.03 64.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.043 0.449 . . . . 0.0 110.427 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.59 -43.59 76.14 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -52.8 55.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.419 -171.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.497 HD22 HG13 ' A' ' 216' ' ' ILE . 2.2 pp -66.85 -32.87 74.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.565 0.541 . . . . 0.0 110.332 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.81 -58.09 10.08 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.878 0.736 . . . . 0.0 110.952 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 42.7 t -69.87 -28.51 65.71 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.251 1.021 . . . . 0.0 111.592 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.51 -49.35 41.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.657 0.783 . . . . 0.0 111.185 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 123.103 0.561 . . . . 0.0 110.095 179.311 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -97.54 142.65 29.12 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.438 0.695 . . . . 0.0 109.937 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 216' ' ' ILE . 15.3 m -143.51 160.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.348 0.659 . . . . 0.0 109.979 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.51 147.31 30.91 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.348 1.059 . . . . 0.0 110.718 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.54 ' HA ' HD13 ' A' ' 216' ' ' ILE . 7.0 t -82.35 110.46 21.57 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.215 1.006 . . . . 0.0 109.473 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.95 -22.46 63.29 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.447 2.765 . . . . 0.0 113.036 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.22 -45.26 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 209' ' ' VAL . 15.3 p -118.86 -33.34 4.24 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -172.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.6 -17.18 9.56 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 168.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.452 HG23 ' SG ' ' A' ' 207' ' ' CYS . 30.5 m -67.19 135.27 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.45 128.86 36.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.681 0.792 . . . . 0.0 109.674 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.79 154.47 26.69 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 123.596 0.758 . . . . 0.0 110.493 -172.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.82 156.85 35.93 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.283 2.655 . . . . 0.0 113.218 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.42 -35.12 12.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.182 1.393 . . . . 0.0 113.875 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 13.2 p -70.62 -52.37 21.84 Favored 'General case' 0 C--O 1.252 1.22 0 C-N-CA 123.279 0.632 . . . . 0.0 111.679 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -75.06 -25.72 58.85 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.872 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 202' ' ' VAL . 7.2 tp -78.39 -39.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -57.18 -43.21 82.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.36 -45.3 80.58 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -52.97 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.415 0.286 . . . . 0.0 111.237 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.92 -30.41 70.55 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.743 0.652 . . . . 0.0 110.49 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.87 -55.06 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.005 0.816 . . . . 0.0 110.113 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.9 t -65.13 -26.52 68.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.935 1.294 . . . . 0.0 111.462 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.4 -39.57 24.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.385 1.074 . . . . 0.0 111.123 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.3 mttt -122.49 138.75 54.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.219 0.608 . . . . 0.0 109.605 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 216' ' ' ILE . 20.3 m -141.27 165.45 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.936 0.494 . . . . 0.0 110.473 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.65 147.81 31.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.72 1.208 . . . . 0.0 111.084 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.432 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.2 t -81.55 112.66 35.9 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.812 0.845 . . . . 0.0 109.079 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.62 -24.47 45.37 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.149 2.566 . . . . 0.0 113.183 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.33 -57.55 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.084 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -111.32 -19.03 12.78 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.17 -29.38 7.39 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 167.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.91 138.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.76 122.42 33.48 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.397 1.079 . . . . 0.0 110.139 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.579 HG13 HD12 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.59 159.45 33.28 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 123.602 0.761 . . . . 0.0 110.19 -176.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.492 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 37.7 Cg_endo -61.63 156.35 48.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.899 2.399 . . . . 0.0 113.401 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.01 -40.57 4.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.963 1.705 . . . . 0.0 114.551 -169.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.3 p -76.89 -46.51 24.21 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.808 0.443 . . . . 0.0 111.651 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -75.22 -23.44 57.58 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.383 0.273 . . . . 0.0 111.361 -174.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.579 HD12 HG13 ' A' ' 211' ' ' ILE . 9.8 tp -78.94 -41.9 23.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.949 0.5 . . . . 0.0 110.685 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -60.09 -39.25 85.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.903 0.383 . . . . 0.0 110.442 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -46.22 85.33 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 174.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.4 -47.7 78.18 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.347 0.404 . . . . 0.0 110.813 -173.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.47 -27.94 65.65 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.8 0.688 . . . . 0.0 110.997 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.65 -50.71 56.52 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 0.0 110.755 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.5 t -66.77 -31.53 72.23 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.645 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 56.9 m -78.88 -26.41 43.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.182 0.993 . . . . 0.0 111.08 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.4 tt . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.524 0.73 . . . . 0.0 109.385 172.162 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 91.5 mttt -119.93 138.23 53.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.836 0.854 . . . . 0.0 108.841 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 216' ' ' ILE . 18.7 m -138.84 160.34 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.866 0.467 . . . . 0.0 110.19 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -78.49 147.98 33.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.214 0.606 . . . . 0.0 110.346 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.508 ' HA ' HD12 ' A' ' 216' ' ' ILE . 5.0 t -76.13 112.51 21.12 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.16 -25.62 56.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.797 2.331 . . . . 0.0 112.542 -175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.2 -57.42 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.17 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.8 p -108.98 -19.37 13.42 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 204' ' ' CYS . . . 110.55 -19.48 26.29 Favored Glycine 0 N--CA 1.478 1.455 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 166.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.05 136.48 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.68 122.88 34.64 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.199 1.0 . . . . 0.0 110.527 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.483 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.33 156.57 35.03 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 123.711 0.805 . . . . 0.0 110.136 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 211' ' ' ILE . 20.3 Cg_endo -58.12 153.58 44.84 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 123.16 2.573 . . . . 0.0 113.374 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.99 -34.32 12.84 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.431 1.492 . . . . 0.0 114.551 -166.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.9 p -74.93 -50.46 16.72 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.784 0.434 . . . . 0.0 111.246 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -72.36 -30.07 64.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.694 0.398 . . . . 0.0 111.115 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 204' ' ' CYS . 8.2 tp -75.4 -36.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.99 -46.8 78.59 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.642 0.589 . . . . 0.0 109.975 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -62.25 -46.28 89.55 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.061 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -51.26 69.33 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.258 0.349 . . . . 0.0 110.994 -172.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -70.4 -27.2 64.11 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.677 0.611 . . . . 0.0 111.181 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.39 -54.54 16.52 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.191 0.932 . . . . 0.0 110.4 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 34.9 t -67.87 -24.66 65.26 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 52.0 m -81.24 -28.09 34.94 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.905 0.882 . . . . 0.0 111.382 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 120.706 0.288 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -113.28 136.4 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.083 0.553 . . . . 0.0 110.153 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 216' ' ' ILE . 19.4 m -138.91 165.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.353 0.661 . . . . 0.0 110.112 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.66 147.87 33.38 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.998 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.524 ' HA ' HD13 ' A' ' 216' ' ' ILE . 12.8 t -82.83 107.4 9.2 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.8 -26.63 67.55 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.963 2.442 . . . . 0.0 112.888 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.3 t -88.67 -31.15 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -128.62 -30.8 2.28 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.371 0.987 . . . . 0.0 112.45 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.44 -16.54 10.55 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 164.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.45 134.73 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.02 124.86 32.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.768 0.827 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.443 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.1 pt -153.9 152.54 27.08 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.987 0.915 . . . . 0.0 110.689 -169.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.83 162.4 28.83 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.661 2.241 . . . . 0.0 112.573 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.83 -32.19 30.73 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.868 1.267 . . . . 0.0 113.456 -171.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.3 p -68.99 -52.63 26.85 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.318 0.647 . . . . 0.0 111.514 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.7 t-160 -76.32 -25.07 54.41 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.023 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 202' ' ' VAL . 6.3 tp -74.39 -42.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 118.847 -0.597 . . . . 0.0 111.445 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -52.48 -48.02 66.16 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -65.13 -50.19 67.0 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.5 OUTLIER -67.21 -48.25 68.43 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.524 0.33 . . . . 0.0 110.514 -167.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.469 HD22 HG13 ' A' ' 216' ' ' ILE . 1.2 pp -67.15 -30.99 71.12 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.801 0.688 . . . . 0.0 109.999 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.73 -56.9 14.65 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.838 0.711 . . . . 0.0 110.418 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -64.05 -31.01 72.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.228 1.011 . . . . 0.0 111.424 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 59.7 m -77.45 -27.8 52.25 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.784 0.834 . . . . 0.0 110.898 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.4 tp . . . . . 0 CA--C 1.552 1.057 0 C-N-CA 123.268 0.627 . . . . 0.0 109.452 173.521 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.76 134.11 54.93 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.706 0.802 . . . . 0.0 109.095 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 216' ' ' ILE . 22.3 m -137.9 167.72 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 121.246 0.546 . . . . 0.0 110.486 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 147.47 32.97 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.929 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.599 ' HA ' HD11 ' A' ' 216' ' ' ILE . 14.8 t -87.21 110.99 37.9 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.168 0.587 . . . . 0.0 109.885 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -53.0 -31.72 54.71 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.43 2.753 . . . . 0.0 113.522 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 8.8 t -85.33 -45.9 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.762 -173.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.9 p -111.43 -34.47 6.1 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 118.464 0.575 . . . . 0.0 112.165 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.89 16.9 14.06 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 168.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.03 143.31 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 117.953 0.876 . . . . 0.0 112.046 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.7 130.02 34.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.371 0.668 . . . . 0.0 109.76 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.52 151.21 20.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.103 0.961 . . . . 0.0 110.744 -172.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.38 159.67 22.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.871 2.381 . . . . 0.0 113.228 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -49.41 -41.68 40.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.631 1.572 . . . . 0.0 114.194 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 35.5 p -66.86 -50.87 61.13 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.134 0.492 . . . . 0.0 110.792 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -66.83 -32.36 73.59 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.701 -173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 204' ' ' CYS . 6.2 tp -73.51 -43.54 55.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.797 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -52.95 -47.25 68.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.448 0.567 . . . . 0.0 110.717 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.34 -44.42 79.12 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.71 -54.91 36.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.307 0.379 . . . . 0.0 110.583 -173.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.529 HD22 HG13 ' A' ' 216' ' ' ILE . 3.5 pp -64.54 -32.26 73.83 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.03 0.831 . . . . 0.0 110.986 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.08 -56.87 10.53 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.963 0.789 . . . . 0.0 110.56 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 35.4 t -66.69 -24.43 66.26 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.989 0.916 . . . . 0.0 111.246 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.5 m -77.97 -37.54 47.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.794 0.838 . . . . 0.0 111.051 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.2 tp . . . . . 0 N--CA 1.479 0.991 0 C-N-CA 123.884 0.874 . . . . 0.0 109.981 177.247 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.8 mttt -126.31 132.42 51.64 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 216' ' ' ILE . 19.6 m -135.18 161.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.383 0.673 . . . . 0.0 109.796 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 146.49 31.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.689 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . 0.423 ' HB2' HD11 ' A' ' 211' ' ' ILE . 30.1 t -80.55 117.89 69.88 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.597 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.71 -26.43 82.15 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.911 2.408 . . . . 0.0 112.735 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 t -86.99 -57.83 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -103.96 -20.26 13.94 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.0 45.87 5.82 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.88 138.49 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.803 0.441 . . . . 0.0 110.742 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -79.08 131.03 36.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.423 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.5 OUTLIER -155.58 150.3 20.36 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 124.406 1.082 . . . . 0.0 110.008 -169.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 44.3 Cg_endo -64.67 161.38 35.96 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.446 2.097 . . . . 0.0 112.308 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.13 -38.76 58.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.036 1.335 . . . . 0.0 113.497 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.5 p -65.61 -48.28 72.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.414 0.626 . . . . 0.0 110.603 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 17.0 t-160 -76.38 -24.79 54.13 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.483 HG13 HD23 ' A' ' 220' ' ' LEU . 5.3 tp -74.06 -46.51 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.822 0.737 . . . . 0.0 110.546 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.44 -44.97 76.83 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.285 0.564 . . . . 0.0 110.248 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.98 -42.85 84.4 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.699 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -68.83 -54.69 14.32 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.921 0.488 . . . . 0.0 109.738 -172.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.483 HD23 HG13 ' A' ' 216' ' ' ILE . 1.8 pp -62.03 -32.65 73.17 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 124.2 0.937 . . . . 0.0 110.08 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.44 -57.93 10.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.8 0.84 . . . . 0.0 111.096 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -67.8 -26.36 66.05 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.246 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 57.9 m -80.74 -37.42 30.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.317 1.047 . . . . 0.0 111.344 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.078 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.358 0.123 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.416 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.8 mttt -112.25 143.68 42.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 0.0 109.492 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.52 HG21 HG12 ' A' ' 216' ' ' ILE . 17.2 m -143.5 170.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 122.661 0.385 . . . . 0.0 110.288 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.93 146.32 32.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.191 0.996 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . . . . . . . . . 14.5 t -85.21 100.04 1.07 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.714 0.806 . . . . 0.0 109.003 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -55.75 -18.08 20.07 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.224 2.616 . . . . 0.0 114.12 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.93 -56.95 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.133 0.573 . . . . 0.0 111.499 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 15.4 p -104.59 -34.16 8.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 97.73 53.82 1.27 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 114.314 0.486 . . . . 0.0 114.314 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.32 143.37 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.332 0.653 . . . . 0.0 110.57 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -95.88 122.23 38.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.373 0.669 . . . . 0.0 109.973 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.527 HG13 HD13 ' A' ' 216' ' ' ILE . 0.4 OUTLIER -155.28 155.19 29.67 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.416 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 18.5 Cg_endo -58.4 159.13 20.46 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.479 2.786 . . . . 0.0 113.976 178.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.94 -36.01 11.68 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.273 1.829 . . . . 0.0 114.552 -169.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.6 p -73.18 -51.07 19.16 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.372 0.669 . . . . 0.0 111.251 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -71.89 -32.06 67.05 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.532 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.527 HD13 HG13 ' A' ' 211' ' ' ILE . 10.8 tp -78.07 -38.49 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.615 0.366 . . . . 0.0 111.14 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.17 -42.4 98.5 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.63 0.581 . . . . 0.0 109.468 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.15 -46.75 79.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.629 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.15 -45.36 92.25 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 119.554 -0.26 . . . . 0.0 110.885 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.94 -32.94 63.73 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.35 0.406 . . . . 0.0 110.677 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.26 -52.75 44.48 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.208 0.943 . . . . 0.0 109.96 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.8 t -60.47 -45.94 91.9 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.261 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.1 m -62.93 -32.85 74.24 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.84 0.856 . . . . 0.0 112.485 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.484 1.244 0 C-N-CA 123.517 0.727 . . . . 0.0 110.121 -178.595 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -122.73 140.92 52.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.541 0.736 . . . . 0.0 109.143 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.574 HG21 HG12 ' A' ' 216' ' ' ILE . 15.5 m -142.38 167.16 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.576 0.35 . . . . 0.0 110.337 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.71 145.37 34.55 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.565 1.146 . . . . 0.0 110.928 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.82 106.95 7.86 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.1 -17.52 32.1 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.692 2.262 . . . . 0.0 113.22 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.91 -57.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.823 0.849 . . . . 0.0 112.224 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 10.8 p -115.41 -3.24 12.44 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -166.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.4 34.27 45.81 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.27 136.28 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 117.046 0.423 . . . . 0.0 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.74 129.2 36.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.992 0.517 . . . . 0.0 109.761 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.576 HG13 HD11 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -155.62 156.02 30.28 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.907 0.883 . . . . 0.0 110.045 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.45 157.62 17.99 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.402 2.735 . . . . 0.0 114.218 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.41 -37.71 17.73 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.238 1.815 . . . . 0.0 113.775 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.9 p -67.2 -52.9 35.51 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.384 0.611 . . . . 0.0 111.309 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' HIS . . . . . 0.485 ' HD2' HG23 ' A' ' 211' ' ' ILE . 50.9 t60 -80.57 -22.44 40.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.57 -172.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 211' ' ' ILE . 10.1 tp -79.44 -43.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.569 0.347 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.24 -43.49 86.45 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.494 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -53.19 59.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.701 0.401 . . . . 0.0 110.553 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.1 -30.71 69.95 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.906 0.754 . . . . 0.0 110.699 -172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.23 -57.88 10.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.89 0.876 . . . . 0.0 110.589 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.6 t -68.19 -27.87 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.035 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.38 -39.61 58.96 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 0.0 111.045 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 CA-C-O 119.927 -0.374 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.6 p -72.12 82.4 0.98 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.179 0.592 . . . . 0.0 110.384 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -152.93 -74.22 0.13 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -160.84 109.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.163 1.385 . . . . 0.0 107.896 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -164.7 131.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 0.0 109.95 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 9.0 t -112.78 150.7 31.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.422 0.689 . . . . 0.0 110.199 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -117.48 143.28 46.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 109.415 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.515 HG21 HG12 ' A' ' 216' ' ' ILE . 18.1 m -142.67 172.14 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 122.737 0.415 . . . . 0.0 110.19 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.85 147.11 29.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.188 0.995 . . . . 0.0 111.224 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.405 ' N ' HD13 ' A' ' 216' ' ' ILE . 7.0 t -85.58 106.56 9.71 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.173 0.989 . . . . 0.0 108.46 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.45 -23.83 33.01 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.291 2.661 . . . . 0.0 113.608 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.7 -54.8 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 C-N-CA 123.026 0.53 . . . . 0.0 111.986 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 12.4 p -108.3 -19.21 13.55 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.19 5.12 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 122.847 0.26 . . . . 0.0 113.696 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.85 147.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.284 0.634 . . . . 0.0 111.301 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.89 126.71 47.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.152 0.581 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.562 HG13 HD11 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.6 155.95 29.35 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.551 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 157.26 29.03 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.996 2.464 . . . . 0.0 112.953 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -39.14 40.96 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.44 1.496 . . . . 0.0 113.86 -167.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 52.7 p -68.07 -50.36 55.59 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.32 0.648 . . . . 0.0 111.041 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.35 -30.51 63.38 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.869 -172.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 211' ' ' ILE . 9.6 tp -77.42 -40.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.198 0.599 . . . . 0.0 110.948 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.44 -43.53 93.12 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.543 0.527 . . . . 0.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -43.38 90.15 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.407 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -52.03 67.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 123.334 0.396 . . . . 0.0 110.322 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.51 -30.73 68.64 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.788 0.68 . . . . 0.0 111.146 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.86 -47.86 76.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.806 0.842 . . . . 0.0 110.846 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.6 t -75.07 -26.75 59.59 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.993 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 36.1 m -77.78 -30.76 51.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.123 0.969 . . . . 0.0 111.65 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.54 -27.24 66.03 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.097 0.959 . . . . 0.0 108.853 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 48.1 m -87.42 -52.99 5.06 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.688 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -133.08 82.7 2.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.038 0.535 . . . . 0.0 111.543 -171.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 124.611 1.164 . . . . 0.0 113.895 165.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.5 m -68.99 95.08 0.68 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.532 0.733 . . . . 0.0 111.046 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -76.71 -36.3 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.875 0.87 . . . . 0.0 110.634 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -97.71 107.72 20.27 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.34 121.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 125.186 1.394 . . . . 0.0 107.284 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.5 t -80.46 142.46 34.25 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.765 0.317 . . . . 0.0 110.297 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.3 mttt -128.15 141.37 51.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.914 0.886 . . . . 0.0 109.248 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.58 HG23 HG12 ' A' ' 216' ' ' ILE . 12.1 m -140.73 158.79 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.561 0.344 . . . . 0.0 110.321 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.0 146.5 35.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.777 0.831 . . . . 0.0 110.011 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.49 ' HA ' HD13 ' A' ' 216' ' ' ILE . 8.0 t -82.58 107.69 9.85 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.774 0.83 . . . . 0.0 109.14 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.55 -27.98 53.06 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.647 2.231 . . . . 0.0 113.142 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 4.1 t -85.39 -43.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.973 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.92 -28.32 5.95 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 118.514 0.597 . . . . 0.0 112.333 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 101.57 23.69 9.28 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 136.51 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 117.625 0.712 . . . . 0.0 111.738 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -89.03 130.66 35.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 109.974 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 155.91 29.3 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 110.285 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 29.7 Cg_endo -59.54 155.21 43.26 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.988 2.459 . . . . 0.0 113.68 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -44.4 -38.48 4.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.676 1.99 . . . . 0.0 114.609 -170.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.9 p -71.01 -52.29 20.44 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.554 0.742 . . . . 0.0 111.25 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -74.1 -27.12 60.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.127 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 202' ' ' VAL . 7.3 tp -79.27 -40.91 22.39 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.174 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -57.38 -43.05 83.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.66 -48.48 79.16 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.388 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -53.97 47.41 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.871 0.468 . . . . 0.0 110.878 -172.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.406 HD23 HG13 ' A' ' 216' ' ' ILE . 3.3 pp -66.14 -31.47 72.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 124.13 0.894 . . . . 0.0 110.838 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.74 -57.87 8.63 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 0.0 110.197 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.5 t -63.93 -33.48 75.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.381 1.072 . . . . 0.0 110.837 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.7 m -69.46 -44.28 71.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 111.014 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.36 -33.43 75.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.077 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 20.5 t -83.67 -9.69 58.69 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.029 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -83.29 -47.61 11.32 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.813 0.445 . . . . 0.0 109.883 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--O 1.247 0.94 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.841 -178.157 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.8 m -67.78 144.87 55.18 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.634 0.773 . . . . 0.0 110.468 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.24 100.67 2.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.4 0.68 . . . . 0.0 109.873 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.25 139.49 57.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.241 0.616 . . . . 0.0 111.033 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.517 HG21 ' HG2' ' A' ' 213' ' ' GLU . 7.6 p -171.83 119.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.159 0.983 . . . . 0.0 108.36 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.7 t -82.82 147.17 28.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.829 0.452 . . . . 0.0 110.505 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -118.57 141.22 48.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.938 0.495 . . . . 0.0 110.785 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.579 HG23 HG12 ' A' ' 216' ' ' ILE . 15.9 m -142.4 160.63 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.996 0.918 . . . . 0.0 109.727 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.73 147.07 30.73 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.488 0.715 . . . . 0.0 110.283 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 216' ' ' ILE . 34.4 t -79.53 110.16 14.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.315 0.646 . . . . 0.0 110.327 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.96 -24.09 37.84 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.609 2.873 . . . . 0.0 113.61 -171.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 t -85.48 -55.27 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 0.0 111.703 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.01 -27.81 9.93 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.59 26.55 8.54 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.03 0.772 . . . . 0.0 115.03 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.48 134.76 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 117.434 0.617 . . . . 0.0 111.489 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -84.39 125.52 32.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.52 151.87 24.77 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.13 0.972 . . . . 0.0 110.876 -169.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.7 161.46 28.47 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.025 2.484 . . . . 0.0 112.689 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.517 ' HG2' HG21 ' A' ' 199' ' ' VAL . 11.6 pt-20 -55.52 -32.15 62.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.484 1.114 . . . . 0.0 112.674 -169.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.7 p -66.25 -52.41 47.96 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.187 0.595 . . . . 0.0 111.017 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -76.74 -26.18 54.3 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.779 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 202' ' ' VAL . 5.6 tp -72.8 -43.92 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.849 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.53 -45.72 73.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.536 0.523 . . . . 0.0 109.869 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -67.4 -42.31 83.5 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.464 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -50.34 33.15 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.699 0.227 . . . . 0.0 111.079 -170.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.478 HD23 HG13 ' A' ' 216' ' ' ILE . 2.4 pp -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.708 0.63 . . . . 0.0 109.765 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.75 -52.79 61.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.92 0.888 . . . . 0.0 110.856 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.0 t -67.76 -27.99 67.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.817 1.247 . . . . 0.0 111.291 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 35.3 m -82.11 -26.43 33.57 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 111.353 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.36 -19.33 36.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.686 0.795 . . . . 0.0 108.983 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 30.4 t -83.32 -44.66 14.65 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.97 0.908 . . . . 0.0 110.618 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -118.45 -171.36 2.07 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 174.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 CA-C-O 119.857 -0.413 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 33.6 t -74.0 122.14 22.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.762 0.825 . . . . 0.0 110.474 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.23 175.14 5.54 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.985 0.914 . . . . 0.0 109.349 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -75.24 97.91 3.65 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.648 0.737 . . . . 0.0 110.2 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.6 p -163.35 132.9 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 125.531 1.532 . . . . 0.0 107.492 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.9 t -96.53 142.23 28.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.532 0.333 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.83 141.04 48.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.912 0.885 . . . . 0.0 108.805 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 216' ' ' ILE . 15.3 m -144.24 158.29 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.44 0.696 . . . . 0.0 109.602 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.17 145.23 33.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.286 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.442 ' HA ' ' CD1' ' A' ' 216' ' ' ILE . 46.1 t -80.36 109.57 13.25 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 110.093 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.32 -27.61 67.93 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.309 2.673 . . . . 0.0 113.392 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.4 t -87.79 -29.03 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.576 0 C-N-CA 123.59 0.756 . . . . 0.0 112.89 -173.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 18.9 p -129.5 -34.36 1.81 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.194 -0.941 . . . . 0.0 112.061 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 96.44 53.85 1.41 Allowed Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.822 0.289 . . . . 0.0 113.822 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.86 130.0 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.633 0.773 . . . . 0.0 109.872 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.56 126.0 30.32 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 215' ' ' HIS . 1.2 pt -154.29 151.76 24.9 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.64 161.38 24.87 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.929 2.42 . . . . 0.0 112.665 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.26 -31.22 53.07 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.47 1.106 . . . . 0.0 113.259 -169.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.6 p -66.86 -51.75 51.77 Favored 'General case' 0 C--O 1.25 1.129 0 C-N-CA 122.716 0.406 . . . . 0.0 111.087 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 211' ' ' ILE . 18.1 t-160 -74.48 -31.51 62.24 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.225 -171.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.528 HG12 HG22 ' A' ' 202' ' ' VAL . 4.5 tp -67.78 -46.18 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.965 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -54.44 -46.59 73.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.623 0.577 . . . . 0.0 110.355 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -67.5 -40.86 85.2 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.52 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -70.73 -49.42 47.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.471 0.308 . . . . 0.0 110.49 -170.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.24 -31.83 72.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 109.642 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.87 -55.46 29.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.118 0.967 . . . . 0.0 111.073 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -69.9 -24.17 63.35 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.154 0.981 . . . . 0.0 111.201 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 34.2 m -81.37 -30.11 33.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.894 0.878 . . . . 0.0 111.062 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.79 -25.11 56.11 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 37.1 t -76.84 -67.91 0.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.881 0.872 . . . . 0.0 110.197 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -103.14 151.56 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.167 0.587 . . . . 0.0 110.659 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 123.719 0.808 . . . . 0.0 109.458 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.46 ' HB2' ' HA ' ' A' ' 200' ' ' THR . 33.0 m -69.12 103.68 1.95 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.828 0.851 . . . . 0.0 110.557 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -67.75 -40.59 84.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.53 -42.69 86.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.28 0.632 . . . . 0.0 111.096 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 213' ' ' GLU . 8.2 p -175.15 108.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-O 122.364 1.078 . . . . 0.0 109.39 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 196' ' ' SER . 1.9 m -74.86 132.8 41.78 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.474 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.7 mttt -115.01 134.2 55.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.431 0.692 . . . . 0.0 110.514 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.04 173.42 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.871 0.868 . . . . 0.0 110.095 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -89.86 146.99 24.03 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.127 0.571 . . . . 0.0 111.019 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.527 ' HB2' HD11 ' A' ' 211' ' ' ILE . 15.5 t -79.27 117.82 69.1 Favored Pre-proline 0 C--O 1.219 -0.511 0 C-N-CA 123.792 0.837 . . . . 0.0 109.839 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.03 -28.43 87.04 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.972 2.448 . . . . 0.0 112.669 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.0 t -85.77 -46.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.372 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.418 ' SG ' HG23 ' A' ' 209' ' ' VAL . 18.4 p -111.78 -33.57 6.28 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.04 6.88 31.73 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.418 HG23 ' SG ' ' A' ' 207' ' ' CYS . 28.2 m -83.5 145.85 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 0.0 112.213 -176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.07 133.15 35.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 0.0 109.974 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.75 147.62 15.42 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.294 1.038 . . . . 0.0 109.979 -169.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.474 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 48.1 Cg_endo -66.82 161.7 40.89 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.428 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.461 ' HG2' HG22 ' A' ' 199' ' ' VAL . 12.2 pt-20 -53.29 -34.72 58.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.718 1.207 . . . . 0.0 113.573 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.7 p -68.6 -50.39 51.93 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.796 0.839 . . . . 0.0 110.817 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.2 t-160 -80.17 -17.31 52.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.912 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 204' ' ' CYS . 4.3 tp -76.36 -44.73 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.689 0.677 . . . . 0.0 109.708 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -53.46 -45.66 69.6 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 124.084 0.865 . . . . 0.0 109.572 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.47 -50.22 64.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.442 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -65.39 -44.99 85.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 117.92 0.327 . . . . 0.0 110.334 -168.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.03 -35.38 78.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.239 0.962 . . . . 0.0 109.478 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.78 -54.3 46.81 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.921 0.888 . . . . 0.0 110.312 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.8 t -62.77 -33.86 76.04 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.042 1.337 . . . . 0.0 111.409 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 30.4 m -79.36 -29.66 42.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.644 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.49 -27.36 51.85 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.8 t -73.67 -44.83 55.68 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.736 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -96.99 178.85 5.14 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.75 0.82 . . . . 0.0 111.311 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.312 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.6 p -74.27 87.31 1.97 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 110.585 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.53 -63.6 1.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.806 0.842 . . . . 0.0 109.376 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.68 94.27 4.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.96 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.03 133.99 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.488 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t -103.66 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 94.1 mttt -125.72 138.37 53.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.385 0.674 . . . . 0.0 110.211 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 216' ' ' ILE . 20.8 m -139.4 164.56 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.54 0.736 . . . . 0.0 109.784 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 147.5 28.88 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.621 0.768 . . . . 0.0 109.864 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.481 ' HA ' HD13 ' A' ' 216' ' ' ILE . 10.3 t -81.89 109.78 16.81 Favored Pre-proline 0 C--O 1.222 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 109.159 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.47 -23.17 62.82 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.19 2.593 . . . . 0.0 113.374 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 11.8 t -87.54 -38.05 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.434 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 209' ' ' VAL . 14.5 p -125.95 -29.2 3.11 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -170.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.18 -5.63 30.31 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.477 HG23 ' SG ' ' A' ' 207' ' ' CYS . 21.5 m -69.12 133.19 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 117.407 0.603 . . . . 0.0 111.773 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.26 124.06 30.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.571 0.748 . . . . 0.0 109.305 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.414 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.9 OUTLIER -150.93 151.47 29.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.595 0.758 . . . . 0.0 110.803 -169.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 39.4 Cg_endo -63.62 160.79 34.58 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.941 2.428 . . . . 0.0 112.797 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.97 -37.43 32.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.348 1.459 . . . . 0.0 113.736 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.2 m -67.71 -51.14 53.04 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.37 -32.17 68.18 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 202' ' ' VAL . 5.5 tp -70.87 -45.32 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -53.4 -45.85 69.47 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -66.91 -48.75 67.72 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.201 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -47.15 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.604 0.362 . . . . 0.0 110.388 -168.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -32.73 74.06 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 123.881 0.738 . . . . 0.0 109.682 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -57.59 12.3 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 123.269 0.628 . . . . 0.0 110.708 174.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.6 t -63.36 -30.94 71.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 36.1 m -79.18 -32.12 44.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.804 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.57 -26.8 68.57 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.481 0.712 . . . . 0.0 111.655 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 51.8 p -95.12 -7.23 39.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.655 0.782 . . . . 0.0 111.668 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -130.98 168.76 16.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.781 0.832 . . . . 0.0 111.05 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.13 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.48 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 32.4 m -77.79 100.17 6.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.537 0.735 . . . . 0.0 110.17 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -63.1 107.49 1.04 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -117.57 165.44 13.57 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.968 0.907 . . . . 0.0 110.684 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.4 p -154.81 115.1 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.401 1.081 . . . . 0.0 108.294 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t -79.85 146.99 31.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.482 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 90.3 mttt -124.26 143.84 50.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.365 0.666 . . . . 0.0 110.394 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.669 HG22 HG12 ' A' ' 216' ' ' ILE . 19.0 m -142.43 163.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.678 0.791 . . . . 0.0 109.753 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 146.69 35.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.801 0.84 . . . . 0.0 110.967 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.512 ' HA ' HD11 ' A' ' 216' ' ' ILE . 9.8 t -84.01 107.74 11.6 Favored Pre-proline 0 C--O 1.218 -0.599 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -56.89 -25.7 63.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.885 2.39 . . . . 0.0 113.127 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.96 -43.98 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.625 0.77 . . . . 0.0 112.13 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.457 ' SG ' HG22 ' A' ' 209' ' ' VAL . 10.1 p -125.36 4.71 7.71 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -170.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.23 45.65 95.69 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 125.223 1.392 . . . . 0.0 115.208 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.457 HG22 ' SG ' ' A' ' 207' ' ' CYS . 27.6 m -117.48 128.69 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 175.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.17 126.07 31.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.414 0.685 . . . . 0.0 109.704 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -152.78 150.68 25.05 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.725 0.81 . . . . 0.0 111.472 -169.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 28.1 Cg_endo -60.49 156.98 38.55 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 123.192 2.595 . . . . 0.0 113.14 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.08 -39.04 12.27 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.229 1.812 . . . . 0.0 114.311 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 37.7 p -69.02 -51.65 36.94 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.317 0.58 . . . . 0.0 111.078 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 12.2 t60 -70.37 -32.29 69.91 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.549 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.669 HG12 HG22 ' A' ' 202' ' ' VAL . 5.0 tp -71.8 -46.09 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.494 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.486 HD21 HG22 ' A' ' 216' ' ' ILE . 0.9 OUTLIER -57.11 -44.21 83.03 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.183 0.302 . . . . 0.0 110.329 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -69.52 -42.39 74.76 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.974 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -64.47 -50.46 67.4 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.583 -172.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.432 HD22 HG13 ' A' ' 216' ' ' ILE . 1.6 pp -69.19 -32.83 72.39 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.889 0.743 . . . . 0.0 110.096 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.42 -55.51 27.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.674 0.79 . . . . 0.0 110.115 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -64.96 -33.1 75.24 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 124.348 1.059 . . . . 0.0 110.674 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 32.7 m -73.61 -36.03 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.961 0.904 . . . . 0.0 111.314 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.72 -32.52 69.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.9 t -82.72 -34.11 27.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.978 0.911 . . . . 0.0 111.249 -174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -161.03 142.37 11.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.921 0.888 . . . . 0.0 109.071 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.251 1.153 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.5 p -69.12 138.67 54.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.686 0.794 . . . . 0.0 111.603 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -127.4 -179.43 4.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.538 1.135 . . . . 0.0 110.243 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 66.08 17.06 10.68 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.056 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.26 114.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.834 0 C-N-CA 124.747 1.219 . . . . 0.0 107.779 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.6 t -73.93 136.94 43.32 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 91.8 mttt -126.91 132.47 50.88 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.147 0.579 . . . . 0.0 109.864 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.532 HG23 HG12 ' A' ' 216' ' ' ILE . 30.4 m -135.79 164.03 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.561 0.744 . . . . 0.0 110.006 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.28 147.24 32.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.271 1.028 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.445 ' HA ' HD11 ' A' ' 216' ' ' ILE . 23.5 t -82.68 108.81 13.33 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.017 0.527 . . . . 0.0 109.764 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.42 -27.24 75.08 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.026 2.484 . . . . 0.0 113.231 -170.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.2 t -86.72 -36.53 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 123.304 0.642 . . . . 0.0 111.976 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.5 p -122.72 -37.54 2.75 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 118.571 0.623 . . . . 0.0 112.176 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.21 -3.34 14.1 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.8 140.02 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 118.425 1.112 . . . . 0.0 112.12 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.95 128.73 34.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -153.2 149.78 22.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.254 0.621 . . . . 0.0 111.025 -170.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 37.9 Cg_endo -63.33 161.7 29.88 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.871 2.381 . . . . 0.0 113.154 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.67 -41.92 44.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.05 1.74 . . . . 0.0 114.573 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.5 p -71.5 -43.56 66.29 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.262 0.553 . . . . 0.0 110.643 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 37.8 t-80 -75.14 -22.81 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.532 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -77.2 -45.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.554 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -51.26 -48.33 62.22 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.783 0.677 . . . . 0.0 110.558 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -69.98 -45.14 67.98 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.344 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -62.59 -51.51 67.02 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 117.869 0.304 . . . . 0.0 110.811 -173.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 216' ' ' ILE . 2.1 pp -64.21 -34.27 77.72 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.915 0.759 . . . . 0.0 110.162 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.36 -54.38 37.71 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.053 0.846 . . . . 0.0 111.289 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -65.37 -27.66 68.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.902 1.281 . . . . 0.0 110.981 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.421 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.1 m -80.66 -36.17 32.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.511 1.124 . . . . 0.0 111.811 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -76.67 -30.38 56.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.511 0.725 . . . . 0.0 109.801 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 55.3 p -69.45 -50.41 45.84 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.15 -173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -137.6 138.41 39.5 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 123.07 0.548 . . . . 0.0 109.83 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.1 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 25.4 m -76.36 122.17 24.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.755 0.822 . . . . 0.0 110.728 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.41 62.61 7.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 122.043 0.925 . . . . 0.0 109.442 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -140.95 -53.55 0.48 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 12.7 p -172.81 125.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.601 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.8 t -83.08 129.34 35.02 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 93.2 mttt -116.52 137.82 51.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.168 0.587 . . . . 0.0 110.026 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.549 HG21 HG12 ' A' ' 216' ' ' ILE . 16.1 m -141.69 164.09 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.746 0.818 . . . . 0.0 110.125 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.64 146.56 34.01 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.495 1.118 . . . . 0.0 111.023 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.506 ' HA ' HD12 ' A' ' 216' ' ' ILE . 19.2 t -84.86 106.19 8.11 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 123.622 0.769 . . . . 0.0 109.154 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -54.32 -25.43 39.0 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.6 2.867 . . . . 0.0 113.62 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.79 -57.1 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.835 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.4 ' SG ' HG23 ' A' ' 209' ' ' VAL . 18.6 p -99.17 -31.34 11.79 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.07 0.395 . . . . 0.0 111.719 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.86 2.79 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.4 HG23 ' SG ' ' A' ' 207' ' ' CYS . 30.1 m -120.61 140.41 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.119 0.568 . . . . 0.0 110.853 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.58 133.71 35.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.897 0.479 . . . . 0.0 109.993 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.4 OUTLIER -157.16 149.43 17.74 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 0.0 110.483 -171.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 37.0 Cg_endo -61.62 159.14 33.66 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.963 2.442 . . . . 0.0 112.897 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -50.3 -37.66 37.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.278 1.431 . . . . 0.0 113.944 -170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.1 p -69.53 -50.82 41.45 Favored 'General case' 0 C--O 1.254 1.298 0 C-N-CA 123.043 0.537 . . . . 0.0 110.912 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.57 -31.43 69.6 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.368 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.549 HG12 HG21 ' A' ' 202' ' ' VAL . 5.7 tp -70.09 -42.42 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.887 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.32 -50.57 61.98 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.22 -42.01 72.85 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.236 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -51.33 61.66 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.455 HD21 HG13 ' A' ' 216' ' ' ILE . 1.9 pp -64.82 -35.32 80.73 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.819 0.7 . . . . 0.0 110.073 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.75 -52.96 61.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.654 0.74 . . . . 0.0 110.685 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -67.83 -25.27 65.48 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.706 1.202 . . . . 0.0 111.438 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.78 -36.55 28.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.286 1.034 . . . . 0.0 111.671 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.12 -26.48 62.13 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 35.4 t -87.37 -68.03 0.78 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.296 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -95.7 97.4 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.252 1.225 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.931 178.425 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 CA-C-O 120.058 -0.301 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 36.7 m -67.9 104.42 1.71 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.726 0.81 . . . . 0.0 110.72 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -67.2 149.61 50.22 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.679 0.792 . . . . 0.0 109.564 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -66.37 -31.01 71.53 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.457 HG21 ' HG2' ' A' ' 213' ' ' GLU . 7.6 p -167.93 117.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.946 1.298 . . . . 0.0 108.328 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.6 t -80.15 144.31 33.13 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.263 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.9 mttt -121.01 137.77 54.49 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.215 0.606 . . . . 0.0 110.552 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.58 HG23 HG12 ' A' ' 216' ' ' ILE . 16.0 m -141.66 161.71 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.584 0.754 . . . . 0.0 110.628 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.41 146.31 32.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.631 1.172 . . . . 0.0 110.918 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.529 ' HA ' HD11 ' A' ' 216' ' ' ILE . 20.1 t -84.01 109.79 21.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 123.599 0.76 . . . . 0.0 109.744 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.08 -23.3 60.2 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.27 2.647 . . . . 0.0 113.691 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 -50.28 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.484 0.713 . . . . 0.0 111.754 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.6 p -113.23 -26.36 8.44 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 94.39 41.67 4.16 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.25 136.9 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.109 0.564 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -86.14 127.64 34.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.982 0.513 . . . . 0.0 109.777 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -154.08 152.02 25.74 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.251 1.02 . . . . 0.0 110.361 -169.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 36.9 Cg_endo -61.25 160.04 28.42 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.198 2.599 . . . . 0.0 112.917 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.457 ' HG2' HG21 ' A' ' 199' ' ' VAL . 12.2 pt-20 -53.66 -34.89 60.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.038 1.335 . . . . 0.0 113.532 -168.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 57.4 p -70.83 -47.73 57.84 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.38 0.672 . . . . 0.0 111.281 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -69.93 -34.37 73.38 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -73.29 -40.47 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.073 0.549 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -55.14 -46.49 75.68 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -66.93 -44.32 80.97 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.247 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -55.85 12.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.759 0.424 . . . . 0.0 110.567 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.427 HD21 HG13 ' A' ' 216' ' ' ILE . 1.3 pp -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.94 0.775 . . . . 0.0 109.976 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.45 -57.63 11.93 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.081 0.863 . . . . 0.0 110.711 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 27.0 t -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.134 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 11.7 m -76.47 -46.03 28.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.107 0.963 . . . . 0.0 110.59 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.25 -32.35 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 68.6 p -89.35 -12.67 39.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.432 0.693 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -69.98 -35.18 74.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 C--O 1.254 1.308 0 C-N-CA 123.977 0.911 . . . . 0.0 111.482 -177.88 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.011 0 N-CA-C 112.346 -0.302 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.3 p -83.52 79.62 9.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 110.273 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -88.17 111.68 21.89 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.611 0.765 . . . . 0.0 109.401 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -72.48 99.72 2.55 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.135 0.574 . . . . 0.0 110.038 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' A' ' 213' ' ' GLU . 4.3 p -163.12 121.21 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.23 1.012 . . . . 0.0 109.442 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t -92.86 151.0 20.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.293 0.637 . . . . 0.0 110.225 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.419 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.5 mttt -117.18 144.69 44.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.429 0.692 . . . . 0.0 109.754 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 216' ' ' ILE . 23.9 m -143.23 169.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 122.844 0.458 . . . . 0.0 110.087 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.09 147.69 26.05 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.6 0.76 . . . . 0.0 110.481 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.426 ' CA ' HD13 ' A' ' 216' ' ' ILE . 4.2 t -73.53 120.08 79.26 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.537 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.55 -25.26 80.3 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.204 1.936 . . . . 0.0 111.874 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.03 -55.61 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 C-N-CA 123.623 0.769 . . . . 0.0 111.956 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 7.9 p -120.05 7.08 10.81 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.58 2.39 80.26 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 162.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.55 138.12 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.702 0.751 . . . . 0.0 112.202 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -91.57 124.98 36.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 0.0 110.652 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.566 HG13 HD11 ' A' ' 216' ' ' ILE . 0.3 OUTLIER -155.76 158.44 31.76 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.312 1.045 . . . . 0.0 110.063 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.419 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 35.0 Cg_endo -61.62 158.95 34.45 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.039 2.493 . . . . 0.0 113.615 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' A' ' 199' ' ' VAL . 10.7 pt-20 -48.72 -34.85 12.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.887 1.675 . . . . 0.0 113.622 -170.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -70.4 -52.78 19.89 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.562 0.745 . . . . 0.0 111.135 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -80.42 -23.66 40.18 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.531 -173.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 211' ' ' ILE . 9.8 tp -80.12 -37.48 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 117.853 0.297 . . . . 0.0 111.305 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.9 -42.19 99.7 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -62.41 -45.76 91.65 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.865 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -48.8 74.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.629 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 1.8 pp -65.69 -33.5 76.03 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 124.003 0.815 . . . . 0.0 110.299 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.64 -57.89 10.98 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.399 1.079 . . . . 0.0 110.989 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 t -65.54 -28.51 69.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.983 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 40.6 m -80.58 -31.46 36.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.931 0.892 . . . . 0.0 111.911 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -81.35 -14.48 57.21 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 24.8 t -113.34 -68.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 110.605 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -78.98 95.8 5.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.586 0.754 . . . . 0.0 109.297 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 C--O 1.252 1.203 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.27 -177.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 32.8 m -91.56 104.81 17.26 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.633 0.773 . . . . 0.0 109.382 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -78.61 165.38 23.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.037 0.535 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.61 101.53 4.98 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.5 p -162.49 122.98 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.662 1.185 . . . . 0.0 108.701 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.0 t -94.52 150.8 19.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 88.5 mttt -127.11 129.0 47.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.584 HG21 HG12 ' A' ' 216' ' ' ILE . 20.9 m -136.03 165.24 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 122.811 0.444 . . . . 0.0 110.423 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.68 146.25 36.16 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.373 1.069 . . . . 0.0 111.004 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.54 ' HA ' HD13 ' A' ' 216' ' ' ILE . 11.7 t -86.56 105.52 8.01 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.82 -24.74 32.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 123.407 2.738 . . . . 0.0 113.68 -171.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.71 -53.26 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.35 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.466 ' SG ' HG22 ' A' ' 209' ' ' VAL . 16.2 p -110.54 -15.51 13.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.03 49.89 6.14 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 123.452 0.549 . . . . 0.0 113.382 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.466 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.3 m -120.46 132.63 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 122.995 0.518 . . . . 0.0 110.123 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.83 129.27 34.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.6 OUTLIER -152.43 151.97 28.22 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.488 0.715 . . . . 0.0 111.053 -172.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 32.3 Cg_endo -60.89 158.7 32.39 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.859 2.372 . . . . 0.0 113.044 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.19 -38.53 40.39 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.203 1.401 . . . . 0.0 114.122 -167.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.3 p -69.64 -49.62 52.05 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-O 121.348 0.594 . . . . 0.0 110.805 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.95 -33.02 73.87 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.677 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.584 HG12 HG21 ' A' ' 202' ' ' VAL . 5.9 tp -72.87 -40.86 60.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.93 -50.03 64.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.043 0.449 . . . . 0.0 110.427 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.59 -43.59 76.14 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -52.8 55.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.419 -171.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.497 HD22 HG13 ' A' ' 216' ' ' ILE . 2.2 pp -66.85 -32.87 74.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.565 0.541 . . . . 0.0 110.332 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.81 -58.09 10.08 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.878 0.736 . . . . 0.0 110.952 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 42.7 t -69.87 -28.51 65.71 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.251 1.021 . . . . 0.0 111.592 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.51 -49.35 41.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.657 0.783 . . . . 0.0 111.185 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 tp -71.25 -28.59 64.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.103 0.561 . . . . 0.0 110.095 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.1 t -76.79 -25.8 53.74 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 64.97 91.12 0.08 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.388 1.075 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 CA--C 1.557 1.218 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.63 175.544 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.4 m 62.85 13.42 6.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.759 1.223 . . . . 0.0 113.59 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -82.5 112.78 19.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.406 0.683 . . . . 0.0 110.706 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -128.62 136.3 50.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.844 0.857 . . . . 0.0 108.866 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.3 p -171.09 93.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 m -65.53 123.99 21.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.503 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -97.54 142.65 29.12 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.438 0.695 . . . . 0.0 109.937 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 216' ' ' ILE . 15.3 m -143.51 160.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.348 0.659 . . . . 0.0 109.979 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.51 147.31 30.91 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.348 1.059 . . . . 0.0 110.718 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.54 ' HA ' HD13 ' A' ' 216' ' ' ILE . 7.0 t -82.35 110.46 21.57 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.215 1.006 . . . . 0.0 109.473 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.95 -22.46 63.29 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.447 2.765 . . . . 0.0 113.036 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.22 -45.26 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.452 ' SG ' HG23 ' A' ' 209' ' ' VAL . 15.3 p -118.86 -33.34 4.24 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -172.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.6 -17.18 9.56 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 168.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.452 HG23 ' SG ' ' A' ' 207' ' ' CYS . 30.5 m -67.19 135.27 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.45 128.86 36.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.681 0.792 . . . . 0.0 109.674 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.79 154.47 26.69 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 123.596 0.758 . . . . 0.0 110.493 -172.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.82 156.85 35.93 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.283 2.655 . . . . 0.0 113.218 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.42 -35.12 12.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.182 1.393 . . . . 0.0 113.875 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 13.2 p -70.62 -52.37 21.84 Favored 'General case' 0 C--O 1.252 1.22 0 C-N-CA 123.279 0.632 . . . . 0.0 111.679 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -75.06 -25.72 58.85 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.872 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 202' ' ' VAL . 7.2 tp -78.39 -39.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -57.18 -43.21 82.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.36 -45.3 80.58 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -52.97 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.415 0.286 . . . . 0.0 111.237 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.92 -30.41 70.55 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.743 0.652 . . . . 0.0 110.49 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.87 -55.06 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.005 0.816 . . . . 0.0 110.113 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.9 t -65.13 -26.52 68.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.935 1.294 . . . . 0.0 111.462 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.4 -39.57 24.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.385 1.074 . . . . 0.0 111.123 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.79 -33.29 68.45 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 33.6 t -83.58 -50.83 7.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.009 -174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 -112.0 113.06 25.14 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.621 0.768 . . . . 0.0 108.953 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 C-N-CA 123.032 0.533 . . . . 0.0 110.895 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.938 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -68.78 109.82 4.04 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 117.556 0.678 . . . . 0.0 110.504 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -73.62 -30.18 62.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.19 0.596 . . . . 0.0 112.325 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -75.11 85.36 2.35 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 12.6 p 175.2 137.15 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.781 1.633 . . . . 0.0 107.962 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.2 t -100.3 142.49 31.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.3 mttt -122.49 138.75 54.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.219 0.608 . . . . 0.0 109.605 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 216' ' ' ILE . 20.3 m -141.27 165.45 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.936 0.494 . . . . 0.0 110.473 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.65 147.81 31.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.72 1.208 . . . . 0.0 111.084 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.432 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.2 t -81.55 112.66 35.9 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.812 0.845 . . . . 0.0 109.079 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.62 -24.47 45.37 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.149 2.566 . . . . 0.0 113.183 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.33 -57.55 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.084 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -111.32 -19.03 12.78 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.17 -29.38 7.39 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 167.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.91 138.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.76 122.42 33.48 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.397 1.079 . . . . 0.0 110.139 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.579 HG13 HD12 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.59 159.45 33.28 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 123.602 0.761 . . . . 0.0 110.19 -176.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.492 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 37.7 Cg_endo -61.63 156.35 48.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.899 2.399 . . . . 0.0 113.401 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.01 -40.57 4.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.963 1.705 . . . . 0.0 114.551 -169.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.3 p -76.89 -46.51 24.21 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.808 0.443 . . . . 0.0 111.651 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -75.22 -23.44 57.58 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.383 0.273 . . . . 0.0 111.361 -174.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.579 HD12 HG13 ' A' ' 211' ' ' ILE . 9.8 tp -78.94 -41.9 23.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.949 0.5 . . . . 0.0 110.685 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -60.09 -39.25 85.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.903 0.383 . . . . 0.0 110.442 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -46.22 85.33 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 174.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.4 -47.7 78.18 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.347 0.404 . . . . 0.0 110.813 -173.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.47 -27.94 65.65 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.8 0.688 . . . . 0.0 110.997 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.65 -50.71 56.52 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 0.0 110.755 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.5 t -66.77 -31.53 72.23 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.645 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 56.9 m -78.88 -26.41 43.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.182 0.993 . . . . 0.0 111.08 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.4 tt -69.53 -27.43 65.16 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.524 0.73 . . . . 0.0 109.385 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.1 t -83.89 -15.87 46.46 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 164.76 25.94 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.664 0.786 . . . . 0.0 111.046 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.531 1.132 . . . . 0.0 109.333 -179.361 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.9 p -162.01 138.99 8.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.046 0.938 . . . . 0.0 109.866 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.29 88.23 2.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.235 1.014 . . . . 0.0 108.853 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -149.66 111.09 4.45 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.238 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.5 p -164.79 142.39 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.621 1.168 . . . . 0.0 108.289 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t -111.03 150.54 29.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.234 0.614 . . . . 0.0 110.107 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 91.5 mttt -119.93 138.23 53.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.836 0.854 . . . . 0.0 108.841 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 216' ' ' ILE . 18.7 m -138.84 160.34 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.866 0.467 . . . . 0.0 110.19 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -78.49 147.98 33.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.214 0.606 . . . . 0.0 110.346 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.508 ' HA ' HD12 ' A' ' 216' ' ' ILE . 5.0 t -76.13 112.51 21.12 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.16 -25.62 56.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.797 2.331 . . . . 0.0 112.542 -175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.2 -57.42 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.17 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.8 p -108.98 -19.37 13.42 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 204' ' ' CYS . . . 110.55 -19.48 26.29 Favored Glycine 0 N--CA 1.478 1.455 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 166.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.05 136.48 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.68 122.88 34.64 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.199 1.0 . . . . 0.0 110.527 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.483 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.33 156.57 35.03 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 123.711 0.805 . . . . 0.0 110.136 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.443 ' HD2' HG22 ' A' ' 211' ' ' ILE . 20.3 Cg_endo -58.12 153.58 44.84 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 123.16 2.573 . . . . 0.0 113.374 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.99 -34.32 12.84 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.431 1.492 . . . . 0.0 114.551 -166.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.9 p -74.93 -50.46 16.72 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.784 0.434 . . . . 0.0 111.246 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -72.36 -30.07 64.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.694 0.398 . . . . 0.0 111.115 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 204' ' ' CYS . 8.2 tp -75.4 -36.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.99 -46.8 78.59 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.642 0.589 . . . . 0.0 109.975 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -62.25 -46.28 89.55 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.061 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -51.26 69.33 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.258 0.349 . . . . 0.0 110.994 -172.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -70.4 -27.2 64.11 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.677 0.611 . . . . 0.0 111.181 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.39 -54.54 16.52 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.191 0.932 . . . . 0.0 110.4 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 34.9 t -67.87 -24.66 65.26 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 52.0 m -81.24 -28.09 34.94 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.905 0.882 . . . . 0.0 111.382 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.89 -24.19 63.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.2 t -83.36 -65.23 1.03 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.546 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -129.5 167.54 17.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.206 1.002 . . . . 0.0 109.273 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.253 1.279 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.914 178.684 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.5 m -73.82 92.52 2.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.121 0.569 . . . . 0.0 109.98 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -144.98 100.83 3.55 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -77.26 95.92 4.45 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-O 121.224 0.535 . . . . 0.0 109.987 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.2 p -146.33 110.62 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.2 t -82.06 135.75 35.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.6 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -113.28 136.4 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.083 0.553 . . . . 0.0 110.153 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 216' ' ' ILE . 19.4 m -138.91 165.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.353 0.661 . . . . 0.0 110.112 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.66 147.87 33.38 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.998 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.524 ' HA ' HD13 ' A' ' 216' ' ' ILE . 12.8 t -82.83 107.4 9.2 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.8 -26.63 67.55 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.963 2.442 . . . . 0.0 112.888 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.3 t -88.67 -31.15 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -128.62 -30.8 2.28 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.371 0.987 . . . . 0.0 112.45 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.44 -16.54 10.55 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 164.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.45 134.73 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.02 124.86 32.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.768 0.827 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.443 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.1 pt -153.9 152.54 27.08 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.987 0.915 . . . . 0.0 110.689 -169.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.83 162.4 28.83 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.661 2.241 . . . . 0.0 112.573 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.83 -32.19 30.73 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.868 1.267 . . . . 0.0 113.456 -171.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.3 p -68.99 -52.63 26.85 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.318 0.647 . . . . 0.0 111.514 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.7 t-160 -76.32 -25.07 54.41 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.023 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 202' ' ' VAL . 6.3 tp -74.39 -42.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 118.847 -0.597 . . . . 0.0 111.445 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -52.48 -48.02 66.16 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -65.13 -50.19 67.0 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.5 OUTLIER -67.21 -48.25 68.43 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.524 0.33 . . . . 0.0 110.514 -167.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.469 HD22 HG13 ' A' ' 216' ' ' ILE . 1.2 pp -67.15 -30.99 71.12 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.801 0.688 . . . . 0.0 109.999 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.73 -56.9 14.65 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.838 0.711 . . . . 0.0 110.418 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -64.05 -31.01 72.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.228 1.011 . . . . 0.0 111.424 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 59.7 m -77.45 -27.8 52.25 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.784 0.834 . . . . 0.0 110.898 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.28 -16.89 63.08 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.268 0.627 . . . . 0.0 109.452 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 27.6 t -101.99 10.91 39.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.317 1.047 . . . . 0.0 110.623 175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -133.56 124.48 26.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.245 0.618 . . . . 0.0 111.054 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 168.105 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 29.7 p -76.29 110.0 10.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.238 0.615 . . . . 0.0 111.04 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -141.79 97.32 3.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.44 116.79 28.64 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.013 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.2 p -161.36 122.06 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.421 1.088 . . . . 0.0 108.906 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t -94.11 142.86 26.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.069 0.547 . . . . 0.0 109.942 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.76 134.11 54.93 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.706 0.802 . . . . 0.0 109.095 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.549 HG23 HG12 ' A' ' 216' ' ' ILE . 22.3 m -137.9 167.72 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 121.246 0.546 . . . . 0.0 110.486 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 147.47 32.97 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.929 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.599 ' HA ' HD11 ' A' ' 216' ' ' ILE . 14.8 t -87.21 110.99 37.9 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.168 0.587 . . . . 0.0 109.885 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -53.0 -31.72 54.71 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.43 2.753 . . . . 0.0 113.522 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 8.8 t -85.33 -45.9 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.762 -173.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.9 p -111.43 -34.47 6.1 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 118.464 0.575 . . . . 0.0 112.165 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.89 16.9 14.06 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 168.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.03 143.31 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 117.953 0.876 . . . . 0.0 112.046 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.7 130.02 34.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.371 0.668 . . . . 0.0 109.76 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.52 151.21 20.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.103 0.961 . . . . 0.0 110.744 -172.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.38 159.67 22.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.871 2.381 . . . . 0.0 113.228 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -49.41 -41.68 40.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.631 1.572 . . . . 0.0 114.194 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 35.5 p -66.86 -50.87 61.13 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.134 0.492 . . . . 0.0 110.792 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -66.83 -32.36 73.59 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.701 -173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 204' ' ' CYS . 6.2 tp -73.51 -43.54 55.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.797 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -52.95 -47.25 68.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.448 0.567 . . . . 0.0 110.717 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.34 -44.42 79.12 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.71 -54.91 36.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.307 0.379 . . . . 0.0 110.583 -173.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.529 HD22 HG13 ' A' ' 216' ' ' ILE . 3.5 pp -64.54 -32.26 73.83 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.03 0.831 . . . . 0.0 110.986 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.08 -56.87 10.53 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.963 0.789 . . . . 0.0 110.56 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 35.4 t -66.69 -24.43 66.26 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.989 0.916 . . . . 0.0 111.246 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.5 m -77.97 -37.54 47.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.794 0.838 . . . . 0.0 111.051 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.2 tp -69.1 -25.36 64.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.884 0.874 . . . . 0.0 109.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.6 t -86.31 -68.26 0.75 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.12 116.88 32.7 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 123.219 0.607 . . . . 0.0 109.594 177.328 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 104.73 7.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.446 0.698 . . . . 0.0 110.102 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -70.77 85.55 0.66 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.97 70.43 10.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.901 0.88 . . . . 0.0 109.938 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.3 p -170.01 120.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.327 1.451 . . . . 0.0 108.056 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.4 t -89.78 147.76 23.63 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.8 mttt -126.31 132.42 51.64 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.47 HG22 HG12 ' A' ' 216' ' ' ILE . 19.6 m -135.18 161.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.383 0.673 . . . . 0.0 109.796 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 146.49 31.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.689 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . 0.423 ' HB2' HD11 ' A' ' 211' ' ' ILE . 30.1 t -80.55 117.89 69.88 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.597 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.71 -26.43 82.15 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.911 2.408 . . . . 0.0 112.735 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.4 t -86.99 -57.83 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -103.96 -20.26 13.94 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.0 45.87 5.82 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.88 138.49 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.803 0.441 . . . . 0.0 110.742 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -79.08 131.03 36.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.423 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.5 OUTLIER -155.58 150.3 20.36 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 124.406 1.082 . . . . 0.0 110.008 -169.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 44.3 Cg_endo -64.67 161.38 35.96 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.446 2.097 . . . . 0.0 112.308 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.13 -38.76 58.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.036 1.335 . . . . 0.0 113.497 -172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.5 p -65.61 -48.28 72.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.414 0.626 . . . . 0.0 110.603 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 17.0 t-160 -76.38 -24.79 54.13 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.483 HG13 HD23 ' A' ' 220' ' ' LEU . 5.3 tp -74.06 -46.51 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.822 0.737 . . . . 0.0 110.546 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.44 -44.97 76.83 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.285 0.564 . . . . 0.0 110.248 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.98 -42.85 84.4 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.699 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -68.83 -54.69 14.32 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.921 0.488 . . . . 0.0 109.738 -172.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.483 HD23 HG13 ' A' ' 216' ' ' ILE . 1.8 pp -62.03 -32.65 73.17 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 124.2 0.937 . . . . 0.0 110.08 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.44 -57.93 10.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.8 0.84 . . . . 0.0 111.096 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -67.8 -26.36 66.05 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.246 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 57.9 m -80.74 -37.42 30.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.317 1.047 . . . . 0.0 111.344 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -76.74 -22.85 53.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 t -73.28 -57.15 4.22 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.087 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -130.63 156.4 44.95 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 109.348 -178.164 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 36.4 t -67.08 -37.13 83.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.715 0.806 . . . . 0.0 110.33 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -156.17 152.63 28.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 109.191 174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.54 105.35 16.76 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.5 0.32 . . . . 0.0 110.449 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.87 128.83 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.683 1.193 . . . . 0.0 108.384 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.7 t -97.87 141.17 31.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.814 0.446 . . . . 0.0 110.81 -174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.416 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.8 mttt -112.25 143.68 42.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 0.0 109.492 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.52 HG21 HG12 ' A' ' 216' ' ' ILE . 17.2 m -143.5 170.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 122.661 0.385 . . . . 0.0 110.288 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.93 146.32 32.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.191 0.996 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . . . . . . . . . 14.5 t -85.21 100.04 1.07 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.714 0.806 . . . . 0.0 109.003 177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -55.75 -18.08 20.07 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.224 2.616 . . . . 0.0 114.12 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.93 -56.95 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.133 0.573 . . . . 0.0 111.499 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 15.4 p -104.59 -34.16 8.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 97.73 53.82 1.27 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 114.314 0.486 . . . . 0.0 114.314 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.32 143.37 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.332 0.653 . . . . 0.0 110.57 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -95.88 122.23 38.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.373 0.669 . . . . 0.0 109.973 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.527 HG13 HD13 ' A' ' 216' ' ' ILE . 0.4 OUTLIER -155.28 155.19 29.67 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.416 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 18.5 Cg_endo -58.4 159.13 20.46 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.479 2.786 . . . . 0.0 113.976 178.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.94 -36.01 11.68 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.273 1.829 . . . . 0.0 114.552 -169.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.6 p -73.18 -51.07 19.16 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.372 0.669 . . . . 0.0 111.251 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -71.89 -32.06 67.05 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.532 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.527 HD13 HG13 ' A' ' 211' ' ' ILE . 10.8 tp -78.07 -38.49 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.615 0.366 . . . . 0.0 111.14 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.17 -42.4 98.5 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.63 0.581 . . . . 0.0 109.468 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.15 -46.75 79.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.629 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.15 -45.36 92.25 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 119.554 -0.26 . . . . 0.0 110.885 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.94 -32.94 63.73 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.35 0.406 . . . . 0.0 110.677 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.26 -52.75 44.48 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.208 0.943 . . . . 0.0 109.96 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.8 t -60.47 -45.94 91.9 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.261 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.1 m -62.93 -32.85 74.24 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.84 0.856 . . . . 0.0 112.485 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.6 tt -73.74 -23.46 59.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.517 0.727 . . . . 0.0 110.121 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 22.9 t -111.05 -15.5 13.71 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.656 0.783 . . . . 0.0 111.644 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -130.92 -179.97 5.63 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.836 0.854 . . . . 0.0 109.886 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 123.797 0.839 . . . . 0.0 109.654 176.421 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.786 -0.126 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 m -95.66 116.4 28.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.06 79.66 1.72 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -86.74 106.45 17.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.39 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.419 HG23 ' HG2' ' A' ' 213' ' ' GLU . 6.8 p -161.63 123.3 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.8 1.24 . . . . 0.0 108.051 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.4 t -94.61 150.4 20.27 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.007 0.523 . . . . 0.0 109.881 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -122.73 140.92 52.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.541 0.736 . . . . 0.0 109.143 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.574 HG21 HG12 ' A' ' 216' ' ' ILE . 15.5 m -142.38 167.16 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.576 0.35 . . . . 0.0 110.337 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.71 145.37 34.55 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.565 1.146 . . . . 0.0 110.928 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.82 106.95 7.86 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.1 -17.52 32.1 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.692 2.262 . . . . 0.0 113.22 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.91 -57.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.823 0.849 . . . . 0.0 112.224 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 10.8 p -115.41 -3.24 12.44 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -166.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.4 34.27 45.81 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.27 136.28 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 117.046 0.423 . . . . 0.0 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.74 129.2 36.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.992 0.517 . . . . 0.0 109.761 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.576 HG13 HD11 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -155.62 156.02 30.28 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.907 0.883 . . . . 0.0 110.045 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.45 157.62 17.99 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.402 2.735 . . . . 0.0 114.218 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 199' ' ' VAL . 10.6 pt-20 -48.41 -37.71 17.73 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.238 1.815 . . . . 0.0 113.775 -171.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.9 p -67.2 -52.9 35.51 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.384 0.611 . . . . 0.0 111.309 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' HIS . . . . . 0.485 ' HD2' HG23 ' A' ' 211' ' ' ILE . 50.9 t60 -80.57 -22.44 40.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.57 -172.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 211' ' ' ILE . 10.1 tp -79.44 -43.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.569 0.347 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.24 -43.49 86.45 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.494 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -53.19 59.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.701 0.401 . . . . 0.0 110.553 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.1 -30.71 69.95 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.906 0.754 . . . . 0.0 110.699 -172.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.23 -57.88 10.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.89 0.876 . . . . 0.0 110.589 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.6 t -68.19 -27.87 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.035 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.38 -39.61 58.96 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 0.0 111.045 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -25.26 64.6 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.2 t -89.57 11.7 18.83 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.864 1.265 . . . . 0.0 111.382 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -139.08 -37.3 0.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.03 0.532 . . . . 0.0 111.35 -175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 123.193 0.597 . . . . 0.0 110.47 -174.749 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -117.48 143.28 46.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 109.415 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 216' ' ' ILE . 18.1 m -142.67 172.14 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 122.737 0.415 . . . . 0.0 110.19 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.85 147.11 29.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.188 0.995 . . . . 0.0 111.224 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.432 ' CA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -85.58 106.56 9.71 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.173 0.989 . . . . 0.0 108.46 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.45 -23.83 33.01 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.291 2.661 . . . . 0.0 113.608 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.7 -54.8 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 C-N-CA 123.026 0.53 . . . . 0.0 111.986 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 12.4 p -108.3 -19.21 13.55 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.19 5.12 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 122.847 0.26 . . . . 0.0 113.696 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.85 147.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.284 0.634 . . . . 0.0 111.301 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.89 126.71 47.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.152 0.581 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.515 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.6 155.95 29.35 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.551 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 157.26 29.03 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.996 2.464 . . . . 0.0 112.953 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -39.14 40.96 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.44 1.496 . . . . 0.0 113.86 -167.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 52.7 p -68.07 -50.36 55.59 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.32 0.648 . . . . 0.0 111.041 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.35 -30.51 63.38 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.869 -172.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 202' ' ' VAL . 9.6 tp -77.42 -40.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.198 0.599 . . . . 0.0 110.948 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.44 -43.53 93.12 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.543 0.527 . . . . 0.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -43.38 90.15 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.407 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -52.03 67.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 123.334 0.396 . . . . 0.0 110.322 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.51 -30.73 68.64 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.788 0.68 . . . . 0.0 111.146 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.86 -47.86 76.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.806 0.842 . . . . 0.0 110.846 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.6 t -75.07 -26.75 59.59 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.993 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 36.1 m -77.78 -30.76 51.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.123 0.969 . . . . 0.0 111.65 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 124.097 0.959 . . . . 0.0 108.853 176.398 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.765 0.317 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -128.15 141.37 51.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.914 0.886 . . . . 0.0 109.248 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.644 HG23 HG12 ' A' ' 216' ' ' ILE . 12.1 m -140.73 158.79 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.561 0.344 . . . . 0.0 110.321 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.0 146.5 35.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.777 0.831 . . . . 0.0 110.011 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 216' ' ' ILE . 8.0 t -82.58 107.69 9.85 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.774 0.83 . . . . 0.0 109.14 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.55 -27.98 53.06 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.647 2.231 . . . . 0.0 113.142 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 4.1 t -85.39 -43.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.973 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.92 -28.32 5.95 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 118.514 0.597 . . . . 0.0 112.333 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 101.57 23.69 9.28 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 136.51 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 117.625 0.712 . . . . 0.0 111.738 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -89.03 130.66 35.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 109.974 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.58 155.91 29.3 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 110.285 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.54 155.21 43.26 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.988 2.459 . . . . 0.0 113.68 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -44.4 -38.48 4.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.676 1.99 . . . . 0.0 114.609 -170.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.9 p -71.01 -52.29 20.44 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.554 0.742 . . . . 0.0 111.25 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.1 -27.12 60.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.127 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.644 HG12 HG23 ' A' ' 202' ' ' VAL . 7.3 tp -79.27 -40.91 22.39 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.174 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -57.38 -43.05 83.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.66 -48.48 79.16 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.388 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -53.97 47.41 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.871 0.468 . . . . 0.0 110.878 -172.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 216' ' ' ILE . 3.3 pp -66.14 -31.47 72.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 124.13 0.894 . . . . 0.0 110.838 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.74 -57.87 8.63 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 0.0 110.197 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.5 t -63.93 -33.48 75.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.381 1.072 . . . . 0.0 110.837 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.7 m -69.46 -44.28 71.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 111.014 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.479 1.006 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.077 177.698 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -118.57 141.22 48.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.938 0.495 . . . . 0.0 110.785 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.9 m -142.4 160.63 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.996 0.918 . . . . 0.0 109.727 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.73 147.07 30.73 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.488 0.715 . . . . 0.0 110.283 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.537 ' HA ' HD11 ' A' ' 216' ' ' ILE . 34.4 t -79.53 110.16 14.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.315 0.646 . . . . 0.0 110.327 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.96 -24.09 37.84 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.609 2.873 . . . . 0.0 113.61 -171.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 t -85.48 -55.27 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 0.0 111.703 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.01 -27.81 9.93 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.59 26.55 8.54 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.03 0.772 . . . . 0.0 115.03 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.48 134.76 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 117.434 0.617 . . . . 0.0 111.489 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -84.39 125.52 32.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.0 OUTLIER -154.52 151.87 24.77 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.13 0.972 . . . . 0.0 110.876 -169.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.7 161.46 28.47 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.025 2.484 . . . . 0.0 112.689 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.422 ' HA ' HG22 ' A' ' 216' ' ' ILE . 11.6 pt-20 -55.52 -32.15 62.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.484 1.114 . . . . 0.0 112.674 -169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.7 p -66.25 -52.41 47.96 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.187 0.595 . . . . 0.0 111.017 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 26.1 t-80 -76.74 -26.18 54.3 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.779 -172.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 5.6 tp -72.8 -43.92 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.849 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.53 -45.72 73.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.536 0.523 . . . . 0.0 109.869 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -67.4 -42.31 83.5 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.464 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -71.37 -50.34 33.15 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.699 0.227 . . . . 0.0 111.079 -170.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 216' ' ' ILE . 2.4 pp -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.708 0.63 . . . . 0.0 109.765 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.75 -52.79 61.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.92 0.888 . . . . 0.0 110.856 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.0 t -67.76 -27.99 67.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.817 1.247 . . . . 0.0 111.291 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 35.3 m -82.11 -26.43 33.57 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 111.353 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.686 0.795 . . . . 0.0 108.983 173.199 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.747 0.308 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.83 141.04 48.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.912 0.885 . . . . 0.0 108.805 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -144.24 158.29 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.44 0.696 . . . . 0.0 109.602 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.17 145.23 33.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.286 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 216' ' ' ILE . 46.1 t -80.36 109.57 13.25 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 110.093 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.32 -27.61 67.93 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.309 2.673 . . . . 0.0 113.392 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.4 t -87.79 -29.03 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.576 0 C-N-CA 123.59 0.756 . . . . 0.0 112.89 -173.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 18.9 p -129.5 -34.36 1.81 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.194 -0.941 . . . . 0.0 112.061 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 96.44 53.85 1.41 Allowed Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.822 0.289 . . . . 0.0 113.822 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.86 130.0 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.633 0.773 . . . . 0.0 109.872 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.56 126.0 30.32 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 215' ' ' HIS . 1.2 pt -154.29 151.76 24.9 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.64 161.38 24.87 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.929 2.42 . . . . 0.0 112.665 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.26 -31.22 53.07 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.47 1.106 . . . . 0.0 113.259 -169.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.6 p -66.86 -51.75 51.77 Favored 'General case' 0 C--O 1.25 1.129 0 C-N-CA 122.716 0.406 . . . . 0.0 111.087 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 211' ' ' ILE . 18.1 t-160 -74.48 -31.51 62.24 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.225 -171.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 202' ' ' VAL . 4.5 tp -67.78 -46.18 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.965 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -54.44 -46.59 73.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.623 0.577 . . . . 0.0 110.355 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -67.5 -40.86 85.2 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.52 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -70.73 -49.42 47.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.471 0.308 . . . . 0.0 110.49 -170.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.24 -31.83 72.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 109.642 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.87 -55.46 29.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.118 0.967 . . . . 0.0 111.073 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -69.9 -24.17 63.35 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.154 0.981 . . . . 0.0 111.201 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 34.2 m -81.37 -30.11 33.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.894 0.878 . . . . 0.0 111.062 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 110.792 -0.077 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.7 mttt -115.01 134.2 55.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.431 0.692 . . . . 0.0 110.514 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.04 173.42 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.871 0.868 . . . . 0.0 110.095 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -89.86 146.99 24.03 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.127 0.571 . . . . 0.0 111.019 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 211' ' ' ILE . 15.5 t -79.27 117.82 69.1 Favored Pre-proline 0 C--O 1.219 -0.511 0 C-N-CA 123.792 0.837 . . . . 0.0 109.839 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.03 -28.43 87.04 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.972 2.448 . . . . 0.0 112.669 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.0 t -85.77 -46.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.372 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.4 p -111.78 -33.57 6.28 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.04 6.88 31.73 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 207' ' ' CYS . 28.2 m -83.5 145.85 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 0.0 112.213 -176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -82.07 133.15 35.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 0.0 109.974 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.75 147.62 15.42 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.294 1.038 . . . . 0.0 109.979 -169.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 48.1 Cg_endo -66.82 161.7 40.89 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.428 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -53.29 -34.72 58.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.718 1.207 . . . . 0.0 113.573 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.7 p -68.6 -50.39 51.93 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.796 0.839 . . . . 0.0 110.817 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.2 t-160 -80.17 -17.31 52.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.912 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 211' ' ' ILE . 4.3 tp -76.36 -44.73 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.689 0.677 . . . . 0.0 109.708 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -53.46 -45.66 69.6 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 124.084 0.865 . . . . 0.0 109.572 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.47 -50.22 64.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.442 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -65.39 -44.99 85.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 117.92 0.327 . . . . 0.0 110.334 -168.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.03 -35.38 78.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.239 0.962 . . . . 0.0 109.478 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.78 -54.3 46.81 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.921 0.888 . . . . 0.0 110.312 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.8 t -62.77 -33.86 76.04 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.042 1.337 . . . . 0.0 111.409 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 30.4 m -79.36 -29.66 42.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.644 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.667 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.72 138.37 53.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.385 0.674 . . . . 0.0 110.211 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 216' ' ' ILE . 20.8 m -139.4 164.56 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.54 0.736 . . . . 0.0 109.784 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 147.5 28.88 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.621 0.768 . . . . 0.0 109.864 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.474 ' HA ' HD11 ' A' ' 216' ' ' ILE . 10.3 t -81.89 109.78 16.81 Favored Pre-proline 0 C--O 1.222 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 109.159 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.47 -23.17 62.82 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.19 2.593 . . . . 0.0 113.374 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 11.8 t -87.54 -38.05 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.434 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 209' ' ' VAL . 14.5 p -125.95 -29.2 3.11 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -170.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.18 -5.63 30.31 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.458 HG22 ' SG ' ' A' ' 207' ' ' CYS . 21.5 m -69.12 133.19 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 117.407 0.603 . . . . 0.0 111.773 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.26 124.06 30.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.571 0.748 . . . . 0.0 109.305 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.9 OUTLIER -150.93 151.47 29.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.595 0.758 . . . . 0.0 110.803 -169.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.62 160.79 34.58 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.941 2.428 . . . . 0.0 112.797 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.97 -37.43 32.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.348 1.459 . . . . 0.0 113.736 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.2 m -67.71 -51.14 53.04 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.37 -32.17 68.18 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 202' ' ' VAL . 5.5 tp -70.87 -45.32 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -53.4 -45.85 69.47 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -66.91 -48.75 67.72 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.201 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -47.15 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.604 0.362 . . . . 0.0 110.388 -168.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -32.73 74.06 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 123.881 0.738 . . . . 0.0 109.682 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -57.59 12.3 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 123.269 0.628 . . . . 0.0 110.708 174.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.6 t -63.36 -30.94 71.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 36.1 m -79.18 -32.12 44.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.804 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.486 1.325 0 C-N-CA 123.481 0.712 . . . . 0.0 111.655 -170.282 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -124.26 143.84 50.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.365 0.666 . . . . 0.0 110.394 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.696 HG23 HG12 ' A' ' 216' ' ' ILE . 19.0 m -142.43 163.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.678 0.791 . . . . 0.0 109.753 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 146.69 35.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.801 0.84 . . . . 0.0 110.967 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.53 ' HA ' HD11 ' A' ' 216' ' ' ILE . 9.8 t -84.01 107.74 11.6 Favored Pre-proline 0 C--O 1.218 -0.599 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -56.89 -25.7 63.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.885 2.39 . . . . 0.0 113.127 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.96 -43.98 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.625 0.77 . . . . 0.0 112.13 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 209' ' ' VAL . 10.1 p -125.36 4.71 7.71 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -170.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.23 45.65 95.69 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 125.223 1.392 . . . . 0.0 115.208 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.456 HG22 ' SG ' ' A' ' 207' ' ' CYS . 27.6 m -117.48 128.69 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 175.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.17 126.07 31.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.414 0.685 . . . . 0.0 109.704 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -152.78 150.68 25.05 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.725 0.81 . . . . 0.0 111.472 -169.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.49 156.98 38.55 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 123.192 2.595 . . . . 0.0 113.14 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.08 -39.04 12.27 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.229 1.812 . . . . 0.0 114.311 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 37.7 p -69.02 -51.65 36.94 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.317 0.58 . . . . 0.0 111.078 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 12.2 t60 -70.37 -32.29 69.91 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.549 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.696 HG12 HG23 ' A' ' 202' ' ' VAL . 5.0 tp -71.8 -46.09 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.494 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.11 -44.21 83.03 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.183 0.302 . . . . 0.0 110.329 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -69.52 -42.39 74.76 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.974 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -64.47 -50.46 67.4 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.583 -172.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 216' ' ' ILE . 1.6 pp -69.19 -32.83 72.39 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.889 0.743 . . . . 0.0 110.096 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.42 -55.51 27.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.674 0.79 . . . . 0.0 110.115 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -64.96 -33.1 75.24 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 124.348 1.059 . . . . 0.0 110.674 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 32.7 m -73.61 -36.03 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.961 0.904 . . . . 0.0 111.314 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.586 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.504 0.192 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.91 132.47 50.88 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.147 0.579 . . . . 0.0 109.864 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.53 HG23 HG12 ' A' ' 216' ' ' ILE . 30.4 m -135.79 164.03 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.561 0.744 . . . . 0.0 110.006 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.28 147.24 32.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.271 1.028 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.451 ' HA ' HD11 ' A' ' 216' ' ' ILE . 23.5 t -82.68 108.81 13.33 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.017 0.527 . . . . 0.0 109.764 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.42 -27.24 75.08 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.026 2.484 . . . . 0.0 113.231 -170.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.2 t -86.72 -36.53 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 123.304 0.642 . . . . 0.0 111.976 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.5 p -122.72 -37.54 2.75 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 118.571 0.623 . . . . 0.0 112.176 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.21 -3.34 14.1 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.8 140.02 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 118.425 1.112 . . . . 0.0 112.12 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.95 128.73 34.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -153.2 149.78 22.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.254 0.621 . . . . 0.0 111.025 -170.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.33 161.7 29.88 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.871 2.381 . . . . 0.0 113.154 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.67 -41.92 44.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.05 1.74 . . . . 0.0 114.573 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.5 p -71.5 -43.56 66.29 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.262 0.553 . . . . 0.0 110.643 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 37.8 t-80 -75.14 -22.81 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.53 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -77.2 -45.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.554 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -51.26 -48.33 62.22 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.783 0.677 . . . . 0.0 110.558 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -69.98 -45.14 67.98 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.344 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -62.59 -51.51 67.02 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 117.869 0.304 . . . . 0.0 110.811 -173.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 216' ' ' ILE . 2.1 pp -64.21 -34.27 77.72 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.915 0.759 . . . . 0.0 110.162 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.36 -54.38 37.71 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.053 0.846 . . . . 0.0 111.289 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -65.37 -27.66 68.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.902 1.281 . . . . 0.0 110.981 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.1 m -80.66 -36.17 32.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.511 1.124 . . . . 0.0 111.811 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.511 0.725 . . . . 0.0 109.801 -176.109 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -116.52 137.82 51.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.168 0.587 . . . . 0.0 110.026 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 216' ' ' ILE . 16.1 m -141.69 164.09 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.746 0.818 . . . . 0.0 110.125 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.64 146.56 34.01 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.495 1.118 . . . . 0.0 111.023 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.513 ' HA ' HD11 ' A' ' 216' ' ' ILE . 19.2 t -84.86 106.19 8.11 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 123.622 0.769 . . . . 0.0 109.154 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -54.32 -25.43 39.0 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.6 2.867 . . . . 0.0 113.62 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.79 -57.1 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.835 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.6 p -99.17 -31.34 11.79 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.07 0.395 . . . . 0.0 111.719 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.86 2.79 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.404 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.1 m -120.61 140.41 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.119 0.568 . . . . 0.0 110.853 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.58 133.71 35.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.897 0.479 . . . . 0.0 109.993 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.16 149.43 17.74 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 0.0 110.483 -171.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.62 159.14 33.66 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.963 2.442 . . . . 0.0 112.897 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -50.3 -37.66 37.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.278 1.431 . . . . 0.0 113.944 -170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.1 p -69.53 -50.82 41.45 Favored 'General case' 0 C--O 1.254 1.298 0 C-N-CA 123.043 0.537 . . . . 0.0 110.912 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.57 -31.43 69.6 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.368 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.571 HG12 HG23 ' A' ' 202' ' ' VAL . 5.7 tp -70.09 -42.42 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.887 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -52.32 -50.57 61.98 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.22 -42.01 72.85 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.236 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -51.33 61.66 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.449 HD23 HG13 ' A' ' 216' ' ' ILE . 1.9 pp -64.82 -35.32 80.73 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.819 0.7 . . . . 0.0 110.073 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.75 -52.96 61.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.654 0.74 . . . . 0.0 110.685 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -67.83 -25.27 65.48 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.706 1.202 . . . . 0.0 111.438 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.78 -36.55 28.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.286 1.034 . . . . 0.0 111.671 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.529 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -121.01 137.77 54.49 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.215 0.606 . . . . 0.0 110.552 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.61 HG23 HG12 ' A' ' 216' ' ' ILE . 16.0 m -141.66 161.71 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.584 0.754 . . . . 0.0 110.628 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.41 146.31 32.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.631 1.172 . . . . 0.0 110.918 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' A' ' 216' ' ' ILE . 20.1 t -84.01 109.79 21.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 123.599 0.76 . . . . 0.0 109.744 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.08 -23.3 60.2 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.27 2.647 . . . . 0.0 113.691 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 -50.28 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.484 0.713 . . . . 0.0 111.754 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.6 p -113.23 -26.36 8.44 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 94.39 41.67 4.16 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.25 136.9 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.109 0.564 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -86.14 127.64 34.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.982 0.513 . . . . 0.0 109.777 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.466 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -154.08 152.02 25.74 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.251 1.02 . . . . 0.0 110.361 -169.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.25 160.04 28.42 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.198 2.599 . . . . 0.0 112.917 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -53.66 -34.89 60.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.038 1.335 . . . . 0.0 113.532 -168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 57.4 p -70.83 -47.73 57.84 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.38 0.672 . . . . 0.0 111.281 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -69.93 -34.37 73.38 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -73.29 -40.47 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.073 0.549 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -55.14 -46.49 75.68 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -66.93 -44.32 80.97 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.247 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -55.85 12.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.759 0.424 . . . . 0.0 110.567 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 216' ' ' ILE . 1.3 pp -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.94 0.775 . . . . 0.0 109.976 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.45 -57.63 11.93 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.081 0.863 . . . . 0.0 110.711 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 27.0 t -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.134 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 11.7 m -76.47 -46.03 28.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.107 0.963 . . . . 0.0 110.59 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 N--CA 1.476 0.852 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 -179.188 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.5 mttt -117.18 144.69 44.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.429 0.692 . . . . 0.0 109.754 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.539 HG23 HG12 ' A' ' 216' ' ' ILE . 23.9 m -143.23 169.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 122.844 0.458 . . . . 0.0 110.087 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.09 147.69 26.05 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.6 0.76 . . . . 0.0 110.481 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.468 ' CA ' HD11 ' A' ' 216' ' ' ILE . 4.2 t -73.53 120.08 79.26 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.537 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.55 -25.26 80.3 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.204 1.936 . . . . 0.0 111.874 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.03 -55.61 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 C-N-CA 123.623 0.769 . . . . 0.0 111.956 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 7.9 p -120.05 7.08 10.81 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.58 2.39 80.26 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 162.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.55 138.12 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.702 0.751 . . . . 0.0 112.202 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -91.57 124.98 36.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 0.0 110.652 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.539 HG13 HD13 ' A' ' 216' ' ' ILE . 0.3 OUTLIER -155.76 158.44 31.76 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.312 1.045 . . . . 0.0 110.063 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 35.0 Cg_endo -61.62 158.95 34.45 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.039 2.493 . . . . 0.0 113.615 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -48.72 -34.85 12.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.887 1.675 . . . . 0.0 113.622 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -70.4 -52.78 19.89 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.562 0.745 . . . . 0.0 111.135 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -80.42 -23.66 40.18 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.531 -173.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -80.12 -37.48 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 117.853 0.297 . . . . 0.0 111.305 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.9 -42.19 99.7 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -62.41 -45.76 91.65 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.865 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -48.8 74.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.629 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 1.8 pp -65.69 -33.5 76.03 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 124.003 0.815 . . . . 0.0 110.299 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.64 -57.89 10.98 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.399 1.079 . . . . 0.0 110.989 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 t -65.54 -28.51 69.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.983 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 40.6 m -80.58 -31.46 36.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.931 0.892 . . . . 0.0 111.911 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -127.11 129.0 47.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.616 HG23 HG12 ' A' ' 216' ' ' ILE . 20.9 m -136.03 165.24 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 122.811 0.444 . . . . 0.0 110.423 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.68 146.25 36.16 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.373 1.069 . . . . 0.0 111.004 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 11.7 t -86.56 105.52 8.01 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.82 -24.74 32.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 123.407 2.738 . . . . 0.0 113.68 -171.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.71 -53.26 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.35 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 209' ' ' VAL . 16.2 p -110.54 -15.51 13.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.03 49.89 6.14 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 123.452 0.549 . . . . 0.0 113.382 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.3 m -120.46 132.63 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 122.995 0.518 . . . . 0.0 110.123 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.83 129.27 34.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.6 OUTLIER -152.43 151.97 28.22 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.488 0.715 . . . . 0.0 111.053 -172.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.89 158.7 32.39 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.859 2.372 . . . . 0.0 113.044 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.19 -38.53 40.39 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.203 1.401 . . . . 0.0 114.122 -167.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.3 p -69.64 -49.62 52.05 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-O 121.348 0.594 . . . . 0.0 110.805 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.95 -33.02 73.87 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.677 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 202' ' ' VAL . 5.9 tp -72.87 -40.86 60.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -52.93 -50.03 64.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.043 0.449 . . . . 0.0 110.427 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.59 -43.59 76.14 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -52.8 55.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.419 -171.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 216' ' ' ILE . 2.2 pp -66.85 -32.87 74.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.565 0.541 . . . . 0.0 110.332 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.81 -58.09 10.08 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.878 0.736 . . . . 0.0 110.952 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 42.7 t -69.87 -28.51 65.71 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.251 1.021 . . . . 0.0 111.592 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.51 -49.35 41.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.657 0.783 . . . . 0.0 111.185 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 123.103 0.561 . . . . 0.0 110.095 179.311 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -97.54 142.65 29.12 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.438 0.695 . . . . 0.0 109.937 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -143.51 160.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.348 0.659 . . . . 0.0 109.979 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.51 147.31 30.91 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.348 1.059 . . . . 0.0 110.718 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.534 ' HA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -82.35 110.46 21.57 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.215 1.006 . . . . 0.0 109.473 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.95 -22.46 63.29 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.447 2.765 . . . . 0.0 113.036 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.22 -45.26 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 209' ' ' VAL . 15.3 p -118.86 -33.34 4.24 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -172.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.6 -17.18 9.56 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 168.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.447 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.5 m -67.19 135.27 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.45 128.86 36.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.681 0.792 . . . . 0.0 109.674 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.79 154.47 26.69 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 123.596 0.758 . . . . 0.0 110.493 -172.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.82 156.85 35.93 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.283 2.655 . . . . 0.0 113.218 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.42 -35.12 12.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.182 1.393 . . . . 0.0 113.875 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 13.2 p -70.62 -52.37 21.84 Favored 'General case' 0 C--O 1.252 1.22 0 C-N-CA 123.279 0.632 . . . . 0.0 111.679 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -75.06 -25.72 58.85 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.872 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 7.2 tp -78.39 -39.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -57.18 -43.21 82.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.36 -45.3 80.58 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -52.97 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.415 0.286 . . . . 0.0 111.237 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.92 -30.41 70.55 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.743 0.652 . . . . 0.0 110.49 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.87 -55.06 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.005 0.816 . . . . 0.0 110.113 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.9 t -65.13 -26.52 68.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.935 1.294 . . . . 0.0 111.462 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.4 -39.57 24.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.385 1.074 . . . . 0.0 111.123 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.655 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.3 mttt -122.49 138.75 54.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.219 0.608 . . . . 0.0 109.605 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 216' ' ' ILE . 20.3 m -141.27 165.45 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.936 0.494 . . . . 0.0 110.473 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.65 147.81 31.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.72 1.208 . . . . 0.0 111.084 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.475 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.2 t -81.55 112.66 35.9 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.812 0.845 . . . . 0.0 109.079 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.62 -24.47 45.37 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.149 2.566 . . . . 0.0 113.183 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.33 -57.55 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.084 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -111.32 -19.03 12.78 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.17 -29.38 7.39 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 167.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.91 138.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.76 122.42 33.48 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.397 1.079 . . . . 0.0 110.139 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.534 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.59 159.45 33.28 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 123.602 0.761 . . . . 0.0 110.19 -176.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.447 ' HD2' HG22 ' A' ' 211' ' ' ILE . 37.7 Cg_endo -61.63 156.35 48.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.899 2.399 . . . . 0.0 113.401 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.01 -40.57 4.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.963 1.705 . . . . 0.0 114.551 -169.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.3 p -76.89 -46.51 24.21 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.808 0.443 . . . . 0.0 111.651 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -75.22 -23.44 57.58 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.383 0.273 . . . . 0.0 111.361 -174.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -78.94 -41.9 23.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.949 0.5 . . . . 0.0 110.685 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -60.09 -39.25 85.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.903 0.383 . . . . 0.0 110.442 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -46.22 85.33 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 174.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.4 -47.7 78.18 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.347 0.404 . . . . 0.0 110.813 -173.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.47 -27.94 65.65 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.8 0.688 . . . . 0.0 110.997 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.65 -50.71 56.52 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 0.0 110.755 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.5 t -66.77 -31.53 72.23 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.645 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 56.9 m -78.88 -26.41 43.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.182 0.993 . . . . 0.0 111.08 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.4 tt . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.524 0.73 . . . . 0.0 109.385 172.162 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 91.5 mttt -119.93 138.23 53.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.836 0.854 . . . . 0.0 108.841 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.514 HG23 HG12 ' A' ' 216' ' ' ILE . 18.7 m -138.84 160.34 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.866 0.467 . . . . 0.0 110.19 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -78.49 147.98 33.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.214 0.606 . . . . 0.0 110.346 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.495 ' HA ' HD11 ' A' ' 216' ' ' ILE . 5.0 t -76.13 112.51 21.12 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.16 -25.62 56.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.797 2.331 . . . . 0.0 112.542 -175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.2 -57.42 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.17 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.8 p -108.98 -19.37 13.42 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 204' ' ' CYS . . . 110.55 -19.48 26.29 Favored Glycine 0 N--CA 1.478 1.455 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 166.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.05 136.48 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.68 122.88 34.64 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.199 1.0 . . . . 0.0 110.527 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.33 156.57 35.03 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 123.711 0.805 . . . . 0.0 110.136 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 211' ' ' ILE . 20.3 Cg_endo -58.12 153.58 44.84 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 123.16 2.573 . . . . 0.0 113.374 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.99 -34.32 12.84 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.431 1.492 . . . . 0.0 114.551 -166.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.9 p -74.93 -50.46 16.72 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.784 0.434 . . . . 0.0 111.246 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -72.36 -30.07 64.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.694 0.398 . . . . 0.0 111.115 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.55 HD13 HG13 ' A' ' 211' ' ' ILE . 8.2 tp -75.4 -36.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.99 -46.8 78.59 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.642 0.589 . . . . 0.0 109.975 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -62.25 -46.28 89.55 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.061 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -51.26 69.33 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.258 0.349 . . . . 0.0 110.994 -172.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 3.7 pp -70.4 -27.2 64.11 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.677 0.611 . . . . 0.0 111.181 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.39 -54.54 16.52 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.191 0.932 . . . . 0.0 110.4 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 34.9 t -67.87 -24.66 65.26 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 52.0 m -81.24 -28.09 34.94 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.905 0.882 . . . . 0.0 111.382 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 120.706 0.288 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -113.28 136.4 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.083 0.553 . . . . 0.0 110.153 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 216' ' ' ILE . 19.4 m -138.91 165.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.353 0.661 . . . . 0.0 110.112 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.66 147.87 33.38 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.998 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 12.8 t -82.83 107.4 9.2 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.8 -26.63 67.55 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.963 2.442 . . . . 0.0 112.888 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.3 t -88.67 -31.15 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -128.62 -30.8 2.28 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.371 0.987 . . . . 0.0 112.45 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.44 -16.54 10.55 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 164.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.45 134.73 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.02 124.86 32.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.768 0.827 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.448 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.1 pt -153.9 152.54 27.08 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.987 0.915 . . . . 0.0 110.689 -169.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.83 162.4 28.83 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.661 2.241 . . . . 0.0 112.573 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.83 -32.19 30.73 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.868 1.267 . . . . 0.0 113.456 -171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.3 p -68.99 -52.63 26.85 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.318 0.647 . . . . 0.0 111.514 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.7 t-160 -76.32 -25.07 54.41 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.023 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.587 HG12 HG23 ' A' ' 202' ' ' VAL . 6.3 tp -74.39 -42.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 118.847 -0.597 . . . . 0.0 111.445 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -52.48 -48.02 66.16 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -65.13 -50.19 67.0 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.5 OUTLIER -67.21 -48.25 68.43 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.524 0.33 . . . . 0.0 110.514 -167.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 216' ' ' ILE . 1.2 pp -67.15 -30.99 71.12 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.801 0.688 . . . . 0.0 109.999 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.73 -56.9 14.65 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.838 0.711 . . . . 0.0 110.418 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -64.05 -31.01 72.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.228 1.011 . . . . 0.0 111.424 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 59.7 m -77.45 -27.8 52.25 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.784 0.834 . . . . 0.0 110.898 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.4 tp . . . . . 0 CA--C 1.552 1.057 0 C-N-CA 123.268 0.627 . . . . 0.0 109.452 173.521 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.76 134.11 54.93 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.706 0.802 . . . . 0.0 109.095 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.563 HG23 HG12 ' A' ' 216' ' ' ILE . 22.3 m -137.9 167.72 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 121.246 0.546 . . . . 0.0 110.486 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 147.47 32.97 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.929 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.647 ' HA ' HD11 ' A' ' 216' ' ' ILE . 14.8 t -87.21 110.99 37.9 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.168 0.587 . . . . 0.0 109.885 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -53.0 -31.72 54.71 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.43 2.753 . . . . 0.0 113.522 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 8.8 t -85.33 -45.9 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.762 -173.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.9 p -111.43 -34.47 6.1 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 118.464 0.575 . . . . 0.0 112.165 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.89 16.9 14.06 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 168.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.03 143.31 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 117.953 0.876 . . . . 0.0 112.046 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.7 130.02 34.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.371 0.668 . . . . 0.0 109.76 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.52 151.21 20.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.103 0.961 . . . . 0.0 110.744 -172.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.38 159.67 22.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.871 2.381 . . . . 0.0 113.228 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -49.41 -41.68 40.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.631 1.572 . . . . 0.0 114.194 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 35.5 p -66.86 -50.87 61.13 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.134 0.492 . . . . 0.0 110.792 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -66.83 -32.36 73.59 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.701 -173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 204' ' ' CYS . 6.2 tp -73.51 -43.54 55.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.797 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -52.95 -47.25 68.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.448 0.567 . . . . 0.0 110.717 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.34 -44.42 79.12 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.71 -54.91 36.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.307 0.379 . . . . 0.0 110.583 -173.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 216' ' ' ILE . 3.5 pp -64.54 -32.26 73.83 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.03 0.831 . . . . 0.0 110.986 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.08 -56.87 10.53 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.963 0.789 . . . . 0.0 110.56 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 35.4 t -66.69 -24.43 66.26 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.989 0.916 . . . . 0.0 111.246 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.5 m -77.97 -37.54 47.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.794 0.838 . . . . 0.0 111.051 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.2 tp . . . . . 0 N--CA 1.479 0.991 0 C-N-CA 123.884 0.874 . . . . 0.0 109.981 177.247 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.8 mttt -126.31 132.42 51.64 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 216' ' ' ILE . 19.6 m -135.18 161.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.383 0.673 . . . . 0.0 109.796 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 146.49 31.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.689 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 211' ' ' ILE . 30.1 t -80.55 117.89 69.88 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.597 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.71 -26.43 82.15 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.911 2.408 . . . . 0.0 112.735 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 9.4 t -86.99 -57.83 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -103.96 -20.26 13.94 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.0 45.87 5.82 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.88 138.49 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.803 0.441 . . . . 0.0 110.742 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -79.08 131.03 36.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.5 OUTLIER -155.58 150.3 20.36 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 124.406 1.082 . . . . 0.0 110.008 -169.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.484 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 44.3 Cg_endo -64.67 161.38 35.96 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.446 2.097 . . . . 0.0 112.308 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 216' ' ' ILE . 10.7 pt-20 -52.13 -38.76 58.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.036 1.335 . . . . 0.0 113.497 -172.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.5 p -65.61 -48.28 72.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.414 0.626 . . . . 0.0 110.603 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 17.0 t-160 -76.38 -24.79 54.13 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.478 HG13 HD23 ' A' ' 220' ' ' LEU . 5.3 tp -74.06 -46.51 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.822 0.737 . . . . 0.0 110.546 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -55.44 -44.97 76.83 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.285 0.564 . . . . 0.0 110.248 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.98 -42.85 84.4 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.699 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -68.83 -54.69 14.32 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.921 0.488 . . . . 0.0 109.738 -172.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.478 HD23 HG13 ' A' ' 216' ' ' ILE . 1.8 pp -62.03 -32.65 73.17 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 124.2 0.937 . . . . 0.0 110.08 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.44 -57.93 10.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.8 0.84 . . . . 0.0 111.096 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -67.8 -26.36 66.05 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.246 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 57.9 m -80.74 -37.42 30.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.317 1.047 . . . . 0.0 111.344 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.078 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.358 0.123 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.402 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.8 mttt -112.25 143.68 42.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 0.0 109.492 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.572 HG23 HG12 ' A' ' 216' ' ' ILE . 17.2 m -143.5 170.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 122.661 0.385 . . . . 0.0 110.288 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.93 146.32 32.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.191 0.996 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.424 ' CA ' HD11 ' A' ' 216' ' ' ILE . 14.5 t -85.21 100.04 1.07 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.714 0.806 . . . . 0.0 109.003 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -55.75 -18.08 20.07 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.224 2.616 . . . . 0.0 114.12 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.93 -56.95 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.133 0.573 . . . . 0.0 111.499 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 15.4 p -104.59 -34.16 8.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 97.73 53.82 1.27 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 114.314 0.486 . . . . 0.0 114.314 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.32 143.37 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.332 0.653 . . . . 0.0 110.57 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -95.88 122.23 38.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.373 0.669 . . . . 0.0 109.973 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 216' ' ' ILE . 0.4 OUTLIER -155.28 155.19 29.67 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.402 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 18.5 Cg_endo -58.4 159.13 20.46 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.479 2.786 . . . . 0.0 113.976 178.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.94 -36.01 11.68 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.273 1.829 . . . . 0.0 114.552 -169.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.6 p -73.18 -51.07 19.16 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.372 0.669 . . . . 0.0 111.251 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -71.89 -32.06 67.05 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.532 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 202' ' ' VAL . 10.8 tp -78.07 -38.49 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.615 0.366 . . . . 0.0 111.14 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.17 -42.4 98.5 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.63 0.581 . . . . 0.0 109.468 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.15 -46.75 79.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.629 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.15 -45.36 92.25 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 119.554 -0.26 . . . . 0.0 110.885 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.94 -32.94 63.73 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.35 0.406 . . . . 0.0 110.677 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.26 -52.75 44.48 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.208 0.943 . . . . 0.0 109.96 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.8 t -60.47 -45.94 91.9 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.261 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.1 m -62.93 -32.85 74.24 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.84 0.856 . . . . 0.0 112.485 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.484 1.244 0 C-N-CA 123.517 0.727 . . . . 0.0 110.121 -178.595 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -122.73 140.92 52.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.541 0.736 . . . . 0.0 109.143 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.628 HG23 HG12 ' A' ' 216' ' ' ILE . 15.5 m -142.38 167.16 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.576 0.35 . . . . 0.0 110.337 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.71 145.37 34.55 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.565 1.146 . . . . 0.0 110.928 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' CYS . . . . . 0.425 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.8 t -82.82 106.95 7.86 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.1 -17.52 32.1 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.692 2.262 . . . . 0.0 113.22 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.91 -57.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.823 0.849 . . . . 0.0 112.224 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 10.8 p -115.41 -3.24 12.44 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -166.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.4 34.27 45.81 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.27 136.28 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 117.046 0.423 . . . . 0.0 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.74 129.2 36.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.992 0.517 . . . . 0.0 109.761 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.547 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -155.62 156.02 30.28 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.907 0.883 . . . . 0.0 110.045 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.45 157.62 17.99 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.402 2.735 . . . . 0.0 114.218 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.41 -37.71 17.73 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.238 1.815 . . . . 0.0 113.775 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.9 p -67.2 -52.9 35.51 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.384 0.611 . . . . 0.0 111.309 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -80.57 -22.44 40.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.57 -172.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 202' ' ' VAL . 10.1 tp -79.44 -43.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.569 0.347 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.24 -43.49 86.45 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.494 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -53.19 59.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.701 0.401 . . . . 0.0 110.553 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.1 -30.71 69.95 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.906 0.754 . . . . 0.0 110.699 -172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.23 -57.88 10.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.89 0.876 . . . . 0.0 110.589 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.6 t -68.19 -27.87 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.035 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.38 -39.61 58.96 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 0.0 111.045 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 CA-C-O 119.927 -0.374 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.6 p -72.12 82.4 0.98 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.179 0.592 . . . . 0.0 110.384 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -152.93 -74.22 0.13 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -160.84 109.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.163 1.385 . . . . 0.0 107.896 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -164.7 131.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 0.0 109.95 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 9.0 t -112.78 150.7 31.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.422 0.689 . . . . 0.0 110.199 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -117.48 143.28 46.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 109.415 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 216' ' ' ILE . 18.1 m -142.67 172.14 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 122.737 0.415 . . . . 0.0 110.19 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.85 147.11 29.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.188 0.995 . . . . 0.0 111.224 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.432 ' CA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -85.58 106.56 9.71 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.173 0.989 . . . . 0.0 108.46 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.45 -23.83 33.01 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.291 2.661 . . . . 0.0 113.608 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.7 -54.8 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 C-N-CA 123.026 0.53 . . . . 0.0 111.986 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 12.4 p -108.3 -19.21 13.55 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.19 5.12 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 122.847 0.26 . . . . 0.0 113.696 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.85 147.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.284 0.634 . . . . 0.0 111.301 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.89 126.71 47.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.152 0.581 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.515 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.6 155.95 29.35 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.551 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 157.26 29.03 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.996 2.464 . . . . 0.0 112.953 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -39.14 40.96 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.44 1.496 . . . . 0.0 113.86 -167.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 52.7 p -68.07 -50.36 55.59 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.32 0.648 . . . . 0.0 111.041 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.35 -30.51 63.38 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.869 -172.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 202' ' ' VAL . 9.6 tp -77.42 -40.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.198 0.599 . . . . 0.0 110.948 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.44 -43.53 93.12 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.543 0.527 . . . . 0.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -43.38 90.15 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.407 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -52.03 67.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 123.334 0.396 . . . . 0.0 110.322 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.51 -30.73 68.64 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.788 0.68 . . . . 0.0 111.146 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.86 -47.86 76.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.806 0.842 . . . . 0.0 110.846 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.6 t -75.07 -26.75 59.59 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.993 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 36.1 m -77.78 -30.76 51.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.123 0.969 . . . . 0.0 111.65 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.54 -27.24 66.03 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.097 0.959 . . . . 0.0 108.853 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 48.1 m -87.42 -52.99 5.06 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.688 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -133.08 82.7 2.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.038 0.535 . . . . 0.0 111.543 -171.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 124.611 1.164 . . . . 0.0 113.895 165.576 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.5 m -68.99 95.08 0.68 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.532 0.733 . . . . 0.0 111.046 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -76.71 -36.3 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.875 0.87 . . . . 0.0 110.634 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -97.71 107.72 20.27 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.34 121.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 125.186 1.394 . . . . 0.0 107.284 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.5 t -80.46 142.46 34.25 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.765 0.317 . . . . 0.0 110.297 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -128.15 141.37 51.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.914 0.886 . . . . 0.0 109.248 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.644 HG23 HG12 ' A' ' 216' ' ' ILE . 12.1 m -140.73 158.79 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.561 0.344 . . . . 0.0 110.321 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.0 146.5 35.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.777 0.831 . . . . 0.0 110.011 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 216' ' ' ILE . 8.0 t -82.58 107.69 9.85 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.774 0.83 . . . . 0.0 109.14 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.55 -27.98 53.06 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.647 2.231 . . . . 0.0 113.142 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 4.1 t -85.39 -43.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.973 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.92 -28.32 5.95 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 118.514 0.597 . . . . 0.0 112.333 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 101.57 23.69 9.28 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 136.51 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 117.625 0.712 . . . . 0.0 111.738 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -89.03 130.66 35.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 109.974 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.58 155.91 29.3 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 110.285 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.54 155.21 43.26 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.988 2.459 . . . . 0.0 113.68 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -44.4 -38.48 4.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.676 1.99 . . . . 0.0 114.609 -170.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.9 p -71.01 -52.29 20.44 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.554 0.742 . . . . 0.0 111.25 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.1 -27.12 60.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.127 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.644 HG12 HG23 ' A' ' 202' ' ' VAL . 7.3 tp -79.27 -40.91 22.39 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.174 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -57.38 -43.05 83.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.66 -48.48 79.16 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.388 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -53.97 47.41 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.871 0.468 . . . . 0.0 110.878 -172.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 216' ' ' ILE . 3.3 pp -66.14 -31.47 72.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 124.13 0.894 . . . . 0.0 110.838 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.74 -57.87 8.63 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 0.0 110.197 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.5 t -63.93 -33.48 75.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.381 1.072 . . . . 0.0 110.837 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.7 m -69.46 -44.28 71.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 111.014 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.36 -33.43 75.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.077 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 20.5 t -83.67 -9.69 58.69 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.029 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -83.29 -47.61 11.32 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.813 0.445 . . . . 0.0 109.883 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--O 1.247 0.94 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.841 -178.157 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.8 m -67.78 144.87 55.18 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.634 0.773 . . . . 0.0 110.468 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.24 100.67 2.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.4 0.68 . . . . 0.0 109.873 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.25 139.49 57.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.241 0.616 . . . . 0.0 111.033 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.518 HG23 ' HG2' ' A' ' 213' ' ' GLU . 7.6 p -171.83 119.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.159 0.983 . . . . 0.0 108.36 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.7 t -82.82 147.17 28.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.829 0.452 . . . . 0.0 110.505 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -118.57 141.22 48.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.938 0.495 . . . . 0.0 110.785 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.9 m -142.4 160.63 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.996 0.918 . . . . 0.0 109.727 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.73 147.07 30.73 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.488 0.715 . . . . 0.0 110.283 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.537 ' HA ' HD11 ' A' ' 216' ' ' ILE . 34.4 t -79.53 110.16 14.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.315 0.646 . . . . 0.0 110.327 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.96 -24.09 37.84 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.609 2.873 . . . . 0.0 113.61 -171.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 t -85.48 -55.27 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 0.0 111.703 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.01 -27.81 9.93 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.59 26.55 8.54 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.03 0.772 . . . . 0.0 115.03 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.48 134.76 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 117.434 0.617 . . . . 0.0 111.489 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -84.39 125.52 32.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.0 OUTLIER -154.52 151.87 24.77 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.13 0.972 . . . . 0.0 110.876 -169.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.7 161.46 28.47 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.025 2.484 . . . . 0.0 112.689 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 199' ' ' VAL . 11.6 pt-20 -55.52 -32.15 62.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.484 1.114 . . . . 0.0 112.674 -169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.7 p -66.25 -52.41 47.96 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.187 0.595 . . . . 0.0 111.017 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 26.1 t-80 -76.74 -26.18 54.3 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.779 -172.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 5.6 tp -72.8 -43.92 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.849 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.53 -45.72 73.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.536 0.523 . . . . 0.0 109.869 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -67.4 -42.31 83.5 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.464 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -71.37 -50.34 33.15 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.699 0.227 . . . . 0.0 111.079 -170.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 216' ' ' ILE . 2.4 pp -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.708 0.63 . . . . 0.0 109.765 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.75 -52.79 61.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.92 0.888 . . . . 0.0 110.856 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.0 t -67.76 -27.99 67.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.817 1.247 . . . . 0.0 111.291 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 35.3 m -82.11 -26.43 33.57 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 111.353 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.36 -19.33 36.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.686 0.795 . . . . 0.0 108.983 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 30.4 t -83.32 -44.66 14.65 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.97 0.908 . . . . 0.0 110.618 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -118.45 -171.36 2.07 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 174.419 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 CA-C-O 119.857 -0.413 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 33.6 t -74.0 122.14 22.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.762 0.825 . . . . 0.0 110.474 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.23 175.14 5.54 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.985 0.914 . . . . 0.0 109.349 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -75.24 97.91 3.65 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.648 0.737 . . . . 0.0 110.2 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.6 p -163.35 132.9 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 125.531 1.532 . . . . 0.0 107.492 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.9 t -96.53 142.23 28.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.532 0.333 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.83 141.04 48.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.912 0.885 . . . . 0.0 108.805 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -144.24 158.29 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.44 0.696 . . . . 0.0 109.602 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.17 145.23 33.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.286 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 216' ' ' ILE . 46.1 t -80.36 109.57 13.25 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 110.093 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.32 -27.61 67.93 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.309 2.673 . . . . 0.0 113.392 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.4 t -87.79 -29.03 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.576 0 C-N-CA 123.59 0.756 . . . . 0.0 112.89 -173.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 18.9 p -129.5 -34.36 1.81 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.194 -0.941 . . . . 0.0 112.061 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 96.44 53.85 1.41 Allowed Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.822 0.289 . . . . 0.0 113.822 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.86 130.0 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.633 0.773 . . . . 0.0 109.872 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.56 126.0 30.32 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 215' ' ' HIS . 1.2 pt -154.29 151.76 24.9 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.64 161.38 24.87 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.929 2.42 . . . . 0.0 112.665 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.26 -31.22 53.07 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.47 1.106 . . . . 0.0 113.259 -169.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.6 p -66.86 -51.75 51.77 Favored 'General case' 0 C--O 1.25 1.129 0 C-N-CA 122.716 0.406 . . . . 0.0 111.087 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 211' ' ' ILE . 18.1 t-160 -74.48 -31.51 62.24 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.225 -171.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 202' ' ' VAL . 4.5 tp -67.78 -46.18 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.965 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -54.44 -46.59 73.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.623 0.577 . . . . 0.0 110.355 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -67.5 -40.86 85.2 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.52 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -70.73 -49.42 47.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.471 0.308 . . . . 0.0 110.49 -170.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.24 -31.83 72.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 109.642 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.87 -55.46 29.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.118 0.967 . . . . 0.0 111.073 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -69.9 -24.17 63.35 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.154 0.981 . . . . 0.0 111.201 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 34.2 m -81.37 -30.11 33.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.894 0.878 . . . . 0.0 111.062 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.79 -25.11 56.11 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 37.1 t -76.84 -67.91 0.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.881 0.872 . . . . 0.0 110.197 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -103.14 151.56 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.167 0.587 . . . . 0.0 110.659 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 123.719 0.808 . . . . 0.0 109.458 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 200' ' ' THR . 33.0 m -69.12 103.68 1.95 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.828 0.851 . . . . 0.0 110.557 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -67.75 -40.59 84.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.53 -42.69 86.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.28 0.632 . . . . 0.0 111.096 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.457 HG23 ' HG2' ' A' ' 213' ' ' GLU . 8.2 p -175.15 108.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-O 122.364 1.078 . . . . 0.0 109.39 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 196' ' ' SER . 1.9 m -74.86 132.8 41.78 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.7 mttt -115.01 134.2 55.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.431 0.692 . . . . 0.0 110.514 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.04 173.42 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.871 0.868 . . . . 0.0 110.095 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -89.86 146.99 24.03 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.127 0.571 . . . . 0.0 111.019 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 211' ' ' ILE . 15.5 t -79.27 117.82 69.1 Favored Pre-proline 0 C--O 1.219 -0.511 0 C-N-CA 123.792 0.837 . . . . 0.0 109.839 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.03 -28.43 87.04 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.972 2.448 . . . . 0.0 112.669 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.0 t -85.77 -46.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.372 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.4 p -111.78 -33.57 6.28 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.04 6.88 31.73 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 207' ' ' CYS . 28.2 m -83.5 145.85 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 0.0 112.213 -176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -82.07 133.15 35.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 0.0 109.974 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.75 147.62 15.42 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.294 1.038 . . . . 0.0 109.979 -169.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 48.1 Cg_endo -66.82 161.7 40.89 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.428 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.457 ' HG2' HG23 ' A' ' 199' ' ' VAL . 12.2 pt-20 -53.29 -34.72 58.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.718 1.207 . . . . 0.0 113.573 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.7 p -68.6 -50.39 51.93 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.796 0.839 . . . . 0.0 110.817 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.2 t-160 -80.17 -17.31 52.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.912 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 211' ' ' ILE . 4.3 tp -76.36 -44.73 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.689 0.677 . . . . 0.0 109.708 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -53.46 -45.66 69.6 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 124.084 0.865 . . . . 0.0 109.572 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.47 -50.22 64.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.442 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -65.39 -44.99 85.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 117.92 0.327 . . . . 0.0 110.334 -168.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.03 -35.38 78.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.239 0.962 . . . . 0.0 109.478 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.78 -54.3 46.81 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.921 0.888 . . . . 0.0 110.312 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.8 t -62.77 -33.86 76.04 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.042 1.337 . . . . 0.0 111.409 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 30.4 m -79.36 -29.66 42.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.644 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.49 -27.36 51.85 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.8 t -73.67 -44.83 55.68 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.736 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -96.99 178.85 5.14 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.75 0.82 . . . . 0.0 111.311 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.312 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.6 p -74.27 87.31 1.97 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 110.585 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.53 -63.6 1.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.806 0.842 . . . . 0.0 109.376 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.68 94.27 4.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.96 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.03 133.99 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.488 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t -103.66 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.72 138.37 53.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.385 0.674 . . . . 0.0 110.211 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 216' ' ' ILE . 20.8 m -139.4 164.56 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.54 0.736 . . . . 0.0 109.784 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 147.5 28.88 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.621 0.768 . . . . 0.0 109.864 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.474 ' HA ' HD11 ' A' ' 216' ' ' ILE . 10.3 t -81.89 109.78 16.81 Favored Pre-proline 0 C--O 1.222 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 109.159 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.47 -23.17 62.82 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.19 2.593 . . . . 0.0 113.374 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 11.8 t -87.54 -38.05 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.434 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 209' ' ' VAL . 14.5 p -125.95 -29.2 3.11 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -170.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.18 -5.63 30.31 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.458 HG22 ' SG ' ' A' ' 207' ' ' CYS . 21.5 m -69.12 133.19 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 117.407 0.603 . . . . 0.0 111.773 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.26 124.06 30.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.571 0.748 . . . . 0.0 109.305 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.9 OUTLIER -150.93 151.47 29.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.595 0.758 . . . . 0.0 110.803 -169.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.62 160.79 34.58 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.941 2.428 . . . . 0.0 112.797 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.97 -37.43 32.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.348 1.459 . . . . 0.0 113.736 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.2 m -67.71 -51.14 53.04 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.37 -32.17 68.18 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 202' ' ' VAL . 5.5 tp -70.87 -45.32 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -53.4 -45.85 69.47 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -66.91 -48.75 67.72 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.201 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -47.15 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.604 0.362 . . . . 0.0 110.388 -168.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -32.73 74.06 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 123.881 0.738 . . . . 0.0 109.682 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -57.59 12.3 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 123.269 0.628 . . . . 0.0 110.708 174.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.6 t -63.36 -30.94 71.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 36.1 m -79.18 -32.12 44.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.804 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.57 -26.8 68.57 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.481 0.712 . . . . 0.0 111.655 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 51.8 p -95.12 -7.23 39.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.655 0.782 . . . . 0.0 111.668 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -130.98 168.76 16.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.781 0.832 . . . . 0.0 111.05 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.13 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.48 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 32.4 m -77.79 100.17 6.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.537 0.735 . . . . 0.0 110.17 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -63.1 107.49 1.04 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -117.57 165.44 13.57 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.968 0.907 . . . . 0.0 110.684 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.4 p -154.81 115.1 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.401 1.081 . . . . 0.0 108.294 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t -79.85 146.99 31.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.482 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -124.26 143.84 50.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.365 0.666 . . . . 0.0 110.394 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.696 HG23 HG12 ' A' ' 216' ' ' ILE . 19.0 m -142.43 163.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.678 0.791 . . . . 0.0 109.753 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 146.69 35.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.801 0.84 . . . . 0.0 110.967 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.53 ' HA ' HD11 ' A' ' 216' ' ' ILE . 9.8 t -84.01 107.74 11.6 Favored Pre-proline 0 C--O 1.218 -0.599 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -56.89 -25.7 63.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.885 2.39 . . . . 0.0 113.127 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.96 -43.98 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.625 0.77 . . . . 0.0 112.13 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 209' ' ' VAL . 10.1 p -125.36 4.71 7.71 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -170.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.23 45.65 95.69 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 125.223 1.392 . . . . 0.0 115.208 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.456 HG22 ' SG ' ' A' ' 207' ' ' CYS . 27.6 m -117.48 128.69 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 175.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.17 126.07 31.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.414 0.685 . . . . 0.0 109.704 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -152.78 150.68 25.05 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.725 0.81 . . . . 0.0 111.472 -169.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.49 156.98 38.55 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 123.192 2.595 . . . . 0.0 113.14 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.08 -39.04 12.27 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.229 1.812 . . . . 0.0 114.311 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 37.7 p -69.02 -51.65 36.94 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.317 0.58 . . . . 0.0 111.078 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 12.2 t60 -70.37 -32.29 69.91 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.549 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.696 HG12 HG23 ' A' ' 202' ' ' VAL . 5.0 tp -71.8 -46.09 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.494 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.11 -44.21 83.03 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.183 0.302 . . . . 0.0 110.329 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -69.52 -42.39 74.76 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.974 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -64.47 -50.46 67.4 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.583 -172.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 216' ' ' ILE . 1.6 pp -69.19 -32.83 72.39 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.889 0.743 . . . . 0.0 110.096 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.42 -55.51 27.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.674 0.79 . . . . 0.0 110.115 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -64.96 -33.1 75.24 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 124.348 1.059 . . . . 0.0 110.674 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 32.7 m -73.61 -36.03 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.961 0.904 . . . . 0.0 111.314 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.72 -32.52 69.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.9 t -82.72 -34.11 27.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.978 0.911 . . . . 0.0 111.249 -174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -161.03 142.37 11.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.921 0.888 . . . . 0.0 109.071 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.251 1.153 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.483 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.5 p -69.12 138.67 54.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.686 0.794 . . . . 0.0 111.603 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -127.4 -179.43 4.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.538 1.135 . . . . 0.0 110.243 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 66.08 17.06 10.68 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.056 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.26 114.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.834 0 C-N-CA 124.747 1.219 . . . . 0.0 107.779 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.6 t -73.93 136.94 43.32 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.91 132.47 50.88 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.147 0.579 . . . . 0.0 109.864 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.53 HG23 HG12 ' A' ' 216' ' ' ILE . 30.4 m -135.79 164.03 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.561 0.744 . . . . 0.0 110.006 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.28 147.24 32.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.271 1.028 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.451 ' HA ' HD11 ' A' ' 216' ' ' ILE . 23.5 t -82.68 108.81 13.33 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.017 0.527 . . . . 0.0 109.764 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.42 -27.24 75.08 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.026 2.484 . . . . 0.0 113.231 -170.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.2 t -86.72 -36.53 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 123.304 0.642 . . . . 0.0 111.976 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.5 p -122.72 -37.54 2.75 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 118.571 0.623 . . . . 0.0 112.176 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.21 -3.34 14.1 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.8 140.02 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 118.425 1.112 . . . . 0.0 112.12 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.95 128.73 34.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -153.2 149.78 22.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.254 0.621 . . . . 0.0 111.025 -170.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.33 161.7 29.88 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.871 2.381 . . . . 0.0 113.154 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.67 -41.92 44.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.05 1.74 . . . . 0.0 114.573 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.5 p -71.5 -43.56 66.29 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.262 0.553 . . . . 0.0 110.643 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 37.8 t-80 -75.14 -22.81 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.53 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -77.2 -45.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.554 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -51.26 -48.33 62.22 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.783 0.677 . . . . 0.0 110.558 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -69.98 -45.14 67.98 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.344 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -62.59 -51.51 67.02 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 117.869 0.304 . . . . 0.0 110.811 -173.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 216' ' ' ILE . 2.1 pp -64.21 -34.27 77.72 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.915 0.759 . . . . 0.0 110.162 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.36 -54.38 37.71 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.053 0.846 . . . . 0.0 111.289 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -65.37 -27.66 68.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.902 1.281 . . . . 0.0 110.981 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.1 m -80.66 -36.17 32.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.511 1.124 . . . . 0.0 111.811 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -76.67 -30.38 56.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.511 0.725 . . . . 0.0 109.801 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 55.3 p -69.45 -50.41 45.84 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.15 -173.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -137.6 138.41 39.5 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 123.07 0.548 . . . . 0.0 109.83 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.1 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 25.4 m -76.36 122.17 24.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.755 0.822 . . . . 0.0 110.728 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.41 62.61 7.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 122.043 0.925 . . . . 0.0 109.442 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -140.95 -53.55 0.48 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 12.7 p -172.81 125.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.601 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.8 t -83.08 129.34 35.02 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -116.52 137.82 51.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.168 0.587 . . . . 0.0 110.026 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 216' ' ' ILE . 16.1 m -141.69 164.09 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.746 0.818 . . . . 0.0 110.125 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.64 146.56 34.01 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.495 1.118 . . . . 0.0 111.023 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.513 ' HA ' HD11 ' A' ' 216' ' ' ILE . 19.2 t -84.86 106.19 8.11 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 123.622 0.769 . . . . 0.0 109.154 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -54.32 -25.43 39.0 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.6 2.867 . . . . 0.0 113.62 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.79 -57.1 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.835 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.6 p -99.17 -31.34 11.79 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.07 0.395 . . . . 0.0 111.719 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.86 2.79 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.404 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.1 m -120.61 140.41 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.119 0.568 . . . . 0.0 110.853 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.58 133.71 35.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.897 0.479 . . . . 0.0 109.993 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.16 149.43 17.74 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 0.0 110.483 -171.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.62 159.14 33.66 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.963 2.442 . . . . 0.0 112.897 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -50.3 -37.66 37.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.278 1.431 . . . . 0.0 113.944 -170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.1 p -69.53 -50.82 41.45 Favored 'General case' 0 C--O 1.254 1.298 0 C-N-CA 123.043 0.537 . . . . 0.0 110.912 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.57 -31.43 69.6 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.368 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.571 HG12 HG23 ' A' ' 202' ' ' VAL . 5.7 tp -70.09 -42.42 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.887 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -52.32 -50.57 61.98 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.22 -42.01 72.85 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.236 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -51.33 61.66 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.449 HD23 HG13 ' A' ' 216' ' ' ILE . 1.9 pp -64.82 -35.32 80.73 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.819 0.7 . . . . 0.0 110.073 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.75 -52.96 61.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.654 0.74 . . . . 0.0 110.685 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -67.83 -25.27 65.48 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.706 1.202 . . . . 0.0 111.438 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.78 -36.55 28.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.286 1.034 . . . . 0.0 111.671 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.12 -26.48 62.13 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 35.4 t -87.37 -68.03 0.78 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.296 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -95.7 97.4 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.252 1.225 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.931 178.425 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 CA-C-O 120.058 -0.301 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 36.7 m -67.9 104.42 1.71 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.726 0.81 . . . . 0.0 110.72 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -67.2 149.61 50.22 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.679 0.792 . . . . 0.0 109.564 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -66.37 -31.01 71.53 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.453 HG23 ' HG2' ' A' ' 213' ' ' GLU . 7.6 p -167.93 117.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.946 1.298 . . . . 0.0 108.328 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.6 t -80.15 144.31 33.13 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.263 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -121.01 137.77 54.49 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.215 0.606 . . . . 0.0 110.552 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.61 HG23 HG12 ' A' ' 216' ' ' ILE . 16.0 m -141.66 161.71 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.584 0.754 . . . . 0.0 110.628 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.41 146.31 32.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.631 1.172 . . . . 0.0 110.918 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' A' ' 216' ' ' ILE . 20.1 t -84.01 109.79 21.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 123.599 0.76 . . . . 0.0 109.744 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.08 -23.3 60.2 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.27 2.647 . . . . 0.0 113.691 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 -50.28 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.484 0.713 . . . . 0.0 111.754 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.6 p -113.23 -26.36 8.44 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 94.39 41.67 4.16 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.25 136.9 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.109 0.564 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -86.14 127.64 34.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.982 0.513 . . . . 0.0 109.777 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.466 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -154.08 152.02 25.74 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.251 1.02 . . . . 0.0 110.361 -169.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.25 160.04 28.42 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.198 2.599 . . . . 0.0 112.917 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 199' ' ' VAL . 12.2 pt-20 -53.66 -34.89 60.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.038 1.335 . . . . 0.0 113.532 -168.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 57.4 p -70.83 -47.73 57.84 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.38 0.672 . . . . 0.0 111.281 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -69.93 -34.37 73.38 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -73.29 -40.47 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.073 0.549 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -55.14 -46.49 75.68 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -66.93 -44.32 80.97 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.247 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -55.85 12.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.759 0.424 . . . . 0.0 110.567 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 216' ' ' ILE . 1.3 pp -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.94 0.775 . . . . 0.0 109.976 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.45 -57.63 11.93 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.081 0.863 . . . . 0.0 110.711 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 27.0 t -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.134 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 11.7 m -76.47 -46.03 28.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.107 0.963 . . . . 0.0 110.59 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.25 -32.35 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 68.6 p -89.35 -12.67 39.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.432 0.693 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -69.98 -35.18 74.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 C--O 1.254 1.308 0 C-N-CA 123.977 0.911 . . . . 0.0 111.482 -177.88 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.011 0 N-CA-C 112.346 -0.302 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.3 p -83.52 79.62 9.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 110.273 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -88.17 111.68 21.89 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.611 0.765 . . . . 0.0 109.401 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -72.48 99.72 2.55 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.135 0.574 . . . . 0.0 110.038 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 213' ' ' GLU . 4.3 p -163.12 121.21 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.23 1.012 . . . . 0.0 109.442 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t -92.86 151.0 20.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.293 0.637 . . . . 0.0 110.225 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.5 mttt -117.18 144.69 44.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.429 0.692 . . . . 0.0 109.754 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.539 HG23 HG12 ' A' ' 216' ' ' ILE . 23.9 m -143.23 169.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 122.844 0.458 . . . . 0.0 110.087 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.09 147.69 26.05 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.6 0.76 . . . . 0.0 110.481 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.468 ' CA ' HD11 ' A' ' 216' ' ' ILE . 4.2 t -73.53 120.08 79.26 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.537 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.55 -25.26 80.3 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.204 1.936 . . . . 0.0 111.874 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.03 -55.61 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 C-N-CA 123.623 0.769 . . . . 0.0 111.956 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 7.9 p -120.05 7.08 10.81 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.58 2.39 80.26 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 162.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.55 138.12 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.702 0.751 . . . . 0.0 112.202 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -91.57 124.98 36.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 0.0 110.652 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.539 HG13 HD13 ' A' ' 216' ' ' ILE . 0.3 OUTLIER -155.76 158.44 31.76 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.312 1.045 . . . . 0.0 110.063 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 35.0 Cg_endo -61.62 158.95 34.45 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.039 2.493 . . . . 0.0 113.615 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.414 ' HG2' HG23 ' A' ' 199' ' ' VAL . 10.7 pt-20 -48.72 -34.85 12.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.887 1.675 . . . . 0.0 113.622 -170.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -70.4 -52.78 19.89 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.562 0.745 . . . . 0.0 111.135 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -80.42 -23.66 40.18 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.531 -173.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -80.12 -37.48 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 117.853 0.297 . . . . 0.0 111.305 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.9 -42.19 99.7 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -62.41 -45.76 91.65 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.865 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -48.8 74.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.629 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 1.8 pp -65.69 -33.5 76.03 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 124.003 0.815 . . . . 0.0 110.299 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.64 -57.89 10.98 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.399 1.079 . . . . 0.0 110.989 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 t -65.54 -28.51 69.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.983 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 40.6 m -80.58 -31.46 36.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.931 0.892 . . . . 0.0 111.911 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -81.35 -14.48 57.21 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 24.8 t -113.34 -68.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 110.605 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -78.98 95.8 5.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.586 0.754 . . . . 0.0 109.297 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 C--O 1.252 1.203 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.27 -177.881 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 32.8 m -91.56 104.81 17.26 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.633 0.773 . . . . 0.0 109.382 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -78.61 165.38 23.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.037 0.535 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.61 101.53 4.98 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.5 p -162.49 122.98 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.662 1.185 . . . . 0.0 108.701 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.0 t -94.52 150.8 19.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -127.11 129.0 47.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.616 HG23 HG12 ' A' ' 216' ' ' ILE . 20.9 m -136.03 165.24 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 122.811 0.444 . . . . 0.0 110.423 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.68 146.25 36.16 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.373 1.069 . . . . 0.0 111.004 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 11.7 t -86.56 105.52 8.01 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.82 -24.74 32.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 123.407 2.738 . . . . 0.0 113.68 -171.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.71 -53.26 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.35 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 209' ' ' VAL . 16.2 p -110.54 -15.51 13.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.03 49.89 6.14 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 123.452 0.549 . . . . 0.0 113.382 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.3 m -120.46 132.63 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 122.995 0.518 . . . . 0.0 110.123 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.83 129.27 34.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.6 OUTLIER -152.43 151.97 28.22 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.488 0.715 . . . . 0.0 111.053 -172.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.89 158.7 32.39 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.859 2.372 . . . . 0.0 113.044 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.19 -38.53 40.39 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.203 1.401 . . . . 0.0 114.122 -167.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.3 p -69.64 -49.62 52.05 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-O 121.348 0.594 . . . . 0.0 110.805 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.95 -33.02 73.87 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.677 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 202' ' ' VAL . 5.9 tp -72.87 -40.86 60.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -52.93 -50.03 64.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.043 0.449 . . . . 0.0 110.427 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.59 -43.59 76.14 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -52.8 55.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.419 -171.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 216' ' ' ILE . 2.2 pp -66.85 -32.87 74.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.565 0.541 . . . . 0.0 110.332 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.81 -58.09 10.08 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.878 0.736 . . . . 0.0 110.952 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 42.7 t -69.87 -28.51 65.71 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.251 1.021 . . . . 0.0 111.592 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.51 -49.35 41.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.657 0.783 . . . . 0.0 111.185 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 tp -71.25 -28.59 64.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.103 0.561 . . . . 0.0 110.095 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.1 t -76.79 -25.8 53.74 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 64.97 91.12 0.08 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.388 1.075 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 CA--C 1.557 1.218 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.63 175.544 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.4 m 62.85 13.42 6.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.759 1.223 . . . . 0.0 113.59 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -82.5 112.78 19.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.406 0.683 . . . . 0.0 110.706 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -128.62 136.3 50.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.844 0.857 . . . . 0.0 108.866 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.3 p -171.09 93.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 m -65.53 123.99 21.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.503 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -97.54 142.65 29.12 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.438 0.695 . . . . 0.0 109.937 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -143.51 160.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.348 0.659 . . . . 0.0 109.979 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.51 147.31 30.91 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.348 1.059 . . . . 0.0 110.718 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.534 ' HA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -82.35 110.46 21.57 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.215 1.006 . . . . 0.0 109.473 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.95 -22.46 63.29 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.447 2.765 . . . . 0.0 113.036 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.22 -45.26 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 209' ' ' VAL . 15.3 p -118.86 -33.34 4.24 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -172.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.6 -17.18 9.56 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 168.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.447 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.5 m -67.19 135.27 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.45 128.86 36.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.681 0.792 . . . . 0.0 109.674 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.79 154.47 26.69 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 123.596 0.758 . . . . 0.0 110.493 -172.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.82 156.85 35.93 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.283 2.655 . . . . 0.0 113.218 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.42 -35.12 12.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.182 1.393 . . . . 0.0 113.875 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 13.2 p -70.62 -52.37 21.84 Favored 'General case' 0 C--O 1.252 1.22 0 C-N-CA 123.279 0.632 . . . . 0.0 111.679 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -75.06 -25.72 58.85 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.872 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 7.2 tp -78.39 -39.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -57.18 -43.21 82.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.36 -45.3 80.58 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -52.97 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.415 0.286 . . . . 0.0 111.237 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.92 -30.41 70.55 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.743 0.652 . . . . 0.0 110.49 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.87 -55.06 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.005 0.816 . . . . 0.0 110.113 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.9 t -65.13 -26.52 68.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.935 1.294 . . . . 0.0 111.462 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.4 -39.57 24.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.385 1.074 . . . . 0.0 111.123 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.79 -33.29 68.45 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 33.6 t -83.58 -50.83 7.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.009 -174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 -112.0 113.06 25.14 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.621 0.768 . . . . 0.0 108.953 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 C-N-CA 123.032 0.533 . . . . 0.0 110.895 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.938 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -68.78 109.82 4.04 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 117.556 0.678 . . . . 0.0 110.504 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -73.62 -30.18 62.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.19 0.596 . . . . 0.0 112.325 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -75.11 85.36 2.35 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 12.6 p 175.2 137.15 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.781 1.633 . . . . 0.0 107.962 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.2 t -100.3 142.49 31.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.3 mttt -122.49 138.75 54.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.219 0.608 . . . . 0.0 109.605 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 216' ' ' ILE . 20.3 m -141.27 165.45 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.936 0.494 . . . . 0.0 110.473 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.65 147.81 31.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.72 1.208 . . . . 0.0 111.084 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.475 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.2 t -81.55 112.66 35.9 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.812 0.845 . . . . 0.0 109.079 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.62 -24.47 45.37 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.149 2.566 . . . . 0.0 113.183 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.33 -57.55 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.084 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -111.32 -19.03 12.78 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.17 -29.38 7.39 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 167.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.91 138.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.76 122.42 33.48 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.397 1.079 . . . . 0.0 110.139 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.534 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.59 159.45 33.28 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 123.602 0.761 . . . . 0.0 110.19 -176.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.447 ' HD2' HG22 ' A' ' 211' ' ' ILE . 37.7 Cg_endo -61.63 156.35 48.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.899 2.399 . . . . 0.0 113.401 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.01 -40.57 4.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.963 1.705 . . . . 0.0 114.551 -169.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.3 p -76.89 -46.51 24.21 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.808 0.443 . . . . 0.0 111.651 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -75.22 -23.44 57.58 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.383 0.273 . . . . 0.0 111.361 -174.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -78.94 -41.9 23.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.949 0.5 . . . . 0.0 110.685 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -60.09 -39.25 85.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.903 0.383 . . . . 0.0 110.442 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -46.22 85.33 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 174.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.4 -47.7 78.18 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.347 0.404 . . . . 0.0 110.813 -173.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.47 -27.94 65.65 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.8 0.688 . . . . 0.0 110.997 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.65 -50.71 56.52 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 0.0 110.755 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.5 t -66.77 -31.53 72.23 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.645 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 56.9 m -78.88 -26.41 43.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.182 0.993 . . . . 0.0 111.08 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.4 tt -69.53 -27.43 65.16 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.524 0.73 . . . . 0.0 109.385 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.1 t -83.89 -15.87 46.46 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 164.76 25.94 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.664 0.786 . . . . 0.0 111.046 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.531 1.132 . . . . 0.0 109.333 -179.361 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.9 p -162.01 138.99 8.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.046 0.938 . . . . 0.0 109.866 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 197' ' ' ARG . 0.1 OUTLIER -125.29 88.23 2.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.235 1.014 . . . . 0.0 108.853 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -149.66 111.09 4.45 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.238 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.5 p -164.79 142.39 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.621 1.168 . . . . 0.0 108.289 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t -111.03 150.54 29.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.234 0.614 . . . . 0.0 110.107 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 91.5 mttt -119.93 138.23 53.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.836 0.854 . . . . 0.0 108.841 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.514 HG23 HG12 ' A' ' 216' ' ' ILE . 18.7 m -138.84 160.34 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.866 0.467 . . . . 0.0 110.19 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -78.49 147.98 33.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.214 0.606 . . . . 0.0 110.346 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.495 ' HA ' HD11 ' A' ' 216' ' ' ILE . 5.0 t -76.13 112.51 21.12 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.16 -25.62 56.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.797 2.331 . . . . 0.0 112.542 -175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.2 -57.42 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.17 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.8 p -108.98 -19.37 13.42 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 204' ' ' CYS . . . 110.55 -19.48 26.29 Favored Glycine 0 N--CA 1.478 1.455 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 166.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.05 136.48 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.68 122.88 34.64 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.199 1.0 . . . . 0.0 110.527 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.33 156.57 35.03 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 123.711 0.805 . . . . 0.0 110.136 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 211' ' ' ILE . 20.3 Cg_endo -58.12 153.58 44.84 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 123.16 2.573 . . . . 0.0 113.374 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.99 -34.32 12.84 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.431 1.492 . . . . 0.0 114.551 -166.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.9 p -74.93 -50.46 16.72 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.784 0.434 . . . . 0.0 111.246 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -72.36 -30.07 64.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.694 0.398 . . . . 0.0 111.115 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.55 HD13 HG13 ' A' ' 211' ' ' ILE . 8.2 tp -75.4 -36.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.99 -46.8 78.59 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.642 0.589 . . . . 0.0 109.975 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -62.25 -46.28 89.55 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.061 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -51.26 69.33 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.258 0.349 . . . . 0.0 110.994 -172.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 3.7 pp -70.4 -27.2 64.11 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.677 0.611 . . . . 0.0 111.181 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.39 -54.54 16.52 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.191 0.932 . . . . 0.0 110.4 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 34.9 t -67.87 -24.66 65.26 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 52.0 m -81.24 -28.09 34.94 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.905 0.882 . . . . 0.0 111.382 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 1.0 OUTLIER -69.89 -24.19 63.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.2 t -83.36 -65.23 1.03 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.546 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -129.5 167.54 17.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.206 1.002 . . . . 0.0 109.273 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.253 1.279 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.914 178.684 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.5 m -73.82 92.52 2.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.121 0.569 . . . . 0.0 109.98 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -144.98 100.83 3.55 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -77.26 95.92 4.45 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-O 121.224 0.535 . . . . 0.0 109.987 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.2 p -146.33 110.62 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.2 t -82.06 135.75 35.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.6 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -113.28 136.4 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.083 0.553 . . . . 0.0 110.153 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 216' ' ' ILE . 19.4 m -138.91 165.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.353 0.661 . . . . 0.0 110.112 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.66 147.87 33.38 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.998 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 12.8 t -82.83 107.4 9.2 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.8 -26.63 67.55 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.963 2.442 . . . . 0.0 112.888 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.3 t -88.67 -31.15 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -128.62 -30.8 2.28 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.371 0.987 . . . . 0.0 112.45 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.44 -16.54 10.55 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 164.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.45 134.73 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.02 124.86 32.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.768 0.827 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.448 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.1 pt -153.9 152.54 27.08 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.987 0.915 . . . . 0.0 110.689 -169.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.83 162.4 28.83 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.661 2.241 . . . . 0.0 112.573 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.83 -32.19 30.73 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.868 1.267 . . . . 0.0 113.456 -171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.3 p -68.99 -52.63 26.85 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.318 0.647 . . . . 0.0 111.514 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.7 t-160 -76.32 -25.07 54.41 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.023 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.587 HG12 HG23 ' A' ' 202' ' ' VAL . 6.3 tp -74.39 -42.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 118.847 -0.597 . . . . 0.0 111.445 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -52.48 -48.02 66.16 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -65.13 -50.19 67.0 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.5 OUTLIER -67.21 -48.25 68.43 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.524 0.33 . . . . 0.0 110.514 -167.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 216' ' ' ILE . 1.2 pp -67.15 -30.99 71.12 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.801 0.688 . . . . 0.0 109.999 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.73 -56.9 14.65 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.838 0.711 . . . . 0.0 110.418 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -64.05 -31.01 72.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.228 1.011 . . . . 0.0 111.424 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 59.7 m -77.45 -27.8 52.25 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.784 0.834 . . . . 0.0 110.898 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.28 -16.89 63.08 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.268 0.627 . . . . 0.0 109.452 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 27.6 t -101.99 10.91 39.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.317 1.047 . . . . 0.0 110.623 175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -133.56 124.48 26.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.245 0.618 . . . . 0.0 111.054 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 168.105 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 29.7 p -76.29 110.0 10.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.238 0.615 . . . . 0.0 111.04 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -141.79 97.32 3.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.44 116.79 28.64 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.013 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.2 p -161.36 122.06 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.421 1.088 . . . . 0.0 108.906 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t -94.11 142.86 26.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.069 0.547 . . . . 0.0 109.942 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.76 134.11 54.93 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.706 0.802 . . . . 0.0 109.095 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.563 HG23 HG12 ' A' ' 216' ' ' ILE . 22.3 m -137.9 167.72 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 121.246 0.546 . . . . 0.0 110.486 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 147.47 32.97 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.929 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.647 ' HA ' HD11 ' A' ' 216' ' ' ILE . 14.8 t -87.21 110.99 37.9 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.168 0.587 . . . . 0.0 109.885 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -53.0 -31.72 54.71 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.43 2.753 . . . . 0.0 113.522 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 8.8 t -85.33 -45.9 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.762 -173.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.9 p -111.43 -34.47 6.1 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 118.464 0.575 . . . . 0.0 112.165 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.89 16.9 14.06 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 168.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.03 143.31 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 117.953 0.876 . . . . 0.0 112.046 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.7 130.02 34.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.371 0.668 . . . . 0.0 109.76 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.52 151.21 20.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.103 0.961 . . . . 0.0 110.744 -172.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.38 159.67 22.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.871 2.381 . . . . 0.0 113.228 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -49.41 -41.68 40.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.631 1.572 . . . . 0.0 114.194 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 35.5 p -66.86 -50.87 61.13 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.134 0.492 . . . . 0.0 110.792 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -66.83 -32.36 73.59 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.701 -173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 204' ' ' CYS . 6.2 tp -73.51 -43.54 55.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.797 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -52.95 -47.25 68.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.448 0.567 . . . . 0.0 110.717 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.34 -44.42 79.12 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.71 -54.91 36.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.307 0.379 . . . . 0.0 110.583 -173.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 216' ' ' ILE . 3.5 pp -64.54 -32.26 73.83 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.03 0.831 . . . . 0.0 110.986 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.08 -56.87 10.53 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.963 0.789 . . . . 0.0 110.56 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 35.4 t -66.69 -24.43 66.26 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.989 0.916 . . . . 0.0 111.246 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.5 m -77.97 -37.54 47.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.794 0.838 . . . . 0.0 111.051 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.2 tp -69.1 -25.36 64.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.884 0.874 . . . . 0.0 109.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.6 t -86.31 -68.26 0.75 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.12 116.88 32.7 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 123.219 0.607 . . . . 0.0 109.594 177.328 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 104.73 7.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.446 0.698 . . . . 0.0 110.102 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -70.77 85.55 0.66 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.97 70.43 10.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.901 0.88 . . . . 0.0 109.938 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.3 p -170.01 120.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.327 1.451 . . . . 0.0 108.056 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.4 t -89.78 147.76 23.63 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.8 mttt -126.31 132.42 51.64 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 216' ' ' ILE . 19.6 m -135.18 161.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.383 0.673 . . . . 0.0 109.796 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 146.49 31.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.689 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 211' ' ' ILE . 30.1 t -80.55 117.89 69.88 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.597 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.71 -26.43 82.15 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.911 2.408 . . . . 0.0 112.735 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 9.4 t -86.99 -57.83 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -103.96 -20.26 13.94 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.0 45.87 5.82 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.88 138.49 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.803 0.441 . . . . 0.0 110.742 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -79.08 131.03 36.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.5 OUTLIER -155.58 150.3 20.36 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 124.406 1.082 . . . . 0.0 110.008 -169.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.484 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 44.3 Cg_endo -64.67 161.38 35.96 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.446 2.097 . . . . 0.0 112.308 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 216' ' ' ILE . 10.7 pt-20 -52.13 -38.76 58.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.036 1.335 . . . . 0.0 113.497 -172.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.5 p -65.61 -48.28 72.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.414 0.626 . . . . 0.0 110.603 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 17.0 t-160 -76.38 -24.79 54.13 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.478 HG13 HD23 ' A' ' 220' ' ' LEU . 5.3 tp -74.06 -46.51 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.822 0.737 . . . . 0.0 110.546 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -55.44 -44.97 76.83 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.285 0.564 . . . . 0.0 110.248 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.98 -42.85 84.4 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.699 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -68.83 -54.69 14.32 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.921 0.488 . . . . 0.0 109.738 -172.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.478 HD23 HG13 ' A' ' 216' ' ' ILE . 1.8 pp -62.03 -32.65 73.17 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 124.2 0.937 . . . . 0.0 110.08 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.44 -57.93 10.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.8 0.84 . . . . 0.0 111.096 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -67.8 -26.36 66.05 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.246 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 57.9 m -80.74 -37.42 30.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.317 1.047 . . . . 0.0 111.344 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -76.74 -22.85 53.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 t -73.28 -57.15 4.22 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.087 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -130.63 156.4 44.95 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 109.348 -178.164 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 36.4 t -67.08 -37.13 83.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.715 0.806 . . . . 0.0 110.33 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -156.17 152.63 28.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 109.191 174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.54 105.35 16.76 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.5 0.32 . . . . 0.0 110.449 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.87 128.83 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.683 1.193 . . . . 0.0 108.384 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.7 t -97.87 141.17 31.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.814 0.446 . . . . 0.0 110.81 -174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.8 mttt -112.25 143.68 42.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 0.0 109.492 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.572 HG23 HG12 ' A' ' 216' ' ' ILE . 17.2 m -143.5 170.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 122.661 0.385 . . . . 0.0 110.288 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.93 146.32 32.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.191 0.996 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.424 ' CA ' HD11 ' A' ' 216' ' ' ILE . 14.5 t -85.21 100.04 1.07 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.714 0.806 . . . . 0.0 109.003 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -55.75 -18.08 20.07 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.224 2.616 . . . . 0.0 114.12 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.93 -56.95 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.133 0.573 . . . . 0.0 111.499 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 15.4 p -104.59 -34.16 8.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 97.73 53.82 1.27 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 114.314 0.486 . . . . 0.0 114.314 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.32 143.37 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.332 0.653 . . . . 0.0 110.57 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -95.88 122.23 38.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.373 0.669 . . . . 0.0 109.973 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 216' ' ' ILE . 0.4 OUTLIER -155.28 155.19 29.67 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.402 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 18.5 Cg_endo -58.4 159.13 20.46 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.479 2.786 . . . . 0.0 113.976 178.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.94 -36.01 11.68 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.273 1.829 . . . . 0.0 114.552 -169.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.6 p -73.18 -51.07 19.16 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.372 0.669 . . . . 0.0 111.251 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -71.89 -32.06 67.05 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.532 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 202' ' ' VAL . 10.8 tp -78.07 -38.49 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.615 0.366 . . . . 0.0 111.14 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.17 -42.4 98.5 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.63 0.581 . . . . 0.0 109.468 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.15 -46.75 79.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.629 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.15 -45.36 92.25 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 119.554 -0.26 . . . . 0.0 110.885 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.94 -32.94 63.73 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.35 0.406 . . . . 0.0 110.677 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.26 -52.75 44.48 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.208 0.943 . . . . 0.0 109.96 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.8 t -60.47 -45.94 91.9 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.261 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.1 m -62.93 -32.85 74.24 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.84 0.856 . . . . 0.0 112.485 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.6 tt -73.74 -23.46 59.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.517 0.727 . . . . 0.0 110.121 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 22.9 t -111.05 -15.5 13.71 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.656 0.783 . . . . 0.0 111.644 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -130.92 -179.97 5.63 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.836 0.854 . . . . 0.0 109.886 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 123.797 0.839 . . . . 0.0 109.654 176.421 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.786 -0.126 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 m -95.66 116.4 28.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.06 79.66 1.72 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -86.74 106.45 17.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.39 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.412 HG23 ' HG2' ' A' ' 213' ' ' GLU . 6.8 p -161.63 123.3 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.8 1.24 . . . . 0.0 108.051 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.4 t -94.61 150.4 20.27 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.007 0.523 . . . . 0.0 109.881 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -122.73 140.92 52.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.541 0.736 . . . . 0.0 109.143 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.628 HG23 HG12 ' A' ' 216' ' ' ILE . 15.5 m -142.38 167.16 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.576 0.35 . . . . 0.0 110.337 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.71 145.37 34.55 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.565 1.146 . . . . 0.0 110.928 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' CYS . . . . . 0.425 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.8 t -82.82 106.95 7.86 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.1 -17.52 32.1 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.692 2.262 . . . . 0.0 113.22 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.91 -57.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.823 0.849 . . . . 0.0 112.224 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 10.8 p -115.41 -3.24 12.44 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -166.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.4 34.27 45.81 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.27 136.28 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 117.046 0.423 . . . . 0.0 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.74 129.2 36.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.992 0.517 . . . . 0.0 109.761 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.547 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -155.62 156.02 30.28 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.907 0.883 . . . . 0.0 110.045 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.45 157.62 17.99 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.402 2.735 . . . . 0.0 114.218 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.412 ' HG2' HG23 ' A' ' 199' ' ' VAL . 10.6 pt-20 -48.41 -37.71 17.73 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.238 1.815 . . . . 0.0 113.775 -171.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.9 p -67.2 -52.9 35.51 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.384 0.611 . . . . 0.0 111.309 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -80.57 -22.44 40.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.57 -172.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 202' ' ' VAL . 10.1 tp -79.44 -43.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.569 0.347 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.24 -43.49 86.45 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.494 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -53.19 59.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.701 0.401 . . . . 0.0 110.553 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.1 -30.71 69.95 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.906 0.754 . . . . 0.0 110.699 -172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.23 -57.88 10.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.89 0.876 . . . . 0.0 110.589 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.6 t -68.19 -27.87 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.035 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.38 -39.61 58.96 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 0.0 111.045 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -25.26 64.6 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.2 t -89.57 11.7 18.83 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.864 1.265 . . . . 0.0 111.382 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -139.08 -37.3 0.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.03 0.532 . . . . 0.0 111.35 -175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 123.193 0.597 . . . . 0.0 110.47 -174.749 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -117.48 143.28 46.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 109.415 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 216' ' ' ILE . 18.1 m -142.67 172.14 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 122.737 0.415 . . . . 0.0 110.19 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.85 147.11 29.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.188 0.995 . . . . 0.0 111.224 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.432 ' CA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -85.58 106.56 9.71 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.173 0.989 . . . . 0.0 108.46 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.45 -23.83 33.01 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.291 2.661 . . . . 0.0 113.608 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.7 -54.8 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 C-N-CA 123.026 0.53 . . . . 0.0 111.986 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 12.4 p -108.3 -19.21 13.55 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.19 5.12 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 122.847 0.26 . . . . 0.0 113.696 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.85 147.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.284 0.634 . . . . 0.0 111.301 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.89 126.71 47.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.152 0.581 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.515 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.6 155.95 29.35 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.551 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 157.26 29.03 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.996 2.464 . . . . 0.0 112.953 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -39.14 40.96 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.44 1.496 . . . . 0.0 113.86 -167.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 52.7 p -68.07 -50.36 55.59 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.32 0.648 . . . . 0.0 111.041 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.35 -30.51 63.38 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.869 -172.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 202' ' ' VAL . 9.6 tp -77.42 -40.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.198 0.599 . . . . 0.0 110.948 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.44 -43.53 93.12 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.543 0.527 . . . . 0.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -43.38 90.15 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.407 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -52.03 67.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 123.334 0.396 . . . . 0.0 110.322 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.51 -30.73 68.64 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.788 0.68 . . . . 0.0 111.146 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.86 -47.86 76.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.806 0.842 . . . . 0.0 110.846 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.6 t -75.07 -26.75 59.59 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.993 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 36.1 m -77.78 -30.76 51.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.123 0.969 . . . . 0.0 111.65 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 124.097 0.959 . . . . 0.0 108.853 176.398 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.765 0.317 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -128.15 141.37 51.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.914 0.886 . . . . 0.0 109.248 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.644 HG23 HG12 ' A' ' 216' ' ' ILE . 12.1 m -140.73 158.79 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.561 0.344 . . . . 0.0 110.321 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.0 146.5 35.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.777 0.831 . . . . 0.0 110.011 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 216' ' ' ILE . 8.0 t -82.58 107.69 9.85 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.774 0.83 . . . . 0.0 109.14 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.55 -27.98 53.06 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.647 2.231 . . . . 0.0 113.142 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 4.1 t -85.39 -43.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.973 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.92 -28.32 5.95 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 118.514 0.597 . . . . 0.0 112.333 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 101.57 23.69 9.28 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 136.51 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 117.625 0.712 . . . . 0.0 111.738 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -89.03 130.66 35.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 109.974 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.58 155.91 29.3 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 110.285 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.54 155.21 43.26 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.988 2.459 . . . . 0.0 113.68 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -44.4 -38.48 4.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.676 1.99 . . . . 0.0 114.609 -170.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.9 p -71.01 -52.29 20.44 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.554 0.742 . . . . 0.0 111.25 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -74.1 -27.12 60.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.127 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.644 HG12 HG23 ' A' ' 202' ' ' VAL . 7.3 tp -79.27 -40.91 22.39 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.174 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -57.38 -43.05 83.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.66 -48.48 79.16 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.388 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -53.97 47.41 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.871 0.468 . . . . 0.0 110.878 -172.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 216' ' ' ILE . 3.3 pp -66.14 -31.47 72.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 124.13 0.894 . . . . 0.0 110.838 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.74 -57.87 8.63 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 0.0 110.197 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.5 t -63.93 -33.48 75.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.381 1.072 . . . . 0.0 110.837 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.7 m -69.46 -44.28 71.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 111.014 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.479 1.006 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.077 177.698 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -118.57 141.22 48.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.938 0.495 . . . . 0.0 110.785 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.9 m -142.4 160.63 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.996 0.918 . . . . 0.0 109.727 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.73 147.07 30.73 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.488 0.715 . . . . 0.0 110.283 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.537 ' HA ' HD11 ' A' ' 216' ' ' ILE . 34.4 t -79.53 110.16 14.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.315 0.646 . . . . 0.0 110.327 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.96 -24.09 37.84 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.609 2.873 . . . . 0.0 113.61 -171.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 t -85.48 -55.27 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 0.0 111.703 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.01 -27.81 9.93 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.59 26.55 8.54 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.03 0.772 . . . . 0.0 115.03 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.48 134.76 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 117.434 0.617 . . . . 0.0 111.489 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -84.39 125.52 32.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.0 OUTLIER -154.52 151.87 24.77 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.13 0.972 . . . . 0.0 110.876 -169.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.7 161.46 28.47 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.025 2.484 . . . . 0.0 112.689 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.422 ' HA ' HG22 ' A' ' 216' ' ' ILE . 11.6 pt-20 -55.52 -32.15 62.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.484 1.114 . . . . 0.0 112.674 -169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.7 p -66.25 -52.41 47.96 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.187 0.595 . . . . 0.0 111.017 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 28.5 t60 -76.74 -26.18 54.3 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.779 -172.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 5.6 tp -72.8 -43.92 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.849 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.53 -45.72 73.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.536 0.523 . . . . 0.0 109.869 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -67.4 -42.31 83.5 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.464 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -71.37 -50.34 33.15 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.699 0.227 . . . . 0.0 111.079 -170.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 216' ' ' ILE . 2.4 pp -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.708 0.63 . . . . 0.0 109.765 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.75 -52.79 61.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.92 0.888 . . . . 0.0 110.856 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.0 t -67.76 -27.99 67.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.817 1.247 . . . . 0.0 111.291 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 35.3 m -82.11 -26.43 33.57 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 111.353 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.686 0.795 . . . . 0.0 108.983 173.199 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.747 0.308 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.83 141.04 48.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.912 0.885 . . . . 0.0 108.805 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -144.24 158.29 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.44 0.696 . . . . 0.0 109.602 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.17 145.23 33.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.286 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 216' ' ' ILE . 46.1 t -80.36 109.57 13.25 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 110.093 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.32 -27.61 67.93 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.309 2.673 . . . . 0.0 113.392 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.4 t -87.79 -29.03 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.576 0 C-N-CA 123.59 0.756 . . . . 0.0 112.89 -173.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 18.9 p -129.5 -34.36 1.81 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.194 -0.941 . . . . 0.0 112.061 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 96.44 53.85 1.41 Allowed Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.822 0.289 . . . . 0.0 113.822 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.86 130.0 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.633 0.773 . . . . 0.0 109.872 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.56 126.0 30.32 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 215' ' ' HIS . 1.2 pt -154.29 151.76 24.9 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.64 161.38 24.87 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.929 2.42 . . . . 0.0 112.665 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.26 -31.22 53.07 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.47 1.106 . . . . 0.0 113.259 -169.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.6 p -66.86 -51.75 51.77 Favored 'General case' 0 C--O 1.25 1.129 0 C-N-CA 122.716 0.406 . . . . 0.0 111.087 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 211' ' ' ILE . 18.1 t-160 -74.48 -31.51 62.24 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.225 -171.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 202' ' ' VAL . 4.5 tp -67.78 -46.18 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.965 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -54.44 -46.59 73.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.623 0.577 . . . . 0.0 110.355 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -67.5 -40.86 85.2 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.52 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -70.73 -49.42 47.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.471 0.308 . . . . 0.0 110.49 -170.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.24 -31.83 72.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 109.642 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.87 -55.46 29.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.118 0.967 . . . . 0.0 111.073 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -69.9 -24.17 63.35 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.154 0.981 . . . . 0.0 111.201 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 34.2 m -81.37 -30.11 33.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.894 0.878 . . . . 0.0 111.062 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 110.792 -0.077 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.7 mttt -115.01 134.2 55.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.431 0.692 . . . . 0.0 110.514 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.04 173.42 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.871 0.868 . . . . 0.0 110.095 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -89.86 146.99 24.03 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.127 0.571 . . . . 0.0 111.019 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 211' ' ' ILE . 15.5 t -79.27 117.82 69.1 Favored Pre-proline 0 C--O 1.219 -0.511 0 C-N-CA 123.792 0.837 . . . . 0.0 109.839 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.03 -28.43 87.04 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.972 2.448 . . . . 0.0 112.669 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.0 t -85.77 -46.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.372 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.4 p -111.78 -33.57 6.28 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.04 6.88 31.73 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 207' ' ' CYS . 28.2 m -83.5 145.85 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 0.0 112.213 -176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.07 133.15 35.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 0.0 109.974 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.75 147.62 15.42 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.294 1.038 . . . . 0.0 109.979 -169.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 48.1 Cg_endo -66.82 161.7 40.89 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.428 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -53.29 -34.72 58.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.718 1.207 . . . . 0.0 113.573 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.7 p -68.6 -50.39 51.93 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.796 0.839 . . . . 0.0 110.817 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.2 t-160 -80.17 -17.31 52.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.912 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 211' ' ' ILE . 4.3 tp -76.36 -44.73 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.689 0.677 . . . . 0.0 109.708 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -53.46 -45.66 69.6 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 124.084 0.865 . . . . 0.0 109.572 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.47 -50.22 64.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.442 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -65.39 -44.99 85.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 117.92 0.327 . . . . 0.0 110.334 -168.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.03 -35.38 78.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.239 0.962 . . . . 0.0 109.478 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.78 -54.3 46.81 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.921 0.888 . . . . 0.0 110.312 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.8 t -62.77 -33.86 76.04 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.042 1.337 . . . . 0.0 111.409 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 30.4 m -79.36 -29.66 42.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.644 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.667 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.72 138.37 53.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.385 0.674 . . . . 0.0 110.211 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 216' ' ' ILE . 20.8 m -139.4 164.56 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.54 0.736 . . . . 0.0 109.784 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 147.5 28.88 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.621 0.768 . . . . 0.0 109.864 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.474 ' HA ' HD11 ' A' ' 216' ' ' ILE . 10.3 t -81.89 109.78 16.81 Favored Pre-proline 0 C--O 1.222 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 109.159 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.47 -23.17 62.82 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.19 2.593 . . . . 0.0 113.374 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 11.8 t -87.54 -38.05 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.434 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 209' ' ' VAL . 14.5 p -125.95 -29.2 3.11 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -170.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.18 -5.63 30.31 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.458 HG22 ' SG ' ' A' ' 207' ' ' CYS . 21.5 m -69.12 133.19 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 117.407 0.603 . . . . 0.0 111.773 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.26 124.06 30.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.571 0.748 . . . . 0.0 109.305 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.9 OUTLIER -150.93 151.47 29.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.595 0.758 . . . . 0.0 110.803 -169.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.62 160.79 34.58 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.941 2.428 . . . . 0.0 112.797 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.97 -37.43 32.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.348 1.459 . . . . 0.0 113.736 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.2 m -67.71 -51.14 53.04 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.37 -32.17 68.18 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 202' ' ' VAL . 5.5 tp -70.87 -45.32 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -53.4 -45.85 69.47 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -66.91 -48.75 67.72 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.201 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -47.15 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.604 0.362 . . . . 0.0 110.388 -168.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -32.73 74.06 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 123.881 0.738 . . . . 0.0 109.682 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -57.59 12.3 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 123.269 0.628 . . . . 0.0 110.708 174.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.6 t -63.36 -30.94 71.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 36.1 m -79.18 -32.12 44.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.804 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.486 1.325 0 C-N-CA 123.481 0.712 . . . . 0.0 111.655 -170.282 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -124.26 143.84 50.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.365 0.666 . . . . 0.0 110.394 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.696 HG23 HG12 ' A' ' 216' ' ' ILE . 19.0 m -142.43 163.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.678 0.791 . . . . 0.0 109.753 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 146.69 35.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.801 0.84 . . . . 0.0 110.967 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.53 ' HA ' HD11 ' A' ' 216' ' ' ILE . 9.8 t -84.01 107.74 11.6 Favored Pre-proline 0 C--O 1.218 -0.599 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -56.89 -25.7 63.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.885 2.39 . . . . 0.0 113.127 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.96 -43.98 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.625 0.77 . . . . 0.0 112.13 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 209' ' ' VAL . 10.1 p -125.36 4.71 7.71 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -170.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.23 45.65 95.69 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 125.223 1.392 . . . . 0.0 115.208 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.456 HG22 ' SG ' ' A' ' 207' ' ' CYS . 27.6 m -117.48 128.69 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 175.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.17 126.07 31.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.414 0.685 . . . . 0.0 109.704 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -152.78 150.68 25.05 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.725 0.81 . . . . 0.0 111.472 -169.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.49 156.98 38.55 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 123.192 2.595 . . . . 0.0 113.14 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.08 -39.04 12.27 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.229 1.812 . . . . 0.0 114.311 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 37.7 p -69.02 -51.65 36.94 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.317 0.58 . . . . 0.0 111.078 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 12.2 t60 -70.37 -32.29 69.91 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.549 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.696 HG12 HG23 ' A' ' 202' ' ' VAL . 5.0 tp -71.8 -46.09 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.494 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.543 HD22 HG23 ' A' ' 216' ' ' ILE . 0.9 OUTLIER -57.11 -44.21 83.03 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.183 0.302 . . . . 0.0 110.329 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -69.52 -42.39 74.76 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.974 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -64.47 -50.46 67.4 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.583 -172.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 216' ' ' ILE . 1.6 pp -69.19 -32.83 72.39 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.889 0.743 . . . . 0.0 110.096 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.42 -55.51 27.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.674 0.79 . . . . 0.0 110.115 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -64.96 -33.1 75.24 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 124.348 1.059 . . . . 0.0 110.674 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 32.7 m -73.61 -36.03 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.961 0.904 . . . . 0.0 111.314 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.586 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.504 0.192 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.91 132.47 50.88 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.147 0.579 . . . . 0.0 109.864 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.53 HG23 HG12 ' A' ' 216' ' ' ILE . 30.4 m -135.79 164.03 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.561 0.744 . . . . 0.0 110.006 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.28 147.24 32.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.271 1.028 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.451 ' HA ' HD11 ' A' ' 216' ' ' ILE . 23.5 t -82.68 108.81 13.33 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.017 0.527 . . . . 0.0 109.764 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.42 -27.24 75.08 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.026 2.484 . . . . 0.0 113.231 -170.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.2 t -86.72 -36.53 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 123.304 0.642 . . . . 0.0 111.976 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.5 p -122.72 -37.54 2.75 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 118.571 0.623 . . . . 0.0 112.176 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.21 -3.34 14.1 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.8 140.02 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 118.425 1.112 . . . . 0.0 112.12 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.95 128.73 34.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -153.2 149.78 22.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.254 0.621 . . . . 0.0 111.025 -170.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.33 161.7 29.88 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.871 2.381 . . . . 0.0 113.154 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.67 -41.92 44.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.05 1.74 . . . . 0.0 114.573 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.5 p -71.5 -43.56 66.29 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.262 0.553 . . . . 0.0 110.643 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 37.8 t-80 -75.14 -22.81 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.53 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -77.2 -45.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.554 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -51.26 -48.33 62.22 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.783 0.677 . . . . 0.0 110.558 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -69.98 -45.14 67.98 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.344 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -62.59 -51.51 67.02 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 117.869 0.304 . . . . 0.0 110.811 -173.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 216' ' ' ILE . 2.1 pp -64.21 -34.27 77.72 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.915 0.759 . . . . 0.0 110.162 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.36 -54.38 37.71 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.053 0.846 . . . . 0.0 111.289 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -65.37 -27.66 68.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.902 1.281 . . . . 0.0 110.981 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.1 m -80.66 -36.17 32.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.511 1.124 . . . . 0.0 111.811 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.511 0.725 . . . . 0.0 109.801 -176.109 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -116.52 137.82 51.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.168 0.587 . . . . 0.0 110.026 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 216' ' ' ILE . 16.1 m -141.69 164.09 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.746 0.818 . . . . 0.0 110.125 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.64 146.56 34.01 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.495 1.118 . . . . 0.0 111.023 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.513 ' HA ' HD11 ' A' ' 216' ' ' ILE . 19.2 t -84.86 106.19 8.11 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 123.622 0.769 . . . . 0.0 109.154 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -54.32 -25.43 39.0 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.6 2.867 . . . . 0.0 113.62 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.79 -57.1 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.835 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.6 p -99.17 -31.34 11.79 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.07 0.395 . . . . 0.0 111.719 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.86 2.79 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.404 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.1 m -120.61 140.41 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.119 0.568 . . . . 0.0 110.853 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.58 133.71 35.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.897 0.479 . . . . 0.0 109.993 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.16 149.43 17.74 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 0.0 110.483 -171.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.62 159.14 33.66 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.963 2.442 . . . . 0.0 112.897 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -50.3 -37.66 37.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.278 1.431 . . . . 0.0 113.944 -170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.1 p -69.53 -50.82 41.45 Favored 'General case' 0 C--O 1.254 1.298 0 C-N-CA 123.043 0.537 . . . . 0.0 110.912 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.57 -31.43 69.6 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.368 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.571 HG12 HG23 ' A' ' 202' ' ' VAL . 5.7 tp -70.09 -42.42 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.887 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.32 -50.57 61.98 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.22 -42.01 72.85 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.236 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -51.33 61.66 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.449 HD23 HG13 ' A' ' 216' ' ' ILE . 1.9 pp -64.82 -35.32 80.73 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.819 0.7 . . . . 0.0 110.073 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.75 -52.96 61.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.654 0.74 . . . . 0.0 110.685 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -67.83 -25.27 65.48 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.706 1.202 . . . . 0.0 111.438 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.78 -36.55 28.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.286 1.034 . . . . 0.0 111.671 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.529 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -121.01 137.77 54.49 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.215 0.606 . . . . 0.0 110.552 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.61 HG23 HG12 ' A' ' 216' ' ' ILE . 16.0 m -141.66 161.71 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.584 0.754 . . . . 0.0 110.628 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.41 146.31 32.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.631 1.172 . . . . 0.0 110.918 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' A' ' 216' ' ' ILE . 20.1 t -84.01 109.79 21.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 123.599 0.76 . . . . 0.0 109.744 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.08 -23.3 60.2 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.27 2.647 . . . . 0.0 113.691 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 -50.28 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.484 0.713 . . . . 0.0 111.754 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.6 p -113.23 -26.36 8.44 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 94.39 41.67 4.16 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.25 136.9 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.109 0.564 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -86.14 127.64 34.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.982 0.513 . . . . 0.0 109.777 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.466 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -154.08 152.02 25.74 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.251 1.02 . . . . 0.0 110.361 -169.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.25 160.04 28.42 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.198 2.599 . . . . 0.0 112.917 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -53.66 -34.89 60.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.038 1.335 . . . . 0.0 113.532 -168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 57.4 p -70.83 -47.73 57.84 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.38 0.672 . . . . 0.0 111.281 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -69.93 -34.37 73.38 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -73.29 -40.47 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.073 0.549 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -55.14 -46.49 75.68 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -66.93 -44.32 80.97 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.247 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -55.85 12.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.759 0.424 . . . . 0.0 110.567 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 216' ' ' ILE . 1.3 pp -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.94 0.775 . . . . 0.0 109.976 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.45 -57.63 11.93 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.081 0.863 . . . . 0.0 110.711 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 27.0 t -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.134 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 11.7 m -76.47 -46.03 28.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.107 0.963 . . . . 0.0 110.59 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 41.9 tp . . . . . 0 N--CA 1.476 0.852 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 -179.188 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.5 mttt -117.18 144.69 44.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.429 0.692 . . . . 0.0 109.754 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.539 HG23 HG12 ' A' ' 216' ' ' ILE . 23.9 m -143.23 169.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 122.844 0.458 . . . . 0.0 110.087 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.09 147.69 26.05 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.6 0.76 . . . . 0.0 110.481 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.468 ' CA ' HD11 ' A' ' 216' ' ' ILE . 4.2 t -73.53 120.08 79.26 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.537 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.55 -25.26 80.3 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.204 1.936 . . . . 0.0 111.874 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.03 -55.61 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 C-N-CA 123.623 0.769 . . . . 0.0 111.956 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 7.9 p -120.05 7.08 10.81 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.58 2.39 80.26 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 162.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.55 138.12 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.702 0.751 . . . . 0.0 112.202 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -91.57 124.98 36.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 0.0 110.652 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.539 HG13 HD13 ' A' ' 216' ' ' ILE . 0.3 OUTLIER -155.76 158.44 31.76 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.312 1.045 . . . . 0.0 110.063 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 35.0 Cg_endo -61.62 158.95 34.45 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.039 2.493 . . . . 0.0 113.615 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -48.72 -34.85 12.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.887 1.675 . . . . 0.0 113.622 -170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -70.4 -52.78 19.89 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.562 0.745 . . . . 0.0 111.135 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -80.42 -23.66 40.18 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.531 -173.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -80.12 -37.48 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 117.853 0.297 . . . . 0.0 111.305 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.9 -42.19 99.7 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -62.41 -45.76 91.65 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.865 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -48.8 74.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.629 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 1.8 pp -65.69 -33.5 76.03 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 124.003 0.815 . . . . 0.0 110.299 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.64 -57.89 10.98 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.399 1.079 . . . . 0.0 110.989 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 t -65.54 -28.51 69.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.983 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 40.6 m -80.58 -31.46 36.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.931 0.892 . . . . 0.0 111.911 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -127.11 129.0 47.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.616 HG23 HG12 ' A' ' 216' ' ' ILE . 20.9 m -136.03 165.24 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 122.811 0.444 . . . . 0.0 110.423 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.68 146.25 36.16 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.373 1.069 . . . . 0.0 111.004 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 11.7 t -86.56 105.52 8.01 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.82 -24.74 32.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 123.407 2.738 . . . . 0.0 113.68 -171.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.71 -53.26 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.35 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 209' ' ' VAL . 16.2 p -110.54 -15.51 13.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.03 49.89 6.14 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 123.452 0.549 . . . . 0.0 113.382 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.3 m -120.46 132.63 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 122.995 0.518 . . . . 0.0 110.123 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.83 129.27 34.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.6 OUTLIER -152.43 151.97 28.22 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.488 0.715 . . . . 0.0 111.053 -172.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.89 158.7 32.39 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.859 2.372 . . . . 0.0 113.044 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.19 -38.53 40.39 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.203 1.401 . . . . 0.0 114.122 -167.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.3 p -69.64 -49.62 52.05 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-O 121.348 0.594 . . . . 0.0 110.805 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.95 -33.02 73.87 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.677 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 202' ' ' VAL . 5.9 tp -72.87 -40.86 60.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.93 -50.03 64.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.043 0.449 . . . . 0.0 110.427 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.59 -43.59 76.14 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -52.8 55.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.419 -171.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 216' ' ' ILE . 2.2 pp -66.85 -32.87 74.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.565 0.541 . . . . 0.0 110.332 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.81 -58.09 10.08 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.878 0.736 . . . . 0.0 110.952 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 42.7 t -69.87 -28.51 65.71 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.251 1.021 . . . . 0.0 111.592 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.51 -49.35 41.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.657 0.783 . . . . 0.0 111.185 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 tp . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 123.103 0.561 . . . . 0.0 110.095 179.311 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -97.54 142.65 29.12 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.438 0.695 . . . . 0.0 109.937 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -143.51 160.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.348 0.659 . . . . 0.0 109.979 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.51 147.31 30.91 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.348 1.059 . . . . 0.0 110.718 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.534 ' HA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -82.35 110.46 21.57 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.215 1.006 . . . . 0.0 109.473 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.95 -22.46 63.29 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.447 2.765 . . . . 0.0 113.036 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.22 -45.26 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 209' ' ' VAL . 15.3 p -118.86 -33.34 4.24 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -172.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.6 -17.18 9.56 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 168.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.447 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.5 m -67.19 135.27 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.45 128.86 36.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.681 0.792 . . . . 0.0 109.674 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.79 154.47 26.69 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 123.596 0.758 . . . . 0.0 110.493 -172.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.82 156.85 35.93 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.283 2.655 . . . . 0.0 113.218 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.42 -35.12 12.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.182 1.393 . . . . 0.0 113.875 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 13.2 p -70.62 -52.37 21.84 Favored 'General case' 0 C--O 1.252 1.22 0 C-N-CA 123.279 0.632 . . . . 0.0 111.679 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -75.06 -25.72 58.85 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.872 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 7.2 tp -78.39 -39.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -57.18 -43.21 82.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.36 -45.3 80.58 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -52.97 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.415 0.286 . . . . 0.0 111.237 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.92 -30.41 70.55 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.743 0.652 . . . . 0.0 110.49 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.87 -55.06 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.005 0.816 . . . . 0.0 110.113 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.9 t -65.13 -26.52 68.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.935 1.294 . . . . 0.0 111.462 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.4 -39.57 24.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.385 1.074 . . . . 0.0 111.123 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.3 mttt -122.49 138.75 54.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.219 0.608 . . . . 0.0 109.605 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 216' ' ' ILE . 20.3 m -141.27 165.45 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.936 0.494 . . . . 0.0 110.473 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.65 147.81 31.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.72 1.208 . . . . 0.0 111.084 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.475 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.2 t -81.55 112.66 35.9 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.812 0.845 . . . . 0.0 109.079 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.62 -24.47 45.37 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.149 2.566 . . . . 0.0 113.183 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.33 -57.55 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.084 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -111.32 -19.03 12.78 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.17 -29.38 7.39 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 167.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.91 138.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.76 122.42 33.48 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.397 1.079 . . . . 0.0 110.139 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.534 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.59 159.45 33.28 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 123.602 0.761 . . . . 0.0 110.19 -176.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.447 ' HD2' HG22 ' A' ' 211' ' ' ILE . 37.7 Cg_endo -61.63 156.35 48.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.899 2.399 . . . . 0.0 113.401 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.01 -40.57 4.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.963 1.705 . . . . 0.0 114.551 -169.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.3 p -76.89 -46.51 24.21 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.808 0.443 . . . . 0.0 111.651 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -75.22 -23.44 57.58 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.383 0.273 . . . . 0.0 111.361 -174.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -78.94 -41.9 23.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.949 0.5 . . . . 0.0 110.685 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -60.09 -39.25 85.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.903 0.383 . . . . 0.0 110.442 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -46.22 85.33 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 174.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.4 -47.7 78.18 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.347 0.404 . . . . 0.0 110.813 -173.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.47 -27.94 65.65 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.8 0.688 . . . . 0.0 110.997 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.65 -50.71 56.52 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 0.0 110.755 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.5 t -66.77 -31.53 72.23 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.645 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 56.9 m -78.88 -26.41 43.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.182 0.993 . . . . 0.0 111.08 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.4 tt . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.524 0.73 . . . . 0.0 109.385 172.162 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 91.5 mttt -119.93 138.23 53.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.836 0.854 . . . . 0.0 108.841 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.514 HG23 HG12 ' A' ' 216' ' ' ILE . 18.7 m -138.84 160.34 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.866 0.467 . . . . 0.0 110.19 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -78.49 147.98 33.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.214 0.606 . . . . 0.0 110.346 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.495 ' HA ' HD11 ' A' ' 216' ' ' ILE . 5.0 t -76.13 112.51 21.12 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.16 -25.62 56.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.797 2.331 . . . . 0.0 112.542 -175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.2 -57.42 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.17 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.8 p -108.98 -19.37 13.42 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 204' ' ' CYS . . . 110.55 -19.48 26.29 Favored Glycine 0 N--CA 1.478 1.455 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 166.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.05 136.48 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.68 122.88 34.64 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.199 1.0 . . . . 0.0 110.527 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.33 156.57 35.03 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 123.711 0.805 . . . . 0.0 110.136 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 211' ' ' ILE . 20.3 Cg_endo -58.12 153.58 44.84 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 123.16 2.573 . . . . 0.0 113.374 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.99 -34.32 12.84 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.431 1.492 . . . . 0.0 114.551 -166.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.9 p -74.93 -50.46 16.72 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.784 0.434 . . . . 0.0 111.246 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -72.36 -30.07 64.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.694 0.398 . . . . 0.0 111.115 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.55 HD13 HG13 ' A' ' 211' ' ' ILE . 8.2 tp -75.4 -36.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.99 -46.8 78.59 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.642 0.589 . . . . 0.0 109.975 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -62.25 -46.28 89.55 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.061 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -51.26 69.33 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.258 0.349 . . . . 0.0 110.994 -172.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 3.7 pp -70.4 -27.2 64.11 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.677 0.611 . . . . 0.0 111.181 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.39 -54.54 16.52 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.191 0.932 . . . . 0.0 110.4 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 34.9 t -67.87 -24.66 65.26 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 52.0 m -81.24 -28.09 34.94 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.905 0.882 . . . . 0.0 111.382 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 120.706 0.288 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -113.28 136.4 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.083 0.553 . . . . 0.0 110.153 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 216' ' ' ILE . 19.4 m -138.91 165.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.353 0.661 . . . . 0.0 110.112 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.66 147.87 33.38 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.998 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 12.8 t -82.83 107.4 9.2 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.8 -26.63 67.55 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.963 2.442 . . . . 0.0 112.888 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.3 t -88.67 -31.15 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -128.62 -30.8 2.28 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.371 0.987 . . . . 0.0 112.45 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.44 -16.54 10.55 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 164.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.45 134.73 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.02 124.86 32.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.768 0.827 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.448 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.1 pt -153.9 152.54 27.08 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.987 0.915 . . . . 0.0 110.689 -169.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.83 162.4 28.83 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.661 2.241 . . . . 0.0 112.573 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.83 -32.19 30.73 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.868 1.267 . . . . 0.0 113.456 -171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.3 p -68.99 -52.63 26.85 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.318 0.647 . . . . 0.0 111.514 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.7 t-160 -76.32 -25.07 54.41 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.023 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.587 HG12 HG23 ' A' ' 202' ' ' VAL . 6.3 tp -74.39 -42.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 118.847 -0.597 . . . . 0.0 111.445 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -52.48 -48.02 66.16 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -65.13 -50.19 67.0 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.5 OUTLIER -67.21 -48.25 68.43 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.524 0.33 . . . . 0.0 110.514 -167.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 216' ' ' ILE . 1.2 pp -67.15 -30.99 71.12 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.801 0.688 . . . . 0.0 109.999 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.73 -56.9 14.65 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.838 0.711 . . . . 0.0 110.418 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -64.05 -31.01 72.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.228 1.011 . . . . 0.0 111.424 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 59.7 m -77.45 -27.8 52.25 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.784 0.834 . . . . 0.0 110.898 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.4 tp . . . . . 0 CA--C 1.552 1.057 0 C-N-CA 123.268 0.627 . . . . 0.0 109.452 173.521 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.76 134.11 54.93 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.706 0.802 . . . . 0.0 109.095 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.563 HG23 HG12 ' A' ' 216' ' ' ILE . 22.3 m -137.9 167.72 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 121.246 0.546 . . . . 0.0 110.486 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 147.47 32.97 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.929 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.647 ' HA ' HD11 ' A' ' 216' ' ' ILE . 14.8 t -87.21 110.99 37.9 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.168 0.587 . . . . 0.0 109.885 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -53.0 -31.72 54.71 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.43 2.753 . . . . 0.0 113.522 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 8.8 t -85.33 -45.9 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.762 -173.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.9 p -111.43 -34.47 6.1 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 118.464 0.575 . . . . 0.0 112.165 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.89 16.9 14.06 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 168.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.03 143.31 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 117.953 0.876 . . . . 0.0 112.046 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.7 130.02 34.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.371 0.668 . . . . 0.0 109.76 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.52 151.21 20.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.103 0.961 . . . . 0.0 110.744 -172.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.38 159.67 22.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.871 2.381 . . . . 0.0 113.228 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -49.41 -41.68 40.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.631 1.572 . . . . 0.0 114.194 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 35.5 p -66.86 -50.87 61.13 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.134 0.492 . . . . 0.0 110.792 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -66.83 -32.36 73.59 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.701 -173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 204' ' ' CYS . 6.2 tp -73.51 -43.54 55.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.797 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -52.95 -47.25 68.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.448 0.567 . . . . 0.0 110.717 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.34 -44.42 79.12 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.71 -54.91 36.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.307 0.379 . . . . 0.0 110.583 -173.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 216' ' ' ILE . 3.5 pp -64.54 -32.26 73.83 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.03 0.831 . . . . 0.0 110.986 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.08 -56.87 10.53 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.963 0.789 . . . . 0.0 110.56 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 35.4 t -66.69 -24.43 66.26 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.989 0.916 . . . . 0.0 111.246 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.5 m -77.97 -37.54 47.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.794 0.838 . . . . 0.0 111.051 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.2 tp . . . . . 0 N--CA 1.479 0.991 0 C-N-CA 123.884 0.874 . . . . 0.0 109.981 177.247 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.8 mttt -126.31 132.42 51.64 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 216' ' ' ILE . 19.6 m -135.18 161.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.383 0.673 . . . . 0.0 109.796 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 146.49 31.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.689 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 211' ' ' ILE . 30.1 t -80.55 117.89 69.88 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.597 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.71 -26.43 82.15 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.911 2.408 . . . . 0.0 112.735 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 9.4 t -86.99 -57.83 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -103.96 -20.26 13.94 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.0 45.87 5.82 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.88 138.49 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.803 0.441 . . . . 0.0 110.742 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -79.08 131.03 36.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.5 OUTLIER -155.58 150.3 20.36 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 124.406 1.082 . . . . 0.0 110.008 -169.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.484 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 44.3 Cg_endo -64.67 161.38 35.96 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.446 2.097 . . . . 0.0 112.308 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 216' ' ' ILE . 10.7 pt-20 -52.13 -38.76 58.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.036 1.335 . . . . 0.0 113.497 -172.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.5 p -65.61 -48.28 72.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.414 0.626 . . . . 0.0 110.603 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 17.0 t-160 -76.38 -24.79 54.13 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.478 HG13 HD23 ' A' ' 220' ' ' LEU . 5.3 tp -74.06 -46.51 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.822 0.737 . . . . 0.0 110.546 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.44 -44.97 76.83 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.285 0.564 . . . . 0.0 110.248 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.98 -42.85 84.4 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.699 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -68.83 -54.69 14.32 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.921 0.488 . . . . 0.0 109.738 -172.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.478 HD23 HG13 ' A' ' 216' ' ' ILE . 1.8 pp -62.03 -32.65 73.17 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 124.2 0.937 . . . . 0.0 110.08 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.44 -57.93 10.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.8 0.84 . . . . 0.0 111.096 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -67.8 -26.36 66.05 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.246 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 57.9 m -80.74 -37.42 30.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.317 1.047 . . . . 0.0 111.344 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.078 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.358 0.123 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.402 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.8 mttt -112.25 143.68 42.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 0.0 109.492 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.572 HG23 HG12 ' A' ' 216' ' ' ILE . 17.2 m -143.5 170.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 122.661 0.385 . . . . 0.0 110.288 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.93 146.32 32.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.191 0.996 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.424 ' CA ' HD11 ' A' ' 216' ' ' ILE . 14.5 t -85.21 100.04 1.07 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.714 0.806 . . . . 0.0 109.003 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -55.75 -18.08 20.07 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.224 2.616 . . . . 0.0 114.12 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.93 -56.95 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.133 0.573 . . . . 0.0 111.499 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 15.4 p -104.59 -34.16 8.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 97.73 53.82 1.27 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 114.314 0.486 . . . . 0.0 114.314 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.32 143.37 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.332 0.653 . . . . 0.0 110.57 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -95.88 122.23 38.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.373 0.669 . . . . 0.0 109.973 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 216' ' ' ILE . 0.4 OUTLIER -155.28 155.19 29.67 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.402 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 18.5 Cg_endo -58.4 159.13 20.46 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.479 2.786 . . . . 0.0 113.976 178.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.94 -36.01 11.68 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.273 1.829 . . . . 0.0 114.552 -169.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.6 p -73.18 -51.07 19.16 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.372 0.669 . . . . 0.0 111.251 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -71.89 -32.06 67.05 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.532 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 202' ' ' VAL . 10.8 tp -78.07 -38.49 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.615 0.366 . . . . 0.0 111.14 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.17 -42.4 98.5 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.63 0.581 . . . . 0.0 109.468 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.15 -46.75 79.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.629 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.15 -45.36 92.25 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 119.554 -0.26 . . . . 0.0 110.885 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.94 -32.94 63.73 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.35 0.406 . . . . 0.0 110.677 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.26 -52.75 44.48 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.208 0.943 . . . . 0.0 109.96 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.8 t -60.47 -45.94 91.9 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.261 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.1 m -62.93 -32.85 74.24 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.84 0.856 . . . . 0.0 112.485 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.484 1.244 0 C-N-CA 123.517 0.727 . . . . 0.0 110.121 -178.595 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -122.73 140.92 52.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.541 0.736 . . . . 0.0 109.143 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.628 HG23 HG12 ' A' ' 216' ' ' ILE . 15.5 m -142.38 167.16 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.576 0.35 . . . . 0.0 110.337 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.71 145.37 34.55 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.565 1.146 . . . . 0.0 110.928 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' CYS . . . . . 0.425 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.8 t -82.82 106.95 7.86 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.1 -17.52 32.1 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.692 2.262 . . . . 0.0 113.22 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.91 -57.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.823 0.849 . . . . 0.0 112.224 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 10.8 p -115.41 -3.24 12.44 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -166.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.4 34.27 45.81 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.27 136.28 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 117.046 0.423 . . . . 0.0 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.74 129.2 36.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.992 0.517 . . . . 0.0 109.761 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.547 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -155.62 156.02 30.28 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.907 0.883 . . . . 0.0 110.045 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.45 157.62 17.99 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.402 2.735 . . . . 0.0 114.218 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.41 -37.71 17.73 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.238 1.815 . . . . 0.0 113.775 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.9 p -67.2 -52.9 35.51 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.384 0.611 . . . . 0.0 111.309 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' HIS . . . . . 0.475 ' HD2' HG21 ' A' ' 211' ' ' ILE . 50.9 t60 -80.57 -22.44 40.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.57 -172.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 202' ' ' VAL . 10.1 tp -79.44 -43.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.569 0.347 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.24 -43.49 86.45 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.494 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -53.19 59.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.701 0.401 . . . . 0.0 110.553 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.1 -30.71 69.95 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.906 0.754 . . . . 0.0 110.699 -172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.23 -57.88 10.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.89 0.876 . . . . 0.0 110.589 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.6 t -68.19 -27.87 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.035 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.38 -39.61 58.96 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 0.0 111.045 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 CA-C-O 119.927 -0.374 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.6 p -72.12 82.4 0.98 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.179 0.592 . . . . 0.0 110.384 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -152.93 -74.22 0.13 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -160.84 109.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.163 1.385 . . . . 0.0 107.896 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -164.7 131.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 0.0 109.95 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 9.0 t -112.78 150.7 31.26 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.422 0.689 . . . . 0.0 110.199 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -117.48 143.28 46.2 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 109.415 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.569 HG23 HG12 ' A' ' 216' ' ' ILE . 18.1 m -142.67 172.14 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 122.737 0.415 . . . . 0.0 110.19 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.85 147.11 29.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.188 0.995 . . . . 0.0 111.224 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.432 ' CA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -85.58 106.56 9.71 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.173 0.989 . . . . 0.0 108.46 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.45 -23.83 33.01 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.291 2.661 . . . . 0.0 113.608 -171.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.7 -54.8 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 C-N-CA 123.026 0.53 . . . . 0.0 111.986 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 12.4 p -108.3 -19.21 13.55 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.19 5.12 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 122.847 0.26 . . . . 0.0 113.696 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.85 147.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.284 0.634 . . . . 0.0 111.301 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -100.89 126.71 47.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.152 0.581 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.515 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.6 155.95 29.35 Favored Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.551 -176.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 157.26 29.03 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.996 2.464 . . . . 0.0 112.953 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -50.04 -39.14 40.96 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.44 1.496 . . . . 0.0 113.86 -167.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 52.7 p -68.07 -50.36 55.59 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.32 0.648 . . . . 0.0 111.041 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.35 -30.51 63.38 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.869 -172.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 202' ' ' VAL . 9.6 tp -77.42 -40.76 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.198 0.599 . . . . 0.0 110.948 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.44 -43.53 93.12 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.543 0.527 . . . . 0.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -43.38 90.15 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.407 176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -52.03 67.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 123.334 0.396 . . . . 0.0 110.322 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.51 -30.73 68.64 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.788 0.68 . . . . 0.0 111.146 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.86 -47.86 76.37 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.806 0.842 . . . . 0.0 110.846 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.6 t -75.07 -26.75 59.59 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.993 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 36.1 m -77.78 -30.76 51.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.123 0.969 . . . . 0.0 111.65 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.54 -27.24 66.03 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.097 0.959 . . . . 0.0 108.853 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 48.1 m -87.42 -52.99 5.06 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.688 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -133.08 82.7 2.01 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.038 0.535 . . . . 0.0 111.543 -171.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 124.611 1.164 . . . . 0.0 113.895 165.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.5 m -68.99 95.08 0.68 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.532 0.733 . . . . 0.0 111.046 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -76.71 -36.3 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.875 0.87 . . . . 0.0 110.634 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -97.71 107.72 20.27 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.34 121.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 125.186 1.394 . . . . 0.0 107.284 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.5 t -80.46 142.46 34.25 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.765 0.317 . . . . 0.0 110.297 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -128.15 141.37 51.5 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.914 0.886 . . . . 0.0 109.248 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.644 HG23 HG12 ' A' ' 216' ' ' ILE . 12.1 m -140.73 158.79 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.561 0.344 . . . . 0.0 110.321 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.0 146.5 35.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.777 0.831 . . . . 0.0 110.011 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.475 ' HA ' HD11 ' A' ' 216' ' ' ILE . 8.0 t -82.58 107.69 9.85 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.774 0.83 . . . . 0.0 109.14 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.55 -27.98 53.06 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.647 2.231 . . . . 0.0 113.142 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 4.1 t -85.39 -43.97 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.973 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.92 -28.32 5.95 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-N 118.514 0.597 . . . . 0.0 112.333 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 101.57 23.69 9.28 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.14 136.51 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 117.625 0.712 . . . . 0.0 111.738 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -89.03 130.66 35.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.793 0.837 . . . . 0.0 109.974 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 216' ' ' ILE . 0.2 OUTLIER -156.58 155.91 29.3 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.064 0.946 . . . . 0.0 110.285 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.54 155.21 43.26 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.988 2.459 . . . . 0.0 113.68 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -44.4 -38.48 4.04 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.676 1.99 . . . . 0.0 114.609 -170.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 33.9 p -71.01 -52.29 20.44 Favored 'General case' 0 C--O 1.248 1.024 0 C-N-CA 123.554 0.742 . . . . 0.0 111.25 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -74.1 -27.12 60.73 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.127 -171.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.644 HG12 HG23 ' A' ' 202' ' ' VAL . 7.3 tp -79.27 -40.91 22.39 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.174 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -57.38 -43.05 83.26 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.66 -48.48 79.16 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.388 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -53.97 47.41 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.871 0.468 . . . . 0.0 110.878 -172.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 216' ' ' ILE . 3.3 pp -66.14 -31.47 72.34 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 124.13 0.894 . . . . 0.0 110.838 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.74 -57.87 8.63 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 0.0 110.197 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.5 t -63.93 -33.48 75.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.381 1.072 . . . . 0.0 110.837 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.7 m -69.46 -44.28 71.53 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.655 1.182 . . . . 0.0 111.014 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.36 -33.43 75.2 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.077 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 20.5 t -83.67 -9.69 58.69 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.029 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -83.29 -47.61 11.32 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.813 0.445 . . . . 0.0 109.883 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--O 1.247 0.94 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.841 -178.157 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.8 m -67.78 144.87 55.18 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.634 0.773 . . . . 0.0 110.468 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -72.24 100.67 2.65 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.4 0.68 . . . . 0.0 109.873 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.25 139.49 57.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.241 0.616 . . . . 0.0 111.033 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.518 HG23 ' HG2' ' A' ' 213' ' ' GLU . 7.6 p -171.83 119.69 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.159 0.983 . . . . 0.0 108.36 -176.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.7 t -82.82 147.17 28.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.829 0.452 . . . . 0.0 110.505 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -118.57 141.22 48.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.938 0.495 . . . . 0.0 110.785 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.9 m -142.4 160.63 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.996 0.918 . . . . 0.0 109.727 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.73 147.07 30.73 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.488 0.715 . . . . 0.0 110.283 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.537 ' HA ' HD11 ' A' ' 216' ' ' ILE . 34.4 t -79.53 110.16 14.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.315 0.646 . . . . 0.0 110.327 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.96 -24.09 37.84 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.609 2.873 . . . . 0.0 113.61 -171.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 t -85.48 -55.27 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 C-N-CA 123.319 0.648 . . . . 0.0 111.703 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.01 -27.81 9.93 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.59 26.55 8.54 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 115.03 0.772 . . . . 0.0 115.03 167.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.48 134.76 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 117.434 0.617 . . . . 0.0 111.489 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -84.39 125.52 32.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.355 0.662 . . . . 0.0 110.114 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.413 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.0 OUTLIER -154.52 151.87 24.77 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.13 0.972 . . . . 0.0 110.876 -169.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.7 161.46 28.47 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.025 2.484 . . . . 0.0 112.689 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 199' ' ' VAL . 11.6 pt-20 -55.52 -32.15 62.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.484 1.114 . . . . 0.0 112.674 -169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.7 p -66.25 -52.41 47.96 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 123.187 0.595 . . . . 0.0 111.017 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 28.5 t60 -76.74 -26.18 54.3 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.779 -172.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 5.6 tp -72.8 -43.92 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 119.221 -0.419 . . . . 0.0 110.849 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -54.53 -45.72 73.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.536 0.523 . . . . 0.0 109.869 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -67.4 -42.31 83.5 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.464 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -71.37 -50.34 33.15 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 117.699 0.227 . . . . 0.0 111.079 -170.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 HG13 ' A' ' 216' ' ' ILE . 2.4 pp -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.708 0.63 . . . . 0.0 109.765 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.75 -52.79 61.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.92 0.888 . . . . 0.0 110.856 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.0 t -67.76 -27.99 67.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.817 1.247 . . . . 0.0 111.291 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 35.3 m -82.11 -26.43 33.57 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.417 1.087 . . . . 0.0 111.353 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -83.36 -19.33 36.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.686 0.795 . . . . 0.0 108.983 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 30.4 t -83.32 -44.66 14.65 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.97 0.908 . . . . 0.0 110.618 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -118.45 -171.36 2.07 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 174.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 CA-C-O 119.857 -0.413 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 33.6 t -74.0 122.14 22.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.762 0.825 . . . . 0.0 110.474 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.23 175.14 5.54 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.985 0.914 . . . . 0.0 109.349 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -75.24 97.91 3.65 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.648 0.737 . . . . 0.0 110.2 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.6 p -163.35 132.9 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 C-N-CA 125.531 1.532 . . . . 0.0 107.492 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.9 t -96.53 142.23 28.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.532 0.333 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -116.83 141.04 48.73 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.912 0.885 . . . . 0.0 108.805 173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.545 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -144.24 158.29 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.44 0.696 . . . . 0.0 109.602 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.17 145.23 33.79 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.286 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 216' ' ' ILE . 46.1 t -80.36 109.57 13.25 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 110.093 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.32 -27.61 67.93 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.309 2.673 . . . . 0.0 113.392 -168.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.4 t -87.79 -29.03 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.576 0 C-N-CA 123.59 0.756 . . . . 0.0 112.89 -173.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 18.9 p -129.5 -34.36 1.81 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.194 -0.941 . . . . 0.0 112.061 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 96.44 53.85 1.41 Allowed Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.822 0.289 . . . . 0.0 113.822 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.86 130.0 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.633 0.773 . . . . 0.0 109.872 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.56 126.0 30.32 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 215' ' ' HIS . 1.2 pt -154.29 151.76 24.9 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 123.813 0.845 . . . . 0.0 110.726 -171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -61.64 161.38 24.87 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.929 2.42 . . . . 0.0 112.665 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.26 -31.22 53.07 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.47 1.106 . . . . 0.0 113.259 -169.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.6 p -66.86 -51.75 51.77 Favored 'General case' 0 C--O 1.25 1.129 0 C-N-CA 122.716 0.406 . . . . 0.0 111.087 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 211' ' ' ILE . 18.1 t-160 -74.48 -31.51 62.24 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.225 -171.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.545 HG12 HG23 ' A' ' 202' ' ' VAL . 4.5 tp -67.78 -46.18 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 118.996 -0.526 . . . . 0.0 110.965 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -54.44 -46.59 73.28 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.623 0.577 . . . . 0.0 110.355 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -67.5 -40.86 85.2 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.52 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -70.73 -49.42 47.08 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.471 0.308 . . . . 0.0 110.49 -170.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 pp -67.24 -31.83 72.46 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.929 0.768 . . . . 0.0 109.642 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.87 -55.46 29.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.118 0.967 . . . . 0.0 111.073 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -69.9 -24.17 63.35 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.154 0.981 . . . . 0.0 111.201 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 34.2 m -81.37 -30.11 33.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.894 0.878 . . . . 0.0 111.062 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.79 -25.11 56.11 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 37.1 t -76.84 -67.91 0.66 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.881 0.872 . . . . 0.0 110.197 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -103.14 151.56 22.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.167 0.587 . . . . 0.0 110.659 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 123.719 0.808 . . . . 0.0 109.458 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.085 -0.406 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 200' ' ' THR . 33.0 m -69.12 103.68 1.95 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.828 0.851 . . . . 0.0 110.557 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -67.75 -40.59 84.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 0.0 111.636 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -66.53 -42.69 86.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.28 0.632 . . . . 0.0 111.096 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.457 HG23 ' HG2' ' A' ' 213' ' ' GLU . 8.2 p -175.15 108.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.827 0 CA-C-O 122.364 1.078 . . . . 0.0 109.39 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.438 ' HA ' ' HB2' ' A' ' 196' ' ' SER . 1.9 m -74.86 132.8 41.78 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.792 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 92.7 mttt -115.01 134.2 55.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.431 0.692 . . . . 0.0 110.514 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 18.6 m -138.04 173.42 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.871 0.868 . . . . 0.0 110.095 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -89.86 146.99 24.03 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.127 0.571 . . . . 0.0 111.019 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 211' ' ' ILE . 15.5 t -79.27 117.82 69.1 Favored Pre-proline 0 C--O 1.219 -0.511 0 C-N-CA 123.792 0.837 . . . . 0.0 109.839 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.03 -28.43 87.04 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.972 2.448 . . . . 0.0 112.669 -171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.0 t -85.77 -46.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.372 -174.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.4 p -111.78 -33.57 6.28 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.04 6.88 31.73 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 207' ' ' CYS . 28.2 m -83.5 145.85 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 0.0 112.213 -176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -82.07 133.15 35.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 0.0 109.974 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.75 147.62 15.42 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.294 1.038 . . . . 0.0 109.979 -169.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 48.1 Cg_endo -66.82 161.7 40.89 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.428 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.457 ' HG2' HG23 ' A' ' 199' ' ' VAL . 12.2 pt-20 -53.29 -34.72 58.46 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.718 1.207 . . . . 0.0 113.573 -169.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 29.7 p -68.6 -50.39 51.93 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.796 0.839 . . . . 0.0 110.817 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.2 t-160 -80.17 -17.31 52.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.912 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 211' ' ' ILE . 4.3 tp -76.36 -44.73 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.689 0.677 . . . . 0.0 109.708 173.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -53.46 -45.66 69.6 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 124.084 0.865 . . . . 0.0 109.572 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.47 -50.22 64.03 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.442 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -65.39 -44.99 85.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 117.92 0.327 . . . . 0.0 110.334 -168.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 pp -68.03 -35.38 78.18 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 124.239 0.962 . . . . 0.0 109.478 -177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.78 -54.3 46.81 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.921 0.888 . . . . 0.0 110.312 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.8 t -62.77 -33.86 76.04 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.042 1.337 . . . . 0.0 111.409 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 30.4 m -79.36 -29.66 42.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.408 1.083 . . . . 0.0 111.644 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.49 -27.36 51.85 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.8 t -73.67 -44.83 55.68 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.736 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -96.99 178.85 5.14 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.75 0.82 . . . . 0.0 111.311 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.312 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.6 p -74.27 87.31 1.97 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.437 0.695 . . . . 0.0 110.585 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.53 -63.6 1.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.806 0.842 . . . . 0.0 109.376 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -77.68 94.27 4.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.96 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.8 p -167.03 133.99 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.528 1.131 . . . . 0.0 108.488 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.1 t -103.66 145.93 29.33 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -125.72 138.37 53.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.385 0.674 . . . . 0.0 110.211 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 216' ' ' ILE . 20.8 m -139.4 164.56 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.54 0.736 . . . . 0.0 109.784 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.27 147.5 28.88 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.621 0.768 . . . . 0.0 109.864 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.474 ' HA ' HD11 ' A' ' 216' ' ' ILE . 10.3 t -81.89 109.78 16.81 Favored Pre-proline 0 C--O 1.222 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 109.159 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.47 -23.17 62.82 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.19 2.593 . . . . 0.0 113.374 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 11.8 t -87.54 -38.05 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.434 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 209' ' ' VAL . 14.5 p -125.95 -29.2 3.11 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -170.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.18 -5.63 30.31 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 165.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.458 HG22 ' SG ' ' A' ' 207' ' ' CYS . 21.5 m -69.12 133.19 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 117.407 0.603 . . . . 0.0 111.773 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.26 124.06 30.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.571 0.748 . . . . 0.0 109.305 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.429 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.9 OUTLIER -150.93 151.47 29.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.595 0.758 . . . . 0.0 110.803 -169.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.62 160.79 34.58 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.941 2.428 . . . . 0.0 112.797 178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.97 -37.43 32.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.348 1.459 . . . . 0.0 113.736 -171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.2 m -67.71 -51.14 53.04 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 123.362 0.665 . . . . 0.0 110.904 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -71.37 -32.17 68.18 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.037 -172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.578 HG12 HG23 ' A' ' 202' ' ' VAL . 5.5 tp -70.87 -45.32 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -53.4 -45.85 69.47 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.469 0.652 . . . . 0.0 109.894 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -66.91 -48.75 67.72 Favored 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.201 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.71 -47.15 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.604 0.362 . . . . 0.0 110.388 -168.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.11 -32.73 74.06 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 123.881 0.738 . . . . 0.0 109.682 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.47 -57.59 12.3 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 123.269 0.628 . . . . 0.0 110.708 174.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.6 t -63.36 -30.94 71.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.192 0.997 . . . . 0.0 111.401 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 36.1 m -79.18 -32.12 44.06 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.085 0.954 . . . . 0.0 111.804 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.57 -26.8 68.57 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.481 0.712 . . . . 0.0 111.655 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 51.8 p -95.12 -7.23 39.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.655 0.782 . . . . 0.0 111.668 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -130.98 168.76 16.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.781 0.832 . . . . 0.0 111.05 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.13 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.48 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 32.4 m -77.79 100.17 6.19 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.537 0.735 . . . . 0.0 110.17 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -63.1 107.49 1.04 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -117.57 165.44 13.57 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.968 0.907 . . . . 0.0 110.684 -173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.4 p -154.81 115.1 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.401 1.081 . . . . 0.0 108.294 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t -79.85 146.99 31.93 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.482 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -124.26 143.84 50.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.365 0.666 . . . . 0.0 110.394 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.696 HG23 HG12 ' A' ' 216' ' ' ILE . 19.0 m -142.43 163.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.678 0.791 . . . . 0.0 109.753 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 146.69 35.61 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.801 0.84 . . . . 0.0 110.967 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.53 ' HA ' HD11 ' A' ' 216' ' ' ILE . 9.8 t -84.01 107.74 11.6 Favored Pre-proline 0 C--O 1.218 -0.599 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -56.89 -25.7 63.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.885 2.39 . . . . 0.0 113.127 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.96 -43.98 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.625 0.77 . . . . 0.0 112.13 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 209' ' ' VAL . 10.1 p -125.36 4.71 7.71 Favored 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -170.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.23 45.65 95.69 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 125.223 1.392 . . . . 0.0 115.208 169.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.456 HG22 ' SG ' ' A' ' 207' ' ' CYS . 27.6 m -117.48 128.69 74.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 175.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.17 126.07 31.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.414 0.685 . . . . 0.0 109.704 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -152.78 150.68 25.05 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.725 0.81 . . . . 0.0 111.472 -169.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.49 156.98 38.55 Favored 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 123.192 2.595 . . . . 0.0 113.14 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -47.08 -39.04 12.27 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.229 1.812 . . . . 0.0 114.311 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 37.7 p -69.02 -51.65 36.94 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.317 0.58 . . . . 0.0 111.078 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 12.2 t60 -70.37 -32.29 69.91 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.549 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.696 HG12 HG23 ' A' ' 202' ' ' VAL . 5.0 tp -71.8 -46.09 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.494 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.543 HD22 HG23 ' A' ' 216' ' ' ILE . 0.9 OUTLIER -57.11 -44.21 83.03 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 123.183 0.302 . . . . 0.0 110.329 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -69.52 -42.39 74.76 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.974 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -64.47 -50.46 67.4 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.583 -172.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 216' ' ' ILE . 1.6 pp -69.19 -32.83 72.39 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.889 0.743 . . . . 0.0 110.096 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.42 -55.51 27.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.674 0.79 . . . . 0.0 110.115 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -64.96 -33.1 75.24 Favored 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 124.348 1.059 . . . . 0.0 110.674 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 32.7 m -73.61 -36.03 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.961 0.904 . . . . 0.0 111.314 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.72 -32.52 69.75 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.9 t -82.72 -34.11 27.36 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.978 0.911 . . . . 0.0 111.249 -174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -161.03 142.37 11.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.921 0.888 . . . . 0.0 109.071 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.251 1.153 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.483 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 34.5 p -69.12 138.67 54.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.686 0.794 . . . . 0.0 111.603 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -127.4 -179.43 4.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.538 1.135 . . . . 0.0 110.243 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 66.08 17.06 10.68 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.988 1.315 . . . . 0.0 113.056 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.26 114.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.834 0 C-N-CA 124.747 1.219 . . . . 0.0 107.779 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.6 t -73.93 136.94 43.32 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.525 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -126.91 132.47 50.88 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.147 0.579 . . . . 0.0 109.864 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.53 HG23 HG12 ' A' ' 216' ' ' ILE . 30.4 m -135.79 164.03 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.561 0.744 . . . . 0.0 110.006 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.28 147.24 32.59 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.271 1.028 . . . . 0.0 110.984 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.451 ' HA ' HD11 ' A' ' 216' ' ' ILE . 23.5 t -82.68 108.81 13.33 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 123.017 0.527 . . . . 0.0 109.764 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.42 -27.24 75.08 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.026 2.484 . . . . 0.0 113.231 -170.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.2 t -86.72 -36.53 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 123.304 0.642 . . . . 0.0 111.976 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.5 p -122.72 -37.54 2.75 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-N 118.571 0.623 . . . . 0.0 112.176 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.21 -3.34 14.1 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.8 140.02 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 118.425 1.112 . . . . 0.0 112.12 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -81.95 128.73 34.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -153.2 149.78 22.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.254 0.621 . . . . 0.0 111.025 -170.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.33 161.7 29.88 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.871 2.381 . . . . 0.0 113.154 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.67 -41.92 44.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.05 1.74 . . . . 0.0 114.573 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.5 p -71.5 -43.56 66.29 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 121.262 0.553 . . . . 0.0 110.643 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 37.8 t-80 -75.14 -22.81 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.103 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.53 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -77.2 -45.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.554 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -51.26 -48.33 62.22 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.783 0.677 . . . . 0.0 110.558 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -69.98 -45.14 67.98 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.344 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.4 OUTLIER -62.59 -51.51 67.02 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 117.869 0.304 . . . . 0.0 110.811 -173.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 216' ' ' ILE . 2.1 pp -64.21 -34.27 77.72 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.915 0.759 . . . . 0.0 110.162 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.36 -54.38 37.71 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 124.053 0.846 . . . . 0.0 111.289 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 45.6 t -65.37 -27.66 68.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.902 1.281 . . . . 0.0 110.981 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.1 m -80.66 -36.17 32.81 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.511 1.124 . . . . 0.0 111.811 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -76.67 -30.38 56.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.511 0.725 . . . . 0.0 109.801 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 55.3 p -69.45 -50.41 45.84 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.15 -173.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -137.6 138.41 39.5 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 123.07 0.548 . . . . 0.0 109.83 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.1 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 25.4 m -76.36 122.17 24.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.755 0.822 . . . . 0.0 110.728 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.41 62.61 7.59 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 122.043 0.925 . . . . 0.0 109.442 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -140.95 -53.55 0.48 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 12.7 p -172.81 125.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.601 171.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 14.8 t -83.08 129.34 35.02 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -116.52 137.82 51.87 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.168 0.587 . . . . 0.0 110.026 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 216' ' ' ILE . 16.1 m -141.69 164.09 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.746 0.818 . . . . 0.0 110.125 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -78.64 146.56 34.01 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.495 1.118 . . . . 0.0 111.023 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.513 ' HA ' HD11 ' A' ' 216' ' ' ILE . 19.2 t -84.86 106.19 8.11 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 123.622 0.769 . . . . 0.0 109.154 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -54.32 -25.43 39.0 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.6 2.867 . . . . 0.0 113.62 -169.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.79 -57.1 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.835 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.404 ' SG ' HG22 ' A' ' 209' ' ' VAL . 18.6 p -99.17 -31.34 11.79 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.07 0.395 . . . . 0.0 111.719 -175.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.86 2.79 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 168.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.404 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.1 m -120.61 140.41 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.119 0.568 . . . . 0.0 110.853 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -81.58 133.71 35.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.897 0.479 . . . . 0.0 109.993 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.4 OUTLIER -157.16 149.43 17.74 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.822 0.849 . . . . 0.0 110.483 -171.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.62 159.14 33.66 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.963 2.442 . . . . 0.0 112.897 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -50.3 -37.66 37.56 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.278 1.431 . . . . 0.0 113.944 -170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.1 p -69.53 -50.82 41.45 Favored 'General case' 0 C--O 1.254 1.298 0 C-N-CA 123.043 0.537 . . . . 0.0 110.912 176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.57 -31.43 69.6 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.368 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.571 HG12 HG23 ' A' ' 202' ' ' VAL . 5.7 tp -70.09 -42.42 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.887 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.32 -50.57 61.98 Favored 'General case' 0 C--O 1.249 1.074 0 O-C-N 123.745 0.653 . . . . 0.0 110.649 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -70.22 -42.01 72.85 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.236 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -51.33 61.66 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.027 0.376 . . . . 0.0 110.602 -172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.449 HD23 HG13 ' A' ' 216' ' ' ILE . 1.9 pp -64.82 -35.32 80.73 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.819 0.7 . . . . 0.0 110.073 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.75 -52.96 61.19 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.654 0.74 . . . . 0.0 110.685 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -67.83 -25.27 65.48 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.706 1.202 . . . . 0.0 111.438 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.78 -36.55 28.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.286 1.034 . . . . 0.0 111.671 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt -72.12 -26.48 62.13 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 35.4 t -87.37 -68.03 0.78 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.296 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -95.7 97.4 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.252 1.225 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.931 178.425 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 CA-C-O 120.058 -0.301 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 36.7 m -67.9 104.42 1.71 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.726 0.81 . . . . 0.0 110.72 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -67.2 149.61 50.22 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.679 0.792 . . . . 0.0 109.564 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -66.37 -31.01 71.53 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.453 HG23 ' HG2' ' A' ' 213' ' ' GLU . 7.6 p -167.93 117.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.946 1.298 . . . . 0.0 108.328 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.6 t -80.15 144.31 33.13 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.263 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -121.01 137.77 54.49 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.215 0.606 . . . . 0.0 110.552 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.61 HG23 HG12 ' A' ' 216' ' ' ILE . 16.0 m -141.66 161.71 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.584 0.754 . . . . 0.0 110.628 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.41 146.31 32.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.631 1.172 . . . . 0.0 110.918 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' A' ' 216' ' ' ILE . 20.1 t -84.01 109.79 21.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 123.599 0.76 . . . . 0.0 109.744 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.08 -23.3 60.2 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.27 2.647 . . . . 0.0 113.691 -171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 -50.28 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 C-N-CA 123.484 0.713 . . . . 0.0 111.754 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.6 p -113.23 -26.36 8.44 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 94.39 41.67 4.16 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 165.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -116.25 136.9 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.109 0.564 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -86.14 127.64 34.74 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.982 0.513 . . . . 0.0 109.777 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.466 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.8 OUTLIER -154.08 152.02 25.74 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.251 1.02 . . . . 0.0 110.361 -169.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.25 160.04 28.42 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.198 2.599 . . . . 0.0 112.917 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.453 ' HG2' HG23 ' A' ' 199' ' ' VAL . 12.2 pt-20 -53.66 -34.89 60.17 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.038 1.335 . . . . 0.0 113.532 -168.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 57.4 p -70.83 -47.73 57.84 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.38 0.672 . . . . 0.0 111.281 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -69.93 -34.37 73.38 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 202' ' ' VAL . 4.9 tp -73.29 -40.47 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.073 0.549 . . . . 0.0 111.213 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -55.14 -46.49 75.68 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -66.93 -44.32 80.97 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.247 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -55.85 12.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.759 0.424 . . . . 0.0 110.567 -170.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 216' ' ' ILE . 1.3 pp -64.51 -32.77 74.55 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 123.94 0.775 . . . . 0.0 109.976 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.45 -57.63 11.93 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.081 0.863 . . . . 0.0 110.711 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 27.0 t -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.134 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 11.7 m -76.47 -46.03 28.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.107 0.963 . . . . 0.0 110.59 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.25 -32.35 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.093 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 68.6 p -89.35 -12.67 39.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.432 0.693 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -69.98 -35.18 74.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 C--O 1.254 1.308 0 C-N-CA 123.977 0.911 . . . . 0.0 111.482 -177.88 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.011 0 N-CA-C 112.346 -0.302 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.3 p -83.52 79.62 9.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.568 0.747 . . . . 0.0 110.273 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -88.17 111.68 21.89 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.611 0.765 . . . . 0.0 109.401 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -72.48 99.72 2.55 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.135 0.574 . . . . 0.0 110.038 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 213' ' ' GLU . 4.3 p -163.12 121.21 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.23 1.012 . . . . 0.0 109.442 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 11.5 t -92.86 151.0 20.23 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.293 0.637 . . . . 0.0 110.225 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.404 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.5 mttt -117.18 144.69 44.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.429 0.692 . . . . 0.0 109.754 174.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.539 HG23 HG12 ' A' ' 216' ' ' ILE . 23.9 m -143.23 169.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 122.844 0.458 . . . . 0.0 110.087 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.09 147.69 26.05 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.6 0.76 . . . . 0.0 110.481 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.468 ' CA ' HD11 ' A' ' 216' ' ' ILE . 4.2 t -73.53 120.08 79.26 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.537 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.55 -25.26 80.3 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 122.204 1.936 . . . . 0.0 111.874 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.03 -55.61 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 C-N-CA 123.623 0.769 . . . . 0.0 111.956 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 7.9 p -120.05 7.08 10.81 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 77.58 2.39 80.26 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 116.062 1.185 . . . . 0.0 116.062 162.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.55 138.12 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.702 0.751 . . . . 0.0 112.202 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -91.57 124.98 36.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.644 0.778 . . . . 0.0 110.652 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.539 HG13 HD13 ' A' ' 216' ' ' ILE . 0.3 OUTLIER -155.76 158.44 31.76 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.312 1.045 . . . . 0.0 110.063 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.404 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 35.0 Cg_endo -61.62 158.95 34.45 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.039 2.493 . . . . 0.0 113.615 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.414 ' HG2' HG23 ' A' ' 199' ' ' VAL . 10.7 pt-20 -48.72 -34.85 12.82 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.887 1.675 . . . . 0.0 113.622 -170.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -70.4 -52.78 19.89 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.562 0.745 . . . . 0.0 111.135 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -80.42 -23.66 40.18 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.531 -173.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -80.12 -37.48 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 117.853 0.297 . . . . 0.0 111.305 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -62.9 -42.19 99.7 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -62.41 -45.76 91.65 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.865 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.31 -48.8 74.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.629 -172.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 1.8 pp -65.69 -33.5 76.03 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 124.003 0.815 . . . . 0.0 110.299 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.64 -57.89 10.98 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.399 1.079 . . . . 0.0 110.989 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 t -65.54 -28.51 69.22 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.983 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 40.6 m -80.58 -31.46 36.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.931 0.892 . . . . 0.0 111.911 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -81.35 -14.48 57.21 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 24.8 t -113.34 -68.86 0.9 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 110.605 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -78.98 95.8 5.58 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.586 0.754 . . . . 0.0 109.297 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 C--O 1.252 1.203 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.27 -177.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 32.8 m -91.56 104.81 17.26 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.633 0.773 . . . . 0.0 109.382 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -78.61 165.38 23.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.037 0.535 . . . . 0.0 110.938 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.61 101.53 4.98 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.601 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.5 p -162.49 122.98 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.662 1.185 . . . . 0.0 108.701 177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.0 t -94.52 150.8 19.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -127.11 129.0 47.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.616 HG23 HG12 ' A' ' 216' ' ' ILE . 20.9 m -136.03 165.24 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 122.811 0.444 . . . . 0.0 110.423 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -77.68 146.25 36.16 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.373 1.069 . . . . 0.0 111.004 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 11.7 t -86.56 105.52 8.01 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.82 -24.74 32.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 123.407 2.738 . . . . 0.0 113.68 -171.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.71 -53.26 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.35 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 209' ' ' VAL . 16.2 p -110.54 -15.51 13.87 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.03 49.89 6.14 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 123.452 0.549 . . . . 0.0 113.382 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.3 m -120.46 132.63 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 122.995 0.518 . . . . 0.0 110.123 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.83 129.27 34.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 216' ' ' ILE . 0.6 OUTLIER -152.43 151.97 28.22 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.488 0.715 . . . . 0.0 111.053 -172.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.89 158.7 32.39 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.859 2.372 . . . . 0.0 113.044 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -50.19 -38.53 40.39 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.203 1.401 . . . . 0.0 114.122 -167.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 77.3 p -69.64 -49.62 52.05 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-O 121.348 0.594 . . . . 0.0 110.805 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.95 -33.02 73.87 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.677 -171.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.616 HG12 HG23 ' A' ' 202' ' ' VAL . 5.9 tp -72.87 -40.86 60.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.674 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.93 -50.03 64.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.043 0.449 . . . . 0.0 110.427 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -68.59 -43.59 76.14 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -52.8 55.9 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.419 -171.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 216' ' ' ILE . 2.2 pp -66.85 -32.87 74.43 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.565 0.541 . . . . 0.0 110.332 -175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.81 -58.09 10.08 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.878 0.736 . . . . 0.0 110.952 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 42.7 t -69.87 -28.51 65.71 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.251 1.021 . . . . 0.0 111.592 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.51 -49.35 41.95 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.657 0.783 . . . . 0.0 111.185 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 tp -71.25 -28.59 64.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.103 0.561 . . . . 0.0 110.095 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.1 t -76.79 -25.8 53.74 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.65 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 64.97 91.12 0.08 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.388 1.075 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 CA--C 1.557 1.218 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.63 175.544 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.4 m 62.85 13.42 6.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.759 1.223 . . . . 0.0 113.59 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -82.5 112.78 19.74 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.406 0.683 . . . . 0.0 110.706 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -128.62 136.3 50.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.844 0.857 . . . . 0.0 108.866 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.3 p -171.09 93.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 5.9 m -65.53 123.99 21.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.913 -1.494 . . . . 0.0 111.503 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -97.54 142.65 29.12 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.438 0.695 . . . . 0.0 109.937 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.602 HG23 HG12 ' A' ' 216' ' ' ILE . 15.3 m -143.51 160.2 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.348 0.659 . . . . 0.0 109.979 175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.51 147.31 30.91 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.348 1.059 . . . . 0.0 110.718 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.534 ' HA ' HD11 ' A' ' 216' ' ' ILE . 7.0 t -82.35 110.46 21.57 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.215 1.006 . . . . 0.0 109.473 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.95 -22.46 63.29 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.447 2.765 . . . . 0.0 113.036 -173.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 6.4 t -86.22 -45.26 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.762 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 209' ' ' VAL . 15.3 p -118.86 -33.34 4.24 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -172.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.6 -17.18 9.56 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 115.282 0.873 . . . . 0.0 115.282 168.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.447 HG22 ' SG ' ' A' ' 207' ' ' CYS . 30.5 m -67.19 135.27 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.45 128.86 36.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.681 0.792 . . . . 0.0 109.674 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.79 154.47 26.69 Favored Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 123.596 0.758 . . . . 0.0 110.493 -172.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.82 156.85 35.93 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.283 2.655 . . . . 0.0 113.218 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.42 -35.12 12.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.182 1.393 . . . . 0.0 113.875 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 13.2 p -70.62 -52.37 21.84 Favored 'General case' 0 C--O 1.252 1.22 0 C-N-CA 123.279 0.632 . . . . 0.0 111.679 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -75.06 -25.72 58.85 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.872 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 202' ' ' VAL . 7.2 tp -78.39 -39.75 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.334 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -57.18 -43.21 82.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.36 -45.3 80.58 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -52.97 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.415 0.286 . . . . 0.0 111.237 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.92 -30.41 70.55 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.743 0.652 . . . . 0.0 110.49 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.87 -55.06 21.73 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.005 0.816 . . . . 0.0 110.113 173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.9 t -65.13 -26.52 68.23 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.935 1.294 . . . . 0.0 111.462 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.4 -39.57 24.78 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.385 1.074 . . . . 0.0 111.123 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.79 -33.29 68.45 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 33.6 t -83.58 -50.83 7.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.009 -174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 -112.0 113.06 25.14 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.621 0.768 . . . . 0.0 108.953 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.224 0 C-N-CA 123.032 0.533 . . . . 0.0 110.895 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.938 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.9 m -68.78 109.82 4.04 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 117.556 0.678 . . . . 0.0 110.504 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -73.62 -30.18 62.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.19 0.596 . . . . 0.0 112.325 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -75.11 85.36 2.35 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.673 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 12.6 p 175.2 137.15 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.781 1.633 . . . . 0.0 107.962 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.2 t -100.3 142.49 31.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.3 mttt -122.49 138.75 54.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.219 0.608 . . . . 0.0 109.605 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 HG12 ' A' ' 216' ' ' ILE . 20.3 m -141.27 165.45 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.936 0.494 . . . . 0.0 110.473 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.65 147.81 31.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.72 1.208 . . . . 0.0 111.084 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.475 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.2 t -81.55 112.66 35.9 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.812 0.845 . . . . 0.0 109.079 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.62 -24.47 45.37 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.149 2.566 . . . . 0.0 113.183 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.33 -57.55 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.084 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -111.32 -19.03 12.78 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.17 -29.38 7.39 Favored Glycine 0 N--CA 1.478 1.459 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 167.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.91 138.38 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -90.76 122.42 33.48 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.397 1.079 . . . . 0.0 110.139 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.534 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.59 159.45 33.28 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 123.602 0.761 . . . . 0.0 110.19 -176.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.447 ' HD2' HG22 ' A' ' 211' ' ' ILE . 37.7 Cg_endo -61.63 156.35 48.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.899 2.399 . . . . 0.0 113.401 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -44.01 -40.57 4.85 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.963 1.705 . . . . 0.0 114.551 -169.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 12.3 p -76.89 -46.51 24.21 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 122.808 0.443 . . . . 0.0 111.651 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -75.22 -23.44 57.58 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.383 0.273 . . . . 0.0 111.361 -174.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 202' ' ' VAL . 9.8 tp -78.94 -41.9 23.88 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 122.949 0.5 . . . . 0.0 110.685 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -60.09 -39.25 85.48 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.903 0.383 . . . . 0.0 110.442 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -46.22 85.33 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.079 174.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.4 -47.7 78.18 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.347 0.404 . . . . 0.0 110.813 -173.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.47 -27.94 65.65 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 123.8 0.688 . . . . 0.0 110.997 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.65 -50.71 56.52 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 0.0 110.755 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.5 t -66.77 -31.53 72.23 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.645 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 56.9 m -78.88 -26.41 43.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.182 0.993 . . . . 0.0 111.08 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.4 tt -69.53 -27.43 65.16 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.524 0.73 . . . . 0.0 109.385 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.1 t -83.89 -15.87 46.46 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.762 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 164.76 25.94 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.664 0.786 . . . . 0.0 111.046 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.531 1.132 . . . . 0.0 109.333 -179.361 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 51.9 p -162.01 138.99 8.28 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.046 0.938 . . . . 0.0 109.866 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 197' ' ' ARG . 0.1 OUTLIER -125.29 88.23 2.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.235 1.014 . . . . 0.0 108.853 176.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -149.66 111.09 4.45 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.238 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.5 p -164.79 142.39 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 124.621 1.168 . . . . 0.0 108.289 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t -111.03 150.54 29.16 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.234 0.614 . . . . 0.0 110.107 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.417 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 91.5 mttt -119.93 138.23 53.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.836 0.854 . . . . 0.0 108.841 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.514 HG23 HG12 ' A' ' 216' ' ' ILE . 18.7 m -138.84 160.34 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.866 0.467 . . . . 0.0 110.19 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -78.49 147.98 33.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.214 0.606 . . . . 0.0 110.346 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.495 ' HA ' HD11 ' A' ' 216' ' ' ILE . 5.0 t -76.13 112.51 21.12 Favored Pre-proline 0 N--CA 1.471 0.619 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.16 -25.62 56.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.797 2.331 . . . . 0.0 112.542 -175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.0 t -86.2 -57.42 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.17 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.8 p -108.98 -19.37 13.42 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 204' ' ' CYS . . . 110.55 -19.48 26.29 Favored Glycine 0 N--CA 1.478 1.455 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 166.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.05 136.48 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.68 122.88 34.64 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.199 1.0 . . . . 0.0 110.527 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -151.33 156.57 35.03 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 123.711 0.805 . . . . 0.0 110.136 -175.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 211' ' ' ILE . 20.3 Cg_endo -58.12 153.58 44.84 Favored 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 123.16 2.573 . . . . 0.0 113.374 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.99 -34.32 12.84 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.431 1.492 . . . . 0.0 114.551 -166.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.9 p -74.93 -50.46 16.72 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.784 0.434 . . . . 0.0 111.246 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -72.36 -30.07 64.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.694 0.398 . . . . 0.0 111.115 -173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.55 HD13 HG13 ' A' ' 211' ' ' ILE . 8.2 tp -75.4 -36.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -55.99 -46.8 78.59 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.642 0.589 . . . . 0.0 109.975 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -62.25 -46.28 89.55 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.061 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.53 -51.26 69.33 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.258 0.349 . . . . 0.0 110.994 -172.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' LEU . 3.7 pp -70.4 -27.2 64.11 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.677 0.611 . . . . 0.0 111.181 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.39 -54.54 16.52 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.191 0.932 . . . . 0.0 110.4 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 34.9 t -67.87 -24.66 65.26 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 52.0 m -81.24 -28.09 34.94 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.905 0.882 . . . . 0.0 111.382 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 220' ' ' LEU . 1.0 OUTLIER -69.89 -24.19 63.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 34.2 t -83.36 -65.23 1.03 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.546 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -129.5 167.54 17.71 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.206 1.002 . . . . 0.0 109.273 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.253 1.279 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.914 178.684 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.5 m -73.82 92.52 2.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.121 0.569 . . . . 0.0 109.98 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -144.98 100.83 3.55 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -77.26 95.92 4.45 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-O 121.224 0.535 . . . . 0.0 109.987 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.2 p -146.33 110.62 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 15.2 t -82.06 135.75 35.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.6 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -113.28 136.4 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.083 0.553 . . . . 0.0 110.153 175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 216' ' ' ILE . 19.4 m -138.91 165.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.353 0.661 . . . . 0.0 110.112 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.66 147.87 33.38 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.998 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.542 ' HA ' HD11 ' A' ' 216' ' ' ILE . 12.8 t -82.83 107.4 9.2 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.8 -26.63 67.55 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.963 2.442 . . . . 0.0 112.888 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 3.3 t -88.67 -31.15 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.554 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 13.7 p -128.62 -30.8 2.28 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 119.371 0.987 . . . . 0.0 112.45 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 119.44 -16.54 10.55 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 164.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.45 134.73 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.02 124.86 32.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.768 0.827 . . . . 0.0 109.715 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.448 HG13 ' HB ' ' A' ' 216' ' ' ILE . 1.1 pt -153.9 152.54 27.08 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.987 0.915 . . . . 0.0 110.689 -169.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.83 162.4 28.83 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.661 2.241 . . . . 0.0 112.573 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.83 -32.19 30.73 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.868 1.267 . . . . 0.0 113.456 -171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.3 p -68.99 -52.63 26.85 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.318 0.647 . . . . 0.0 111.514 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 16.7 t-160 -76.32 -25.07 54.41 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.023 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.587 HG12 HG23 ' A' ' 202' ' ' VAL . 6.3 tp -74.39 -42.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 118.847 -0.597 . . . . 0.0 111.445 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -52.48 -48.02 66.16 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.356 0.598 . . . . 0.0 109.856 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -65.13 -50.19 67.0 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.5 OUTLIER -67.21 -48.25 68.43 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.524 0.33 . . . . 0.0 110.514 -167.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.465 HD23 HG13 ' A' ' 216' ' ' ILE . 1.2 pp -67.15 -30.99 71.12 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.801 0.688 . . . . 0.0 109.999 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.73 -56.9 14.65 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 123.838 0.711 . . . . 0.0 110.418 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -64.05 -31.01 72.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.228 1.011 . . . . 0.0 111.424 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 59.7 m -77.45 -27.8 52.25 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.784 0.834 . . . . 0.0 110.898 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.4 tp -70.28 -16.89 63.08 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.268 0.627 . . . . 0.0 109.452 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 27.6 t -101.99 10.91 39.26 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.317 1.047 . . . . 0.0 110.623 175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -133.56 124.48 26.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.245 0.618 . . . . 0.0 111.054 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 168.105 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 29.7 p -76.29 110.0 10.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.238 0.615 . . . . 0.0 111.04 -175.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -141.79 97.32 3.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -90.44 116.79 28.64 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.013 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.2 p -161.36 122.06 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 124.421 1.088 . . . . 0.0 108.906 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.5 t -94.11 142.86 26.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.069 0.547 . . . . 0.0 109.942 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.76 134.11 54.93 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.706 0.802 . . . . 0.0 109.095 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.563 HG23 HG12 ' A' ' 216' ' ' ILE . 22.3 m -137.9 167.72 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 121.246 0.546 . . . . 0.0 110.486 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 147.47 32.97 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.929 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.647 ' HA ' HD11 ' A' ' 216' ' ' ILE . 14.8 t -87.21 110.99 37.9 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.168 0.587 . . . . 0.0 109.885 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -53.0 -31.72 54.71 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.43 2.753 . . . . 0.0 113.522 -172.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 8.8 t -85.33 -45.9 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.762 -173.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 17.9 p -111.43 -34.47 6.1 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 118.464 0.575 . . . . 0.0 112.165 -173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.89 16.9 14.06 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 168.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.03 143.31 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 117.953 0.876 . . . . 0.0 112.046 177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.7 130.02 34.95 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.371 0.668 . . . . 0.0 109.76 174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.52 151.21 20.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.103 0.961 . . . . 0.0 110.744 -172.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.38 159.67 22.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.871 2.381 . . . . 0.0 113.228 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -49.41 -41.68 40.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.631 1.572 . . . . 0.0 114.194 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 35.5 p -66.86 -50.87 61.13 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.134 0.492 . . . . 0.0 110.792 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -66.83 -32.36 73.59 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.701 -173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 204' ' ' CYS . 6.2 tp -73.51 -43.54 55.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.797 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -52.95 -47.25 68.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 118.448 0.567 . . . . 0.0 110.717 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -67.34 -44.42 79.12 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.798 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.71 -54.91 36.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.307 0.379 . . . . 0.0 110.583 -173.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 216' ' ' ILE . 3.5 pp -64.54 -32.26 73.83 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.03 0.831 . . . . 0.0 110.986 -175.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.08 -56.87 10.53 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.963 0.789 . . . . 0.0 110.56 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 35.4 t -66.69 -24.43 66.26 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.989 0.916 . . . . 0.0 111.246 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 25.5 m -77.97 -37.54 47.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.794 0.838 . . . . 0.0 111.051 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 46.2 tp -69.1 -25.36 64.38 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.884 0.874 . . . . 0.0 109.981 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.6 t -86.31 -68.26 0.75 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.452 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.12 116.88 32.7 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 173.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 123.219 0.607 . . . . 0.0 109.594 177.328 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 104.73 7.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.446 0.698 . . . . 0.0 110.102 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -70.77 85.55 0.66 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -83.97 70.43 10.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.901 0.88 . . . . 0.0 109.938 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 5.3 p -170.01 120.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.327 1.451 . . . . 0.0 108.056 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 13.4 t -89.78 147.76 23.63 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 212' ' ' PRO . 82.8 mttt -126.31 132.42 51.64 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.138 0.575 . . . . 0.0 109.6 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 216' ' ' ILE . 19.6 m -135.18 161.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.383 0.673 . . . . 0.0 109.796 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.5 146.49 31.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.689 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 211' ' ' ILE . 30.1 t -80.55 117.89 69.88 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.911 0.884 . . . . 0.0 109.597 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -59.71 -26.43 82.15 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.911 2.408 . . . . 0.0 112.735 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 223' ' ' CYS . 9.4 t -86.99 -57.83 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -103.96 -20.26 13.94 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -172.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 85.0 45.87 5.82 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 169.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 31.1 m -117.88 138.49 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.803 0.441 . . . . 0.0 110.742 176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -79.08 131.03 36.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 204' ' ' CYS . 0.5 OUTLIER -155.58 150.3 20.36 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 124.406 1.082 . . . . 0.0 110.008 -169.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.484 ' HA ' ' HG2' ' A' ' 201' ' ' LYS . 44.3 Cg_endo -64.67 161.38 35.96 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.446 2.097 . . . . 0.0 112.308 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.423 ' HA ' HG22 ' A' ' 216' ' ' ILE . 10.7 pt-20 -52.13 -38.76 58.52 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.036 1.335 . . . . 0.0 113.497 -172.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.5 p -65.61 -48.28 72.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.414 0.626 . . . . 0.0 110.603 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 17.0 t-160 -76.38 -24.79 54.13 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.047 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.478 HG13 HD23 ' A' ' 220' ' ' LEU . 5.3 tp -74.06 -46.51 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 118.822 0.737 . . . . 0.0 110.546 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -55.44 -44.97 76.83 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.285 0.564 . . . . 0.0 110.248 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -66.98 -42.85 84.4 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.699 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 215' ' ' HIS . 0.3 OUTLIER -68.83 -54.69 14.32 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.921 0.488 . . . . 0.0 109.738 -172.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.478 HD23 HG13 ' A' ' 216' ' ' ILE . 1.8 pp -62.03 -32.65 73.17 Favored 'General case' 0 C--N 1.351 0.632 0 O-C-N 124.2 0.937 . . . . 0.0 110.08 -175.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.44 -57.93 10.81 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.8 0.84 . . . . 0.0 111.096 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.4 t -67.8 -26.36 66.05 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.246 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 206' ' ' VAL . 57.9 m -80.74 -37.42 30.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.317 1.047 . . . . 0.0 111.344 -177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -76.74 -22.85 53.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 t -73.28 -57.15 4.22 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.087 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -130.63 156.4 44.95 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 . . . . . 0 C--O 1.249 1.041 0 C-N-CA 124.38 1.072 . . . . 0.0 109.348 -178.164 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.391 -0.283 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 36.4 t -67.08 -37.13 83.44 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.715 0.806 . . . . 0.0 110.33 176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -156.17 152.63 28.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 109.191 174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.54 105.35 16.76 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.5 0.32 . . . . 0.0 110.449 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.87 128.83 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.683 1.193 . . . . 0.0 108.384 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.7 t -97.87 141.17 31.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.814 0.446 . . . . 0.0 110.81 -174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' HE2' ' HD3' ' A' ' 212' ' ' PRO . 88.8 mttt -112.25 143.68 42.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 0.0 109.492 175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.572 HG23 HG12 ' A' ' 216' ' ' ILE . 17.2 m -143.5 170.35 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 122.661 0.385 . . . . 0.0 110.288 177.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.93 146.32 32.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.191 0.996 . . . . 0.0 111.005 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.424 ' CA ' HD11 ' A' ' 216' ' ' ILE . 14.5 t -85.21 100.04 1.07 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.714 0.806 . . . . 0.0 109.003 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -55.75 -18.08 20.07 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.224 2.616 . . . . 0.0 114.12 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.93 -56.95 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.133 0.573 . . . . 0.0 111.499 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 15.4 p -104.59 -34.16 8.28 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -172.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 97.73 53.82 1.27 Allowed Glycine 0 N--CA 1.47 0.96 0 N-CA-C 114.314 0.486 . . . . 0.0 114.314 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.32 143.37 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.332 0.653 . . . . 0.0 110.57 174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -95.88 122.23 38.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.373 0.669 . . . . 0.0 109.973 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 216' ' ' ILE . 0.4 OUTLIER -155.28 155.19 29.67 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.808 0.843 . . . . 0.0 110.92 -176.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.402 ' HD3' ' HE2' ' A' ' 201' ' ' LYS . 18.5 Cg_endo -58.4 159.13 20.46 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 123.479 2.786 . . . . 0.0 113.976 178.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -47.94 -36.01 11.68 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.273 1.829 . . . . 0.0 114.552 -169.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.6 p -73.18 -51.07 19.16 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.372 0.669 . . . . 0.0 111.251 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -71.89 -32.06 67.05 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.532 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.572 HG12 HG23 ' A' ' 202' ' ' VAL . 10.8 tp -78.07 -38.49 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.615 0.366 . . . . 0.0 111.14 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -61.17 -42.4 98.5 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.63 0.581 . . . . 0.0 109.468 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -65.15 -46.75 79.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.629 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -63.15 -45.36 92.25 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 119.554 -0.26 . . . . 0.0 110.885 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.94 -32.94 63.73 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.35 0.406 . . . . 0.0 110.677 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.26 -52.75 44.48 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.208 0.943 . . . . 0.0 109.96 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.8 t -60.47 -45.94 91.9 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.261 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.1 m -62.93 -32.85 74.24 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.84 0.856 . . . . 0.0 112.485 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.6 tt -73.74 -23.46 59.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.517 0.727 . . . . 0.0 110.121 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 22.9 t -111.05 -15.5 13.71 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.656 0.783 . . . . 0.0 111.644 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -130.92 -179.97 5.63 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.836 0.854 . . . . 0.0 109.886 -174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 123.797 0.839 . . . . 0.0 109.654 176.421 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.786 -0.126 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 47.6 m -95.66 116.4 28.81 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.06 79.66 1.72 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -86.74 106.45 17.67 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.39 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.412 HG23 ' HG2' ' A' ' 213' ' ' GLU . 6.8 p -161.63 123.3 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.8 1.24 . . . . 0.0 108.051 175.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 12.4 t -94.61 150.4 20.27 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.007 0.523 . . . . 0.0 109.881 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -122.73 140.92 52.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.541 0.736 . . . . 0.0 109.143 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.628 HG23 HG12 ' A' ' 216' ' ' ILE . 15.5 m -142.38 167.16 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.576 0.35 . . . . 0.0 110.337 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.71 145.37 34.55 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.565 1.146 . . . . 0.0 110.928 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' CYS . . . . . 0.425 ' CA ' HD11 ' A' ' 216' ' ' ILE . 8.8 t -82.82 106.95 7.86 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.1 -17.52 32.1 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.692 2.262 . . . . 0.0 113.22 -171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.4 t -86.91 -57.48 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.823 0.849 . . . . 0.0 112.224 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 10.8 p -115.41 -3.24 12.44 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -166.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 76.4 34.27 45.81 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 114.877 0.711 . . . . 0.0 114.877 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.27 136.28 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 117.046 0.423 . . . . 0.0 111.073 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -89.74 129.2 36.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.992 0.517 . . . . 0.0 109.761 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.547 HG13 HD13 ' A' ' 216' ' ' ILE . 0.1 OUTLIER -155.62 156.02 30.28 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.907 0.883 . . . . 0.0 110.045 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.45 157.62 17.99 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.402 2.735 . . . . 0.0 114.218 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.412 ' HG2' HG23 ' A' ' 199' ' ' VAL . 10.6 pt-20 -48.41 -37.71 17.73 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.238 1.815 . . . . 0.0 113.775 -171.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 36.9 p -67.2 -52.9 35.51 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.384 0.611 . . . . 0.0 111.309 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' HIS . . . . . 0.475 ' HD2' HG21 ' A' ' 211' ' ' ILE . 50.9 t60 -80.57 -22.44 40.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.57 -172.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 202' ' ' VAL . 10.1 tp -79.44 -43.19 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.569 0.347 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.24 -43.49 86.45 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.494 173.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -53.19 59.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.701 0.401 . . . . 0.0 110.553 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.1 -30.71 69.95 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.906 0.754 . . . . 0.0 110.699 -172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.23 -57.88 10.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.89 0.876 . . . . 0.0 110.589 174.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 30.6 t -68.19 -27.87 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.035 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' CYS . . . . . . . . . . . . . 30.5 m -75.38 -39.61 58.96 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.968 0.907 . . . . 0.0 111.045 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.79 -25.26 64.6 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.2 t -89.57 11.7 18.83 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.864 1.265 . . . . 0.0 111.382 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -139.08 -37.3 0.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.03 0.532 . . . . 0.0 111.35 -175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 123.193 0.597 . . . . 0.0 110.47 -174.749 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_